gene	disease
A2M	ALZHEIMER DISEASE 
A4GALT	BLOOD GROUP, P SYSTEM 
AAAS	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME 
AANAT	DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO 
AARS	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N 
AARS2	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE 
AARS2	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8 
AASS	HYPERLYSINEMIA 
AASS	SACCHAROPINURIA
ABAT	GABA-TRANSAMINASE DEFICIENCY 
ABCA1	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
ABCA1	HYPOALPHALIPOPROTEINEMIA, PRIMARY 
ABCA1	TANGIER DISEASE 
ABCA12	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 
ABCA12	ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE 
ABCA12	ICHTHYOSIS, LAMELLAR, 2 
ABCA3	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3 
ABCA4	CONE-ROD DYSTROPHY 3 
ABCA4	MACULAR DEGENERATION, AGE-RELATED, 2 
ABCA4	RETINITIS PIGMENTOSA 19 
ABCA4	STARGARDT DISEASE 1 
ABCB1	COLCHICINE RESISTANCE 
ABCB1	INFLAMMATORY BOWEL DISEASE 13 
ABCB11	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2 
ABCB11	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2 
ABCB4	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 
ABCB4	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3 
ABCB4	GALLBLADDER DISEASE 1 
ABCB7	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA 
ABCC11	APOCRINE GLAND SECRETION, VARIATION IN 
ABCC2	DUBIN-JOHNSON SYNDROME 
ABCC6	PSEUDOXANTHOMA ELASTICUM 
ABCC6	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE 
ABCC8	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
ABCC8	DIABETES MELLITUS, PERMANENT NEONATAL 
ABCC8	DIABETES MELLITUS, TRANSIENT NEONATAL, 2 
ABCC8	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1 
ABCC8	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3 
ABCC8	HYPOGLYCEMIA, LEUCINE-INDUCED 
ABCC9	ATRIAL FIBRILLATION, FAMILIAL, 12 
ABCC9	CARDIOMYOPATHY, DILATED, 1O 
ABCD1	ADRENOLEUKODYSTROPHY 
ABCG5	SITOSTEROLEMIA 
ABCG8	GALLBLADDER DISEASE 4 
ABCG8	SITOSTEROLEMIA 
ABHD12	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT 
ABHD5	CHANARIN-DORFMAN SYNDROME 
ABHD5	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 
ABL1	LEUKEMIA, CHRONIC MYELOID 
ABR	MEDULLOBLASTOMA 
AC021066.1	MONILETHRIX 
AC217778.1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6 
AC217779.2	FRONTOTEMPORAL DEMENTIA 
AC217779.2	PARKINSON DISEASE, LATE-ONSET 
AC217779.2	PARKINSON-DEMENTIA SYNDROME 
AC217779.2	PICK DISEASE OF BRAIN 
AC217779.2	SUPRANUCLEAR PALSY, PROGRESSIVE, 1 
ACAA1	D-BIFUNCTIONAL PROTEIN DEFICIENCY 
ACACA	ACETYL-CoACARBOXYLASEDEFICIENCY
ACAD8	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY 
ACAD9	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF 
ACAD9	MITOCHONDRIAL COMPLEX I DEFICIENCY 
ACADL	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF 
ACADM	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF 
ACADS	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF 
ACADSB	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY 
ACADVL	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF 
ACAN	OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS 
ACAN	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE 
ACAN	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE 
ACAT1	ALPHA-METHYLACETOACETIC ACIDURIA 
ACE	ALZHEIMER DISEASE 
ACE	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1 
ACE	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 
ACE	RENAL TUBULAR DYSGENESIS 
ACE	STROKE, ISCHEMIC 
ACHE	YT BLOOD GROUP ANTIGEN 
ACOX1	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY 
ACP5	SPONDYLOENCHONDRODYSPLASIA
ACP5	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION 
ACSF3	COMBINED MALONIC AND METHYLMALONIC ACIDURIA 
ACSL4	AMME COMPLEX 
ACSL4	MENTAL RETARDATION, X-LINKED 63 
ACTA1	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION 
ACTA1	NEMALINE MYOPATHY 3 
ACTA2	AORTIC ANEURYSM, FAMILIAL THORACIC 6 
ACTA2	MOYAMOYA DISEASE 5 
ACTA2	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME 
ACTB	DYSTONIA, JUVENILE-ONSET 
ACTC1	ATRIAL SEPTAL DEFECT 5 
ACTC1	CARDIOMYOPATHY, DILATED, 1R 
ACTC1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
ACTC1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11 
ACTG1	DEAFNESS, AUTOSOMAL DOMINANT 20 
ACTN2	CARDIOMYOPATHY, DILATED, 1AA 
ACTN4	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 
ACVR1	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA 
ACVR2B	HETEROTAXY, VISCERAL, 4, AUTOSOMAL 
ACVRL1	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2 
ACY1	AMINOACYLASE 1 DEFICIENCY 
ADA	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
ADAM17	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL 
ADAM33	ASTHMA, SUSCEPTIBILITY TO 
ADAM9	CONE-ROD DYSTROPHY 9 
ADAMTS10	WEILL-MARCHESANI SYNDROME 1 
ADAMTS13	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL 
ADAMTS17	WEILL-MARCHESANI-LIKE SYNDROME 
ADAMTS18	KNOBLOCH SYNDROME 2 
ADAMTS2	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE 
ADAMTSL2	GELEOPHYSIC DYSPLASIA 1 
ADAMTSL4	ECTOPIA LENTIS, ISOLATED, AUTOSOMAL RECESSIVE 
ADAR	DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1 
ADCK3	COENZYME Q10 DEFICIENCY 
ADCK3	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9 
ADCY10	HYPERCALCIURIA, ABSORPTIVE, 2 
ADD1	HYPERTENSION, ESSENTIAL 
ADH1B	ALCOHOL DEPENDENCE 
ADH1C	ALCOHOL DEPENDENCE 
ADH1C	PARKINSON DISEASE, LATE-ONSET 
ADIPOQ	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
ADIPOQ	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
ADK	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY 
ADRB1	RESTING HEART RATE, VARIATION IN 
ADRB2	ASTHMA, SUSCEPTIBILITY TO 
ADRB2	OBESITY 
ADRB3	OBESITY 
ADSL	ADENYLOSUCCINASE DEFICIENCY 
AFF2	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE 
AFG3L2	SPINOCEREBELLAR ATAXIA 28 
AGA	ASPARTYLGLUCOSAMINURIA 
AGGF1	KLIPPEL-TRENAUNAY-WEBERSYNDROME
AGL	GLYCOGEN STORAGE DISEASE III 
AGPAT2	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1 
AGPS	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3 
AGRN	MYASTHENIA, LIMB-GIRDLE, FAMILIAL 
AGRP	OBESITY 
AGT	HYPERTENSION, ESSENTIAL 
AGT	RENAL TUBULAR DYSGENESIS 
AGTR1	HYPERTENSION, ESSENTIAL 
AGTR1	RENAL TUBULAR DYSGENESIS 
AGTR2	MENTAL RETARDATION, X-LINKED 88 
AGXT	HYPEROXALURIA, PRIMARY, TYPE I 
AHCY	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY 
AHI1	JOUBERT SYNDROME 3 
AICDA	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2 
AIFM1	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6 
AIMP1	LEUKODYSTROPHY, HYPOMYELINATING, 3 
AIP	PITUITARY ADENOMA, ACTH-SECRETING 
AIP	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING 
AIP	PITUITARY ADENOMA, PROLACTIN-SECRETING 
AIPL1	LEBER CONGENITAL AMAUROSIS 4 
AIRE	AUTOIMMUNE DISEASE 
AIRE	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I 
AK1	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO 
AK2	RETICULAR DYSGENESIS 
AKAP10	CARDIAC CONDUCTION DEFECT 
AKAP10	LONGEVITY1
AKAP9	LONG QT SYNDROME 11 
AKR1C2	46,XY SEX REVERSAL 8 
AKR1C4	46,XY SEX REVERSAL 8 
AKR1D1	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2 
AKT1	BREAST CANCER 
AKT1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 
AKT1	COLORECTAL CANCER 
AKT1	OVARIAN CANCER 
AKT1	PROTEUS SYNDROME 
AKT1	SCHIZOPHRENIA 
AKT2	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
AKT2	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY 
AL731683.2	CELIAC DISEASE 
ALAD	PORPHYRIA, ACUTE HEPATIC 
ALAS2	ANEMIA, SIDEROBLASTIC, X-LINKED 
ALAS2	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED 
ALB	ZINC,ELEVATEDPLASMA
ALDH18A1	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA 
ALDH2	ALCOHOL SENSITIVITY, ACUTE 
ALDH3A2	SJOGREN-LARSSON SYNDROME 
ALDH4A1	HYPERPROLINEMIA, TYPE II 
ALDH5A1	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY 
ALDH6A1	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY 
ALDH7A1	EPILEPSY, PYRIDOXINE-DEPENDENT 
ALDOA	GLYCOGEN STORAGE DISEASE XII 
ALDOB	FRUCTOSE INTOLERANCE, HEREDITARY 
ALG1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik 
ALG10	LONG QT SYNDROME 2 
ALG10	SHORT QT SYNDROME 1 
ALG10B	LONG QT SYNDROME 2 
ALG11	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip 
ALG12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig 
ALG2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii 
ALG3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id 
ALG6	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic 
ALG8	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih 
ALG9	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il 
ALK	NEUROBLASTOMA, SUSCEPTIBILITY TO 
ALK	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3 
ALMS1	ALSTROM SYNDROME 
ALOX12B	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 
ALOX5	ASTHMA, SUSCEPTIBILITY TO 
ALOX5AP	STROKE, ISCHEMIC 
ALOXE3	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 
ALPL	HYPOPHOSPHATASIA, ADULT 
ALPL	HYPOPHOSPHATASIA, CHILDHOOD 
ALPL	HYPOPHOSPHATASIA, INFANTILE 
ALS2	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE 
ALS2	PRIMARY LATERAL SCLEROSIS, JUVENILE 
ALS2	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING 
ALX1	FRONTONASAL DYSPLASIA 3 
ALX3	FRONTONASAL DYSPLASIA 1 
ALX4	FRONTONASAL DYSPLASIA 2 
ALX4	PARIETAL FORAMINA 
ALX4	PARIETAL FORAMINA 2 
ALX4	POTOCKI-SHAFFER SYNDROME 
AMACR	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY 
AMACR	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4 
AMELX	AMELOGENESIS IMPERFECTA, TYPE IE 
AMH	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II 
AMHR2	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II 
AMMECR1	AMME COMPLEX 
AMN	MEGALOBLASTIC ANEMIA 1 
AMPD3	ERYTHROCYTE AMP DEAMINASE DEFICIENCY 
AMT	GLYCINE ENCEPHALOPATHY 
ANG	AMYOTROPHIC LATERAL SCLEROSIS 1 
ANG	AMYOTROPHIC LATERAL SCLEROSIS 9 
ANGPTL3	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2 
ANK1	SPHEROCYTOSIS, TYPE 1 
ANK2	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED 
ANKH	CHONDROCALCINOSIS 2 
ANKH	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT 
ANKRD1	TOTALANOMALOUSPULMONARYVENOUSRETURN1
ANKRD11	KBG SYNDROME 
ANKRD26	THROMBOCYTOPENIA 2 
ANO10	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10 
ANO5	GNATHODIAPHYSEAL DYSPLASIA 
ANO5	MIYOSHI MUSCULAR DYSTROPHY 3 
ANO5	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L 
ANO6	SCOTT SYNDROME 
ANTXR1	HEMANGIOMA, CAPILLARY INFANTILE 
ANTXR2	FIBROMATOSIS, JUVENILE HYALINE 
ANTXR2	HYALINOSIS, INFANTILE SYSTEMIC 
AP1S2	MENTAL RETARDATION, X-LINKED, SYNDROMIC, FRIED TYPE 
AP3B1	HERMANSKY-PUDLAK SYNDROME 1 
AP3B1	HERMANSKY-PUDLAK SYNDROME 2 
AP4B1	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 5 
AP4E1	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4 
AP4M1	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3 
AP4S1	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 6 
APBB2	ALZHEIMER DISEASE 
APC	COLORECTAL CANCER 
APC	DESMOID DISEASE, HEREDITARY 
APC	FAMILIAL ADENOMATOUS POLYPOSIS 1 
APC	GASTRIC CANCER 
APC	GASTRIC CANCER, HEREDITARY DIFFUSE 
APC	HEPATOCELLULAR CARCINOMA 
APC	MEDULLOBLASTOMA 
APC	MISMATCH REPAIR CANCER SYNDROME 
APCDD1	HYPOTRICHOSIS 1 
APOA1	AMYLOIDOSIS, FAMILIAL VISCERAL 
APOA1	HYPOALPHALIPOPROTEINEMIA, PRIMARY 
APOA1	MYELOMA, MULTIPLE 
APOA1	TANGIER DISEASE 
APOA2	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
APOA5	HYPERLIPOPROTEINEMIA, TYPE V 
APOA5	HYPERTRIGLYCERIDEMIA, FAMILIAL 
APOB	ABETALIPOPROTEINEMIA 
APOB	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B 
APOB	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2 
APOC2	APOLIPOPROTEIN C-II DEFICIENCY 
APOC3	HYPERALPHALIPOPROTEINEMIA 1 
APOC3	HYPERALPHALIPOPROTEINEMIA 2 
APOE	ALZHEIMER DISEASE 2 
APOE	LIPOPROTEIN GLOMERULOPATHY 
APOE	MACULAR DEGENERATION, AGE-RELATED, 1 
APOE	SEA-BLUE HISTIOCYTE DISEASE 
APOL1	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO 
APOL1	SCHIZOPHRENIA 
APOL2	SCHIZOPHRENIA 
APOL4	SCHIZOPHRENIA 
APP	ALZHEIMER DISEASE 
APP	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED 
APTX	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA 
APTX	COENZYME Q10 DEFICIENCY 
AQP1	BLOOD GROUP--COLTON 
AQP2	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL 
AQP3	GIL BLOOD GROUP 
AQP7	GLYCEROL QUANTITATIVE TRAIT LOCUS 
AR	ANDROGEN INSENSITIVITY SYNDROME 
AR	ANDROGEN INSENSITIVITY, PARTIAL 
AR	HYPOSPADIAS 1, X-LINKED 
AR	PROSTATE CANCER 
AR	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1 
ARFGEF2	HETEROTOPIA, PERIVENTRICULAR, AUTOSOMAL RECESSIVE 
ARFGEF2	HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT 
ARG1	ARGININEMIA 
ARHGAP26	JUVENILE MYELOMONOCYTIC LEUKEMIA 
ARHGAP31	ADAMS-OLIVER SYNDROME 1 
ARHGEF10	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT 
ARHGEF12	LEUKEMIA, ACUTE MYELOID 
ARHGEF6	MENTAL RETARDATION, X-LINKED 46 
ARHGEF9	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8 
ARID5B	LEUKEMIA,ACUTELYMPHOBLASTIC
ARL11	LEUKEMIA, CHRONIC LYMPHOCYTIC 
ARL13B	JOUBERT SYNDROME 8 
ARL6	BARDET-BIEDL SYNDROME 
ARL6	RETINITIS PIGMENTOSA 55 
ARMS2	MACULAR DEGENERATION, AGE-RELATED, 8 
ARSA	METACHROMATIC LEUKODYSTROPHY 
ARSA	MULTIPLE SULFATASE DEFICIENCY 
ARSB	MUCOPOLYSACCHARIDOSIS TYPE VI 
ARSB	MULTIPLE SULFATASE DEFICIENCY 
ARSE	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE 
ARX	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA 
ARX	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 
ARX	LISSENCEPHALY, X-LINKED, 2 
ARX	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED 
ARX	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME 
ASAH1	FARBER LIPOGRANULOMATOSIS 
ASCC1	BARRETT ESOPHAGUS 
ASCL1	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL 
ASIP	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9 
ASL	ARGININOSUCCINIC ACIDURIA 
ASPA	CANAVAN DISEASE 
ASPM	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE 
ASPN	INTERVERTEBRAL DISC DISEASE 
ASPN	OSTEOARTHRITIS SUSCEPTIBILITY 3 
ASPSCR1	ALVEOLAR SOFT PART SARCOMA 
ASS1	CITRULLINEMIA, CLASSIC 
ASXL1	BOHRING-OPITZ SYNDROME 
ASXL1	MYELODYSPLASTIC SYNDROME 
ATCAY	CEREBELLAR ATAXIA, CAYMAN TYPE 
ATF1	HISTIOCYTOMA, ANGIOMATOID FIBROUS 
ATG16L1	INFLAMMATORY BOWEL DISEASE 10 
ATIC	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY 
ATL1	NEUROPATHY, HEREDITARY SENSORY, TYPE ID 
ATL1	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT 
ATM	ATAXIA-TELANGIECTASIA 
ATM	BREAST CANCER 
ATN1	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY 
ATOH7	RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL 
ATP10A	ANGELMAN SYNDROME 
ATP13A2	KUFOR-RAKEB SYNDROME 
ATP1A2	ALTERNATING HEMIPLEGIA OF CHILDHOOD 
ATP1A2	MIGRAINE, FAMILIAL HEMIPLEGIC, 2 
ATP1A3	DYSTONIA 12 
ATP1B1	HYPERTENSION, ESSENTIAL 
ATP2A1	BRODY MYOPATHY 
ATP2A2	ACROKERATOSIS VERRUCIFORMIS 
ATP2A2	DARIER-WHITE DISEASE 
ATP2B2	DEAFNESS, AUTOSOMAL RECESSIVE 12 
ATP2C1	BENIGN CHRONIC PEMPHIGUS 
ATP5E	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3 
ATP6AP2	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE 
ATP6V0A2	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA 
ATP6V0A2	WRINKLY SKIN SYNDROME 
ATP6V0A4	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE 
ATP6V1B1	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS 
ATP7A	MENKES DISEASE 
ATP7A	OCCIPITAL HORN SYNDROME 
ATP7A	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3 
ATP7B	WILSON DISEASE 
ATP8B1	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1 
ATP8B1	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 
ATP8B1	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1 
ATPAF2	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1 
ATR	SECKEL SYNDROME 1 
ATRX	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME 
ATRX	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED 
ATRX	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1 
ATXN1	SPINOCEREBELLAR ATAXIA 1 
ATXN10	SPINOCEREBELLAR ATAXIA 10 
ATXN2	SPINOCEREBELLAR ATAXIA 2 
ATXN3	MACHADO-JOSEPH DISEASE 
ATXN7	SPINOCEREBELLAR ATAXIA 7 
AUH	3-@METHYLGLUTACONIC ACIDURIA, TYPE I 
AURKA	COLORECTAL CANCER 
AURKC	SPERMATOGENIC FAILURE 5 
AVP	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL 
AVPR2	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED 
AVPR2	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS 
AXIN1	CAUDAL DUPLICATION ANOMALY 
AXIN1	HEPATOCELLULAR CARCINOMA 
AXIN2	COLORECTAL CANCER 
AXIN2	OLIGODONTIA-COLORECTAL CANCER SYNDROME 
B2M	HYPOPROTEINEMIA, HYPERCATABOLIC 
B3GALNT1	BLOOD GROUP, P SYSTEM 
B3GALTL	PETERS-PLUS SYNDROME 
B3GAT3	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, 
B4GALT1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId 
B4GALT7	EHLERS-DANLOS SYNDROME, PROGEROID FORM 
B9D1	MECKEL SYNDROME, TYPE 9 
B9D2	MECKEL SYNDROME, TYPE 10 
BAAT	HYPERCHOLANEMIA, FAMILIAL 
BAG3	CARDIOMYOPATHY, DILATED, 1HH 
BAG3	MYOPATHY, MYOFIBRILLAR 6, MFM6 
BANF1	NESTOR-GUILLERMO PROGERIA SYNDROME 
BANK1	SYSTEMIC LUPUS ERYTHEMATOSUS 
BAP1	MESOTHELIOMA, MALIGNANT 
BAP1	TUMOR PREDISPOSITION SYNDROME 
BARD1	BREAST CANCER 
BAZ1B	WILLIAMS-BEUREN SYNDROME 
BBS1	BARDET-BIEDL SYNDROME 
BBS10	BARDET-BIEDL SYNDROME 
BBS12	BARDET-BIEDL SYNDROME 
BBS2	BARDET-BIEDL SYNDROME 
BBS4	BARDET-BIEDL SYNDROME 
BBS5	BARDET-BIEDL SYNDROME 
BBS7	BARDET-BIEDL SYNDROME 
BBS9	BARDET-BIEDL SYNDROME 
BBS9	WILMS TUMOR 5 
BCAM	BLOOD GROUP--LUTHERAN SYSTEM 
BCAM	LUTHERAN NULL 
BCKDHA	MAPLE SYRUP URINE DISEASE 
BCKDHB	MAPLE SYRUP URINE DISEASE 
BCL10	COLORECTAL CANCER 
BCL10	FOLLICULARLYMPHOMA,SUSCEPTIBILITYTO,1
BCL10	MESOTHELIOMA, MALIGNANT 
BCL10	TESTICULAR GERM CELL TUMOR 
BCL11A	FETALHEMOGLOBINQUANTITATIVETRAITLOCUS5
BCL2	FOLLICULARLYMPHOMA,SUSCEPTIBILITYTO,1
BCL6	FOLLICULARLYMPHOMA,SUSCEPTIBILITYTO,1
BCL7B	WILLIAMS-BEUREN SYNDROME 
BCMO1	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT 
BCOR	MICROPHTHALMIA, SYNDROMIC 2 
BCOR	MICROPHTHALMIA,SYNDROMIC1
BCR	LEUKEMIA, CHRONIC MYELOID 
BCR	LEUKEMIA,ACUTELYMPHOBLASTIC
BCS1L	BJORNSTAD SYNDROME 
BCS1L	GRACILE SYNDROME 
BCS1L	LEIGH SYNDROME 
BCS1L	MITOCHONDRIAL COMPLEX III DEFICIENCY 
BDNF	ANOREXIANERVOSA,SUSCEPTIBILITYTO,1
BDNF	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2 
BDNF	BULIMIANERVOSA,SUSCEPTIBILITYTO,1
BDNF	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL 
BDNF	OBSESSIVE-COMPULSIVE DISORDER 
BDNF	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION, 
BEAN1	SPINOCEREBELLAR ATAXIA 31 
BEST1	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE 
BEST1	MACULAR DYSTROPHY, VITELLIFORM 
BEST1	MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET 
BEST1	MACULARDYSTROPHY,CONCENTRICANNULAR
BEST1	RETINITIS PIGMENTOSA 50 
BEST1	VITREORETINOCHOROIDOPATHY 
BFSP1	CATARACT, CORTICAL, JUVENILE-ONSET 
BFSP2	CATARACT, AUTOSOMAL DOMINANT 
BFSP2	CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1 
BHLHE41	SHORT SLEEPER 
BIN1	MYOPATHY, CENTRONUCLEAR, 2 
BLK	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11 
BLM	BLOOM SYNDROME 
BLMH	ALZHEIMER DISEASE 
BLNK	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE 
BLOC1S3	HERMANSKY-PUDLAK SYNDROME 1 
BLOC1S3	HERMANSKY-PUDLAK SYNDROME 8 
BLVRA	HYPERBILIVERDINEMIA 
BMP15	OVARIAN DYSGENESIS 2 
BMP2	BRACHYDACTYLY, TYPE A2 
BMP2	HEMOCHROMATOSIS 
BMP4	MICROPHTHALMIA, SYNDROMIC 6 
BMP4	OROFACIAL CLEFT 11 
BMPER	DIAPHANOSPONDYLODYSOSTOSIS 
BMPR1A	CHROMOSOME 10q23 DELETION SYNDROME 
BMPR1A	COWDEN DISEASE 
BMPR1A	JUVENILE POLYPOSIS SYNDROME 
BMPR1A	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2 
BMPR1B	BRACHYDACTYLY, TYPE A2 
BMPR1B	BRACHYDACTYLY, TYPE C 
BMPR1B	CHONDRODYSPLASIA, ACROMESOMELIC, WITH GENITAL ANOMALIES 
BMPR2	PULMONARY HYPERTENSION, PRIMARY, 1 
BMPR2	PULMONARY VENOOCCLUSIVE DISEASE 
BOLA3	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 
BPGM	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY 
BRAF	CARDIOFACIOCUTANEOUS SYNDROME 
BRAF	COLORECTAL CANCER 
BRAF	LEOPARD SYNDROME 3 
BRAF	LUNG CANCER 
BRAF	LYMPHOMA, NON-HODGKIN, FAMILIAL 
BRAF	NOONAN SYNDROME 7 
BRCA1	BREAST CANCER 
BRCA1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 
BRCA1	OVARIAN CANCER 
BRCA1	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4 
BRCA2	BREAST CANCER 
BRCA2	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 
BRCA2	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
BRCA2	FANCONI ANEMIA, COMPLEMENTATION GROUP D1 
BRCA2	GLIOMA SUSCEPTIBILITY 1 
BRCA2	GLIOMA SUSCEPTIBILITY 3 
BRCA2	MEDULLOBLASTOMA 
BRCA2	PANCREATIC CANCER 
BRCA2	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2 
BRCA2	PROSTATE CANCER 
BRCA2	WILMS TUMOR 1 
BRCC3	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, 
BRIP1	BREAST CANCER 
BRIP1	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
BRIP1	FANCONI ANEMIA, COMPLEMENTATION GROUP J 
BRWD3	MENTAL RETARDATION, X-LINKED 93 
BSCL2	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2 
BSCL2	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V 
BSCL2	SPASTIC PARAPLEGIA 17 
BSG	BLOOD GROUP--OK 
BSND	BARTTER SYNDROME, TYPE 4A 
BTBD9	RESTLESSLEGSSYNDROME,SUSCEPTIBILITYTO,6
BTD	BIOTINIDASE DEFICIENCY 
BTK	AGAMMAGLOBULINEMIA, X-LINKED 
BTK	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III 
BTNL2	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 
BTNL2	SARCOIDOSIS, SUSCEPTIBILITY TO, 2 
BUB1B	COLORECTAL CANCER 
BUB1B	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1 
BUB1B	PREMATURE CHROMATID SEPARATION TRAIT 
C10orf2	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE) 
C10orf2	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE) 
C10orf2	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, 
C10orf2	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS 
C12orf65	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7 
C14orf133	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2 
C16orf57	POIKILODERMA WITH NEUTROPENIA 
C19orf12	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4 
C1GALT1C1	TN SYNDROME 
C1QA	C1q DEFICIENCY 
C1QB	C1q DEFICIENCY 
C1QC	C1q DEFICIENCY 
C1QTNF5	LATE-ONSET RETINAL DEGENERATION 
C1R	COMPLEMENTCOMPONENTC1r/C1sDEFICIENCY
C1S	COMPLEMENT COMPONENT C1s DEFICIENCY 
C2	COMPLEMENT COMPONENT 2 DEFICIENCY 
C2	MACULAR DEGENERATION, AGE-RELATED, 1 
C20orf54	BROWN-VIALETTO-VAN LAERE SYNDROME 
C20orf54	FAZIO-LONDE DISEASE 
C20orf7	MITOCHONDRIAL COMPLEX I DEFICIENCY 
C2orf71	RETINITIS PIGMENTOSA 
C2orf71	RETINITIS PIGMENTOSA 54 
C3	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE 
C3	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5 
C3	MACULAR DEGENERATION, AGE-RELATED, 9 
C4A	BLOOD GROUP, CHIDO/RODGERS SYSTEM 
C4A	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF 
C4A	COMPLEMENT COMPONENT 4A DEFICIENCY 
C4A	COMPLEMENT COMPONENT 4B DEFICIENCY 
C4A	SYSTEMIC LUPUS ERYTHEMATOSUS 
C4B	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF 
C4B	COMPLEMENT COMPONENT 4B DEFICIENCY 
C4B	SYSTEMIC LUPUS ERYTHEMATOSUS 
C5	COMPLEMENT COMPONENT 5 DEFICIENCY 
C6	COMPLEMENT COMPONENT 6 DEFICIENCY 
C6orf221	HYDATIDIFORM MOLE, RECURRENT, 2 
C7	COMPLEMENT COMPONENT 7 DEFICIENCY 
C7orf10	GLUTARIC ACIDURIA III 
C7orf11	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1 
C8A	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I 
C8B	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II 
C8orf38	LEIGH SYNDROME 
C8orf38	MITOCHONDRIAL COMPLEX I DEFICIENCY 
C9	COMPLEMENT COMPONENT 9 DEFICIENCY 
C9orf72	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 
CA12	HYPERCHLORHIDROSIS, ISOLATED 
CA2	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3 
CA4	RETINITIS PIGMENTOSA 17 
CA8	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 
CABP4	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B 
CACNA1A	ALTERNATING HEMIPLEGIA OF CHILDHOOD 
CACNA1A	EPISODIC ATAXIA, TYPE 2 
CACNA1A	MIGRAINE, FAMILIAL HEMIPLEGIC, 1 
CACNA1A	SPINOCEREBELLAR ATAXIA 6 
CACNA1C	BRUGADA SYNDROME 3 
CACNA1C	TIMOTHY SYNDROME 
CACNA1F	ALAND ISLAND EYE DISEASE 
CACNA1F	CONE-ROD DYSTROPHY, X-LINKED, 3 
CACNA1F	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A 
CACNA1H	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6 
CACNA1S	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 
CACNA1S	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5 
CACNA1S	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1 
CACNA2D4	RETINAL CONE DYSTROPHY 4 
CACNB2	BRUGADA SYNDROME 4 
CACNB4	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9 
CACNB4	EPILEPSY, MYOCLONIC JUVENILE 
CACNB4	EPILEPSY,IDIOPATHICGENERALIZED
CACNB4	EPISODIC ATAXIA, TYPE 5 
CACNG2	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10 
CALCR	OSTEOPOROSIS 
CALR3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19 
CAMKMT	HYPOTONIA-CYSTINURIA SYNDROME 
CANT1	DESBUQUOIS DYSPLASIA 
CAPN10	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1 
CAPN3	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A 
CARD9	CANDIDIASIS, FAMILIAL, 2 
CARTPT	OBESITY 
CASK	FG SYNDROME 4 
CASK	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA 
CASP10	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA 
CASP10	GASTRIC CANCER 
CASP10	GASTRIC CANCER, HEREDITARY DIFFUSE 
CASP10	LYMPHOMA, NON-HODGKIN, FAMILIAL 
CASP8	BREAST CANCER 
CASP8	CASPASE 8 DEFICIENCY 
CASP8	HEPATOCELLULAR CARCINOMA 
CASP8	LUNG CANCER 
CASQ2	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR 
CASQ2	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2 
CASR	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8 
CASR	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY 
CASR	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I 
CASR	HYPOPARATHYROIDISM, FAMILIAL ISOLATED 
CAT	ACATALASEMIA 
CATSPER1	SPERMATOGENIC FAILURE 7 
CATSPER2	DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY 
CAV1	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3 
CAV3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
CAV3	CREATINE PHOSPHOKINASE, ELEVATED SERUM 
CAV3	LONG QT SYNDROME 9 
CAV3	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C 
CAV3	MYOPATHY, DISTAL, TATEYAMA TYPE 
CAV3	RIPPLING MUSCLE DISEASE 
CAV3	SUDDEN INFANT DEATH SYNDROME 
CBFB	LEUKEMIA, ACUTE MYELOID 
CBL	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC 
CBS	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY 
CBX2	46,XY SEX REVERSAL 5 
CC2D1A	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3 
CC2D2A	COACH SYNDROME 
CC2D2A	JOUBERT SYNDROME 9 
CC2D2A	MECKEL SYNDROME, TYPE 6 
CCBE1	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 
CCDC28B	BARDET-BIEDL SYNDROME 
CCDC39	CILIARY DYSKINESIA, PRIMARY, 14 
CCDC40	CILIARY DYSKINESIA, PRIMARY, 15 
CCDC50	DEAFNESS, AUTOSOMAL DOMINANT 44 
CCDC6	THYROID CARCINOMA, PAPILLARY 
CCDC8	THREE M SYNDROME 3 
CCL11	ASTHMA, SUSCEPTIBILITY TO 
CCL11	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCL2	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCL2	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
CCL2	NEURAL TUBE DEFECTS 
CCL26	ESOPHAGITIS,EOSINOPHILIC,1
CCL3	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCL3L1	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCL3L3	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCM2	CEREBRAL CAVERNOUS MALFORMATIONS 2 
CCND1	COLORECTAL CANCER 
CCND1	LEUKEMIA, CHRONIC LYMPHOCYTIC 
CCND1	MYELOMA, MULTIPLE 
CCND1	VON HIPPEL-LINDAU SYNDROME 
CCR2	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCR5	DIABETES MELLITUS, INSULIN-DEPENDENT, 22 
CCR5	HEPATITIS C VIRUS, SUSCEPTIBILITY TO 
CCR5	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CCR5	WEST NILE VIRUS, SUSCEPTIBILITY TO 
CCT5	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL 
CD151	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS 
CD151	RAPH BLOOD GROUP SYSTEM 
CD19	IMMUNODEFICIENCY, COMMON VARIABLE, 3 
CD207	BIRBECK GRANULE DEFICIENCY 
CD209	DENGUE VIRUS, SUSCEPTIBILITY TO 
CD209	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CD209	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
CD244	RHEUMATOID ARTHRITIS 
CD247	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA 
CD2AP	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO 
CD320	METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT 
CD36	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7 
CD36	MALARIA, SUSCEPTIBILITY TO 
CD36	PLASMODIUMFALCIPARUMBLOODINFECTIONLEVEL
CD36	PLATELET GLYCOPROTEIN IV DEFICIENCY 
CD3D	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
CD3E	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
CD4	OKT4 EPITOPE DEFICIENCY 
CD40	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3 
CD40LG	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1 
CD44	INDIAN BLOOD GROUP SYSTEM 
CD46	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 
CD46	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2 
CD55	BLOOD GROUP, CROMER SYSTEM 
CD59	CD59 DEFICIENCY 
CD79A	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE 
CD79B	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE 
CD81	IMMUNODEFICIENCY, COMMON VARIABLE, 6 
CD82	PROSTATE CANCER 
CD8A	CD8 DEFICIENCY, FAMILIAL 
CD96	BOHRING-OPITZ SYNDROME 
CD96	C SYNDROME 
CDAN1	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I 
CDC6	MEIER-GORLIN SYNDROME 5 
CDC73	HYPERPARATHYROIDISM 1 
CDC73	HYPERPARATHYROIDISM 2 
CDC73	PARATHYROID CARCINOMA 
CDH1	BREAST CANCER 
CDH1	ENDOMETRIAL CANCER 
CDH1	GASTRIC CANCER, HEREDITARY DIFFUSE 
CDH1	OVARIAN CANCER 
CDH1	PROSTATE CANCER 
CDH15	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3 
CDH23	DEAFNESS, AUTOSOMAL RECESSIVE 12 
CDH23	USHER SYNDROME, TYPE I 
CDH23	USHER SYNDROME, TYPE ID 
CDH3	EEM SYNDROME 
CDH3	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY 
CDHR1	CONE-ROD DYSTROPHY 15 
CDK4	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3 
CDK5RAP2	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE 
CDK6	STATUREQUANTITATIVETRAITLOCUS11
CDKAL1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
CDKL5	ANGELMAN SYNDROME 
CDKL5	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 
CDKL5	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2 
CDKL5	RETT SYNDROME 
CDKN1B	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV 
CDKN1C	BECKWITH-WIEDEMANN SYNDROME 
CDKN2A	LI-FRAUMENI SYNDROME 1 
CDKN2A	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2 
CDKN2A	MELANOMA-ASTROCYTOMA SYNDROME 
CDKN2A	MELANOMA-PANCREATIC CANCER SYNDROME 
CDKN3	HEPATOCELLULAR CARCINOMA 
CDON	HOLOPROSENCEPHALY 11 
CDSN	HYPOTRICHOSIS 2 
CDSN	PEELING SKIN SYNDROME 
CDT1	MEIER-GORLIN SYNDROME 4 
CEBPA	LEUKEMIA, ACUTE MYELOID 
CEBPE	SPECIFIC GRANULE DEFICIENCY 
CECR1	CAT EYE SYNDROME 
CECR2	CAT EYE SYNDROME 
CEL	MATURITY-ONSET DIABETES OF THE YOUNG 
CEL	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION 
CENPJ	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE 
CENPJ	SECKEL SYNDROME 4 
CEP152	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE 
CEP152	SECKEL SYNDROME 5 
CEP290	BARDET-BIEDL SYNDROME 
CEP290	JOUBERT SYNDROME 5 
CEP290	LEBER CONGENITAL AMAUROSIS 10 
CEP290	MECKEL SYNDROME, TYPE 4 
CEP290	SENIOR-LOKEN SYNDROME 6 
CEP57	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2 
CERKL	RETINITIS PIGMENTOSA 26 
CETP	HYPERALPHALIPOPROTEINEMIA 1 
CETP	LONGEVITY1
CFB	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4 
CFB	MACULAR DEGENERATION, AGE-RELATED, 1 
CFC1	CONOTRUNCAL HEART MALFORMATIONS 
CFC1	HETEROTAXY, VISCERAL, 2, AUTOSOMAL 
CFC1	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2 
CFD	COMPLEMENT FACTOR D DEFICIENCY 
CFH	BASAL LAMINAR DRUSEN 
CFH	COMPLEMENT FACTOR H DEFICIENCY 
CFH	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 
CFH	MACULAR DEGENERATION, AGE-RELATED, 4 
CFHR1	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 
CFHR1	MACULAR DEGENERATION, AGE-RELATED, 1 
CFHR3	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 
CFHR3	MACULAR DEGENERATION, AGE-RELATED, 1 
CFI	COMPLEMENT FACTOR I DEFICIENCY 
CFI	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 
CFI	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3 
CFL2	NEMALINE MYOPATHY 7 
CFP	PROPERDIN DEFICIENCY, X-LINKED 
CFTR	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1 
CFTR	CYSTIC FIBROSIS 
CFTR	PANCREATITIS, HEREDITARY 
CFTR	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF 
CGNL1	AROMATASE EXCESS SYNDROME 
CHAT	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA 
CHD7	CHARGE SYNDROME 
CHD7	HYPOGONADOTROPIC HYPOGONADISM 
CHD7	KALLMANN SYNDROME 5 
CHD7	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3 
CHEK2	BREAST CANCER 
CHEK2	LI-FRAUMENI SYNDROME 2 
CHEK2	OSTEOGENIC SARCOMA 
CHEK2	PROSTATE CANCER 
CHI3L1	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7 
CHI3L1	SCHIZOPHRENIA 
CHIC2	LEUKEMIA, ACUTE MYELOID 
CHIT1	CHITOTRIOSIDASE DEFICIENCY 
CHKB	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE 
CHL1	CHROMOSOME 3pter-p25 DELETION SYNDROME 
CHM	CHOROIDEREMIA 
CHMP2B	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED 
CHMP4B	CATARACT, POSTERIOR POLAR, 3 
CHN1	DUANE RETRACTION SYNDROME 2 
CHRM2	ALCOHOL DEPENDENCE 
CHRM2	MAJOR DEPRESSIVE DISORDER 
CHRM3	ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND 
CHRNA1	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE 
CHRNA1	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL 
CHRNA1	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL 
CHRNA2	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4 
CHRNA3	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3 
CHRNA4	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1 
CHRNA4	TOBACCO ADDICTION, SUSCEPTIBILITY TO 
CHRNA5	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3 
CHRNA7	CHROMOSOME 15q13.3 DELETION SYNDROME 
CHRNB1	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR 
CHRNB1	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL 
CHRNB2	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 3 
CHRND	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE 
CHRND	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL 
CHRND	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL 
CHRNE	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR 
CHRNE	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL 
CHRNE	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL 
CHRNG	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT 
CHRNG	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE 
CHST14	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 
CHST3	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS 
CHST6	MACULAR DYSTROPHY, CORNEAL, 1 
CHSY1	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME 
CHUK	COCOON SYNDROME 
CIITA	BARE LYMPHOCYTE SYNDROME, TYPE II 
CIITA	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO 
CIITA	RHEUMATOID ARTHRITIS 
CILP	INTERVERTEBRAL DISC DISEASE 
CIRH1A	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS 
CISD2	WOLFRAM SYNDROME 2 
CISH	BACTEREMIA, SUSCEPTIBILITY TO, 2 
CISH	MALARIA, SUSCEPTIBILITY TO 
CISH	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
CITED2	ATRIAL SEPTAL DEFECT 8 
CITED2	TETRALOGY OF FALLOT 
CITED2	VENTRICULAR SEPTAL DEFECT 2 
CLCF1	COLD-INDUCED SWEATING SYNDROME 2 
CLCN1	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT 
CLCN1	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE 
CLCN2	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11 
CLCN2	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9 
CLCN2	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1 
CLCN2	EPILEPSY, MYOCLONIC JUVENILE 
CLCN5	DENT DISEASE 1 
CLCN5	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE 
CLCN5	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE 
CLCN5	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS 
CLCN7	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2 
CLCN7	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4 
CLCN7	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6 
CLCNKA	BARTTER SYNDROME, TYPE 4A 
CLCNKA	BARTTER SYNDROME, TYPE 4B 
CLCNKB	BARTTER SYNDROME, TYPE 3 
CLCNKB	BARTTER SYNDROME, TYPE 4A 
CLCNKB	BARTTER SYNDROME, TYPE 4B 
CLCNKB	GITELMAN SYNDROME 
CLDN1	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS 
CLDN14	DEAFNESS, AUTOSOMAL RECESSIVE 29 
CLDN16	HYPOMAGNESEMIA 3, RENAL 
CLDN16	HYPOMAGNESEMIA 4, RENAL 
CLDN19	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT 
CLEC7A	ASPERGILLOSIS, SUSCEPTIBILITY TO 
CLEC7A	CANDIDIASIS, FAMILIAL, 4 
CLINT1	SCHIZOPHRENIA1
CLIP2	WILLIAMS-BEUREN SYNDROME 
CLN3	CEROID LIPOFUSCINOSIS, NEURONAL, 3 
CLN5	CEROID LIPOFUSCINOSIS, NEURONAL, 5 
CLN6	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE 
CLN6	CEROID LIPOFUSCINOSIS, NEURONAL, 6 
CLN8	CEROID LIPOFUSCINOSIS, NEURONAL, 8 
CLN8	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT 
CLRN1	RETINITIS PIGMENTOSA 61 
CLRN1	USHER SYNDROME, TYPE III 
CNBP	MYOTONIC DYSTROPHY 2 
CNGA1	RETINITIS PIGMENTOSA 49 
CNGA3	ACHROMATOPSIA 2 
CNGB1	RETINITIS PIGMENTOSA 
CNGB1	RETINITIS PIGMENTOSA 45 
CNGB3	ACHROMATOPSIA 3 
CNGB3	STARGARDT DISEASE 1 
CNNM2	HYPOMAGNESEMIA 6, RENAL 
CNNM4	JALILI SYNDROME 
CNTN1	MYOPATHY, CONGENITAL, COMPTON-NORTH 
CNTN4	CHROMOSOME 3pter-p25 DELETION SYNDROME 
CNTNAP2	AUTISM, SUSCEPTIBILITY TO, 15 
CNTNAP2	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME 
COA5	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
COCH	DEAFNESS, AUTOSOMAL DOMINANT 9 
COG1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg 
COG4	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj 
COG5	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi 
COG7	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe 
COG8	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh 
COL10A1	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE 
COL11A1	FIBROCHONDROGENESIS 
COL11A1	INTERVERTEBRAL DISC DISEASE 
COL11A1	MARSHALL SYNDROME 
COL11A1	STICKLER SYNDROME, TYPE II 
COL11A2	DEAFNESS, AUTOSOMAL DOMINANT 13 
COL11A2	DEAFNESS, AUTOSOMAL RECESSIVE 53 
COL11A2	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA 
COL11A2	STICKLER SYNDROME, TYPE III 
COL11A2	WEISSENBACHER-ZWEYMULLER SYNDROME 
COL17A1	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE 
COL18A1	KNOBLOCH SYNDROME 1 
COL1A1	CAFFEY DISEASE 
COL1A1	DERMATOFIBROSARCOMA PROTUBERANS 
COL1A1	EHLERS-DANLOS SYNDROME, TYPE I 
COL1A1	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT 
COL1A1	OSTEOGENESIS IMPERFECTA, TYPE I 
COL1A1	OSTEOGENESIS IMPERFECTA, TYPE II 
COL1A1	OSTEOGENESIS IMPERFECTA, TYPE III 
COL1A1	OSTEOGENESIS IMPERFECTA, TYPE IV 
COL1A1	OSTEOPOROSIS 
COL1A2	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM 
COL1A2	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT 
COL1A2	OSTEOGENESIS IMPERFECTA, TYPE I 
COL1A2	OSTEOGENESIS IMPERFECTA, TYPE II 
COL1A2	OSTEOGENESIS IMPERFECTA, TYPE III 
COL1A2	OSTEOGENESIS IMPERFECTA, TYPE IV 
COL1A2	OSTEOPOROSIS 
COL2A1	ACHONDROGENESIS, TYPE II 
COL2A1	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY 
COL2A1	CZECH DYSPLASIA 
COL2A1	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS 
COL2A1	KNIEST DYSPLASIA 
COL2A1	LEGG-CALVE-PERTHES DISEASE 
COL2A1	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA 
COL2A1	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA 
COL2A1	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE 
COL2A1	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE 
COL2A1	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA 
COL2A1	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE 
COL2A1	SPONDYLOMETAPHYSEALDYSPLASIA,CORNERFRACTURETYPE
COL2A1	SPONDYLOPERIPHERAL DYSPLASIA 
COL2A1	STICKLER SYNDROME, TYPE I 
COL2A1	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR 
COL3A1	AORTICANEURYSM,FAMILIALABDOMINAL,1
COL3A1	EHLERS-DANLOS SYNDROME, TYPE III 
COL3A1	EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT 
COL4A1	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS 
COL4A1	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE 
COL4A1	PORENCEPHALY, FAMILIAL 
COL4A3	ALPORT SYNDROME, AUTOSOMAL DOMINANT 
COL4A3	ALPORT SYNDROME, AUTOSOMAL RECESSIVE 
COL4A3	HEMATURIA, BENIGN FAMILIAL 
COL4A4	ALPORT SYNDROME, AUTOSOMAL RECESSIVE 
COL4A4	HEMATURIA, BENIGN FAMILIAL 
COL4A5	ALPORT SYNDROME, X-LINKED 
COL4A5	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME 
COL4A6	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME 
COL5A1	EHLERS-DANLOS SYNDROME, TYPE I 
COL5A1	EHLERS-DANLOS SYNDROME, TYPE II 
COL5A2	EHLERS-DANLOS SYNDROME, TYPE I 
COL5A2	EHLERS-DANLOS SYNDROME, TYPE II 
COL6A1	BETHLEM MYOPATHY 
COL6A1	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE 
COL6A1	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 
COL6A2	BETHLEM MYOPATHY 
COL6A2	MYOSCLEROSIS, AUTOSOMAL RECESSIVE 
COL6A2	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 
COL6A3	BETHLEM MYOPATHY 
COL6A3	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 
COL7A1	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT 
COL7A1	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE 
COL7A1	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL 
COL7A1	EPIDERMOLYSIS BULLOSA PRURIGINOSA 
COL7A1	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND 
COL7A1	EPIDERMOLYSISBULLOSASIMPLEXSUPERFICIALIS
COL7A1	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8 
COL7A1	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN 
COL8A2	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1 
COL8A2	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1 
COL8A2	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2 
COL9A1	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6 
COL9A1	STICKLER SYNDROME, TYPE IV 
COL9A2	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2 
COL9A2	INTERVERTEBRAL DISC DISEASE 
COL9A2	STICKLER SYNDROME, TYPE V 
COL9A3	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3 
COL9A3	INTERVERTEBRAL DISC DISEASE 
COLEC11	3MC SYNDROME 2 
COLQ	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY 
COMP	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1 
COMP	PSEUDOACHONDROPLASIA 
COMT	ALCOHOL DEPENDENCE 
COMT	PANICDISORDER1
COMT	SCHIZOPHRENIA 
COQ2	COENZYME Q10 DEFICIENCY 
COQ9	COENZYME Q10 DEFICIENCY 
COX10	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE 
COX10	LEIGH SYNDROME 
COX10	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
COX15	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE 
COX15	LEIGH SYNDROME 
COX15	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
COX4I2	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL 
COX6B1	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
CP	ACERULOPLASMINEMIA 
CPA6	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5 
CPA6	FEBRILE SEIZURES, FAMILIAL, 11 
CPN1	CARBOXYPEPTIDASE N DEFICIENCY 
CPOX	COPROPORPHYRIA, HEREDITARY 
CPS1	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS 
CPS1	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO 
CPT1A	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY 
CPT2	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE 
CPT2	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET 
CPT2	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL 
CPT2	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, 4, SUSCEPTIBILITY TO 
CR1	KNOPS BLOOD GROUP SYSTEM 
CR1	MALARIA, SUSCEPTIBILITY TO 
CR2	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9 
CRB1	LEBER CONGENITAL AMAUROSIS 8 
CRB1	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY 
CRB1	RETINITIS PIGMENTOSA 
CRB1	RETINITIS PIGMENTOSA 12 
CRBN	CHROMOSOME 3pter-p25 DELETION SYNDROME 
CRBN	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2 
CREB1	HISTIOCYTOMA, ANGIOMATOID FIBROUS 
CREBBP	RUBINSTEIN-TAYBI SYNDROME 1 
CRELD1	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2 
CRH	ACTH DEFICIENCY, ISOLATED 
CRLF1	COLD-INDUCED SWEATING SYNDROME 1 
CRLF1	CRISPONI SYNDROME 
CRTAP	OSTEOGENESIS IMPERFECTA, TYPE VII 
CRX	CONE-ROD DYSTROPHY 2 
CRX	LEBER CONGENITAL AMAUROSIS 7 
CRX	RETINITIS PIGMENTOSA 
CRYAA	CATARACT, AUTOSOMAL DOMINANT 
CRYAB	CATARACT, POSTERIOR POLAR, 2 
CRYAB	MYOPATHY, MYOFIBRILLAR, 2, MFM2 
CRYAB	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED 
CRYBA1	CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES 
CRYBA4	CATARACT, LAMELLAR 2 
CRYBA4	MICROPHTHALMIA, ISOLATED, WITH CATARACT 4 
CRYBB1	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 3 
CRYBB1	CATARACT-MICROCORNEA SYNDROME 
CRYBB2	CATARACT, AUTOSOMAL DOMINANT 
CRYBB2	CATARACT, CONGENITAL, CERULEAN TYPE, 2 
CRYBB2	CATARACT, COPPOCK-LIKE 
CRYBB2	CATARACT, SUTURAL, WITH PUNCTATE AND CERULEAN OPACITIES 
CRYBB3	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 2 
CRYGC	CATARACT, AUTOSOMAL DOMINANT 
CRYGC	CATARACT, COPPOCK-LIKE 
CRYGD	CATARACT, AUTOSOMAL DOMINANT 
CRYGD	CATARACT, CONGENITAL, CERULEAN TYPE, 3 
CRYGD	CATARACT, COPPOCK-LIKE 
CRYGD	CATARACT, CRYSTALLINE ACULEIFORM 
CRYGD	CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL, AUTOSOMAL DOMINANT 
CRYGD	CATARACT,CRYSTALLINECORALLIFORM
CRYGS	CATARACT, CORTICAL, JUVENILE-ONSET 
CSF2RA	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4 
CSF2RB	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1 
CSF2RB	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5 
CSF3R	NEUTROPHILIA, HEREDITARY 
CSNK1D	ADVANCED SLEEP-PHASE SYNDROME, FAMILIAL 
CSRP3	CARDIOMYOPATHY, DILATED, 1M 
CSRP3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12 
CST3	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED 
CST3	MACULAR DEGENERATION, AGE-RELATED, 11 
CSTA	EXFOLIATIVE ICHTHYOSIS, AUTOSOMAL RECESSIVE, ICHTHYOSIS BULLOSA OF 
CSTB	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG 
CTDP1	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY 
CTH	CYSTATHIONINURIA 
CTHRC1	BARRETT ESOPHAGUS 
CTLA4	AUTOIMMUNE DISEASE 
CTLA4	CELIAC DISEASE, SUSCEPTIBILITY TO, 3 
CTLA4	DIABETES MELLITUS, INSULIN-DEPENDENT, 12 
CTLA4	GRAVESDISEASE
CTLA4	HASHIMOTOTHYROIDITIS
CTLA4	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
CTLA4	SYSTEMIC LUPUS ERYTHEMATOSUS 
CTNNB1	COLORECTAL CANCER 
CTNNB1	DESMOID DISEASE, HEREDITARY 
CTNNB1	HEPATOCELLULAR CARCINOMA 
CTNNB1	MEDULLOBLASTOMA 
CTNNB1	MESOTHELIOMA, MALIGNANT 
CTNNB1	OVARIAN CANCER 
CTNNB1	PILOMATRIXOMA 
CTNNB1	SALIVARY GLAND ADENOMA, PLEOMORPHIC 
CTNND2	CRI-DU-CHAT SYNDROME 
CTNS	CYSTINOSIS, ADULT NONNEPHROPATHIC 
CTNS	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE 
CTNS	CYSTINOSIS, NEPHROPATHIC 
CTRC	PANCREATITIS, HEREDITARY 
CTSA	GALACTOSIALIDOSIS 
CTSC	HAIM-MUNK SYNDROME 
CTSC	PAPILLON-LEFEVRE SYNDROME 
CTSC	PERIODONTITIS, AGGRESSIVE, 1 
CTSD	CEROID LIPOFUSCINOSIS, NEURONAL, 10 
CTSK	PYCNODYSOSTOSIS 
CTSZ	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
CUBN	MEGALOBLASTIC ANEMIA 1 
CUL4B	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND 
CUL7	THREE M SYNDROME 1 
CX3CR1	CORONARYHEARTDISEASE,SUSCEPTIBILITYTO,1
CX3CR1	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CX3CR1	MACULAR DEGENERATION, AGE-RELATED, 1 
CX3CR1	MACULAR DEGENERATION, AGE-RELATED, 12 
CXCL12	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CXCR1	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
CXCR4	WHIM SYNDROME 
CYB5A	METHEMOGLOBINEMIA TYPE IV 
CYB5R3	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE 
CYBA	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE 
CYBB	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2 
CYBB	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED 
CYCS	THROMBOCYTOPENIA 4 
CYFIP1	ANGELMAN SYNDROME 
CYLD	BROOKE-SPIEGLER SYNDROME 
CYLD	CYLINDROMATOSIS, FAMILIAL 
CYLD	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1 
CYP11A1	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL 
CYP11A1	LIPOID CONGENITAL ADRENAL HYPERPLASIA 
CYP11B1	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE 
CYP11B1	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM 
CYP11B2	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY 
CYP11B2	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY 
CYP11B2	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM 
CYP11B2	HYPERRENINEMICHYPOALDOSTERONISM,FAMILIAL,2
CYP17A1	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY 
CYP19A1	AROMATASE DEFICIENCY 
CYP19A1	AROMATASE EXCESS SYNDROME 
CYP1B1	GLAUCOMA 1, OPEN ANGLE, A 
CYP1B1	GLAUCOMA 3, PRIMARY CONGENITAL, A 
CYP1B1	GLAUCOMA, PRIMARY OPEN ANGLE 
CYP1B1	PETERS ANOMALY 
CYP21A2	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY 
CYP24A1	HYPERCALCEMIA, INFANTILE 
CYP27A1	CEREBROTENDINOUS XANTHOMATOSIS 
CYP27B1	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A 
CYP2A6	COUMARIN RESISTANCE 
CYP2A6	LUNG CANCER 
CYP2A6	TOBACCO ADDICTION, SUSCEPTIBILITY TO 
CYP2C19	DRUG METABOLISM, POOR, CYP2C19-RELATED 
CYP2C9	COUMARIN RESISTANCE 
CYP2D6	DRUG METABOLISM, POOR, CYP2D6-RELATED 
CYP2R1	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B 
CYP3A5	HYPERTENSION, ESSENTIAL 
CYP4F22	ICHTHYOSIS, LAMELLAR, 3 
CYP4V2	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY 
CYP7B1	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3 
CYP7B1	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE 
D2HGDH	D-2-@HYDROXYGLUTARIC ACIDURIA 1 
DAG1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7 
DAGLA	SPINOCEREBELLAR ATAXIA 20 
DAO	SCHIZOPHRENIA 
DAOA	SCHIZOPHRENIA 
DARC	BLOOD GROUP, DUFFY SYSTEM 
DARC	MALARIA, SUSCEPTIBILITY TO 
DARC	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1 
DARS2	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND 
DAZ1	SPERMATOGENIC FAILURE, Y-LINKED, 2 
DAZ2	SPERMATOGENIC FAILURE, Y-LINKED, 2 
DAZ4	SPERMATOGENIC FAILURE, Y-LINKED, 2 
DBH	DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL 
DBH	PARKINSON DISEASE, LATE-ONSET 
DBT	MAPLE SYRUP URINE DISEASE 
DCAF17	HYPOGONADISM, ALOPECIA, DIABETES MELLITUS, MENTAL RETARDATION, AND 
DCC	MIRROR MOVEMENTS, CONGENITAL 
DCDC2	DYSLEXIA,SUSCEPTIBILITYTO,2
DCLRE1B	HOYERAAL-HREIDARSSON SYNDROME 
DCLRE1C	OMENN SYNDROME 
DCLRE1C	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION 
DCN	CORNEAL DYSTROPHY, CONGENITAL STROMAL 
DCTN1	AMYOTROPHIC LATERAL SCLEROSIS 1 
DCTN1	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB 
DCTN1	PERRY SYNDROME 
DCX	LISSENCEPHALY, X-LINKED, 1 
DCXR	PENTOSURIA
DDB2	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E 
DDC	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY 
DDIT3	MYXOID LIPOSARCOMA 
DDR2	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE 
DDX11	WARSAW BREAKAGE SYNDROME 
DEC1	ESOPHAGEAL CANCER 
DEFB4A	INFLAMMATORY BOWEL DISEASE 1 
DEFB4B	INFLAMMATORY BOWEL DISEASE 1 
DES	CARDIOMYOPATHY, DILATED, 1I 
DES	MYOPATHY, MYOFIBRILLAR, 1 
DES	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE 
DFNA5	DEAFNESS, AUTOSOMAL DOMINANT 5 
DFNB31	DEAFNESS, AUTOSOMAL RECESSIVE 31 
DFNB31	USHER SYNDROME, TYPE IID 
DFNB59	DEAFNESS, AUTOSOMAL RECESSIVE 59 
DGUOK	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE) 
DHCR24	DESMOSTEROLOSIS 
DHCR7	SMITH-LEMLI-OPITZ SYNDROME 
DHDDS	RETINITIS PIGMENTOSA 59 
DHFR	MEGALOBLASTIC ANEMIA 1 
DHFR	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY 
DHH	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY 
DHH	46,XY SEX REVERSAL 7 
DHODH	POSTAXIAL ACROFACIAL DYSOSTOSIS 
DIABLO	DEAFNESS, AUTOSOMAL DOMINANT 64 
DIAPH1	DEAFNESS, AUTOSOMAL DOMINANT 1 
DIAPH2	PREMATURE OVARIAN FAILURE 2A 
DIAPH3	AUDITORYNEUROPATHY,AUTOSOMALDOMINANT,1
DICER1	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS 
DICER1	PLEUROPULMONARY BLASTOMA 
DIP2B	MENTAL RETARDATION, FRA12A TYPE 
DIRC1	RENAL CELL CARCINOMA, NONPAPILLARY 
DIRC2	RENAL CELL CARCINOMA, NONPAPILLARY 
DISC1	SCHIZOPHRENIA 
DISC1	SCHIZOPHRENIA 9 
DISP1	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR 
DKC1	DYSKERATOSIS CONGENITA, X-LINKED 
DKC1	HOYERAAL-HREIDARSSON SYNDROME 
DLAT	PYRUVATE DEHYDROGENASE E2 DEFICIENCY 
DLD	LEIGH SYNDROME 
DLD	MAPLE SYRUP URINE DISEASE 
DLEC1	ESOPHAGEAL CANCER 
DLEC1	LUNG CANCER 
DLG3	MENTAL RETARDATION, X-LINKED 90 
DLG5	INFLAMMATORY BOWEL DISEASE 1 
DLK1	UNIPARENTAL DISOMY, PATERNAL, CHROMOSOME 14 
DLL3	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE 
DLX3	AMELOGENESIS IMPERFECTA, TYPE IV 
DLX3	TRICHODENTOOSSEOUS SYNDROME 
DMBT1	GLIOMA SUSCEPTIBILITY 1 
DMBT1	MEDULLOBLASTOMA 
DMD	CARDIOMYOPATHY, DILATED, 3B 
DMD	MUSCULAR DYSTROPHY, BECKER TYPE 
DMD	MUSCULAR DYSTROPHY, DUCHENNE TYPE 
DMGDH	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY 
DMP1	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1 
DMPK	MYOTONIC DYSTROPHY 1 
DNAAF1	CILIARY DYSKINESIA, PRIMARY, 13 
DNAAF2	CILIARY DYSKINESIA, PRIMARY, 10 
DNAH11	CILIARY DYSKINESIA, PRIMARY, 1 
DNAH11	CILIARY DYSKINESIA, PRIMARY, 7 
DNAH5	CILIARY DYSKINESIA, PRIMARY, 1 
DNAH5	CILIARY DYSKINESIA, PRIMARY, 3 
DNAI1	CILIARY DYSKINESIA, PRIMARY, 1 
DNAI2	CILIARY DYSKINESIA, PRIMARY, 1 
DNAI2	CILIARY DYSKINESIA, PRIMARY, 9 
DNAJC19	3-@METHYLGLUTACONIC ACIDURIA, TYPE V 
DNAJC30	WILLIAMS-BEUREN SYNDROME 
DNAJC5	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT 
DNAL1	CILIARY DYSKINESIA, PRIMARY, 16 
DNASE1	SYSTEMIC LUPUS ERYTHEMATOSUS 
DNASE1L3	SYSTEMIC LUPUS ERYTHEMATOSUS 16 
DNM1L	ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL 
DNM2	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B 
DNM2	MYOPATHY, CENTRONUCLEAR, 1 
DNMT1	NEUROPATHY, HEREDITARY SENSORY, TYPE IE 
DNMT3B	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 
DOCK6	ADAMS-OLIVER SYNDROME 2 
DOCK8	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE 
DOCK8	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2 
DOK7	FETAL AKINESIA DEFORMATION SEQUENCE 
DOK7	MYASTHENIA, LIMB-GIRDLE, FAMILIAL 
DOLK	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im 
DPAGT1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij 
DPCR1	PANBRONCHIOLITIS,DIFFUSE
DPM1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie 
DPM3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io 
DPP10	ASTHMA, SUSCEPTIBILITY TO 
DPP6	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2 
DPY19L2	SPERMATOGENIC FAILURE 9 
DPYD	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 
DPYS	DIHYDROPYRIMIDINASE DEFICIENCY 
DRD2	ALCOHOL DEPENDENCE 
DRD2	MYOCLONIC DYSTONIA 
DRD3	SCHIZOPHRENIA 
DRD3	TREMOR, HEREDITARY ESSENTIAL, 1 
DRD4	ATTENTION DEFICIT-HYPERACTIVITY DISORDER 
DRD4	PARKINSON DISEASE, LATE-ONSET 
DRD5	ATTENTION DEFICIT-HYPERACTIVITY DISORDER 
DRD5	BLEPHAROSPASM, BENIGN ESSENTIAL 
DSC2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11 
DSC3	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES 
DSG1	KERATOSIS PALMOPLANTARIS STRIATA I 
DSG2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10 
DSG2	CARDIOMYOPATHY, DILATED, 1BB 
DSG4	HYPOTRICHOSIS 6 
DSP	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8 
DSP	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA 
DSP	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC 
DSP	KERATOSIS PALMOPLANTARIS STRIATA II 
DSP	SKIN FRAGILITY-WOOLLY HAIR SYNDROME 
DSPP	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1 
DSPP	DENTIN DYSPLASIA, TYPE II 
DSPP	DENTINOGENESIS IMPERFECTA 1 
DSPP	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III 
DTNA	LEFT VENTRICULAR NONCOMPACTION 1 
DTNBP1	HERMANSKY-PUDLAK SYNDROME 1 
DTNBP1	HERMANSKY-PUDLAK SYNDROME 7 
DTNBP1	SCHIZOPHRENIA 
DUOX2	THYROID DYSHORMONOGENESIS 6 
DUOXA2	THYROID DYSHORMONOGENESIS 5 
DYM	DYGGVE-MELCHIOR-CLAUSEN DISEASE 
DYM	SMITH-MCCORT DYSPLASIA 
DYNC1H1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O 
DYNC2H1	ASPHYXIATING THORACIC DYSTROPHY 3 
DYNC2H1	SHORT RIB-POLYDACTYLY SYNDROME, TYPE II 
DYNC2H1	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III 
DYRK1A	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7 
DYSF	MIYOSHI MUSCULAR DYSTROPHY 1 
DYSF	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B 
DYSF	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET 
DYX1C1-CCPG1	DYSLEXIA, SUSCEPTIBILITY TO, 1 
EBP	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT 
ECE1	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION 
ECE1	HYPERTENSION, ESSENTIAL 
ECM1	LIPOID PROTEINOSIS OF URBACH AND WIETHE 
EDA	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, X-LINKED 
EDA	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1 
EDAR	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT 
EDAR	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE 
EDAR	HAIR MORPHOLOGY 1 
EDARADD	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT 
EDARADD	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE 
EDN3	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL 
EDN3	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
EDN3	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4 
EDN3	WAARDENBURG SYNDROME, TYPE 4A 
EDN3	WAARDENBURG SYNDROME, TYPE 4B 
EDNRA	MIGRAINEWITHORWITHOUTAURA,SUSCEPTIBILITYTO,1
EDNRB	ABCD SYNDROME 
EDNRB	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
EDNRB	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2 
EDNRB	WAARDENBURG SYNDROME, TYPE 4A 
EFEMP1	DOYNE HONEYCOMB RETINAL DYSTROPHY 
EFEMP2	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA 
EFEMP2	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB 
EFHC1	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1 
EFHC1	EPILEPSY, MYOCLONIC JUVENILE 
EFNB1	CRANIOFRONTONASAL SYNDROME 
EGF	COLORECTAL CANCER 
EGF	HYPOMAGNESEMIA 4, RENAL 
EGFR	LUNG CANCER 
EGLN1	ERYTHROCYTOSIS, FAMILIAL, 3 
EGR2	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D 
EGR2	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS 
EGR2	NEUROPATHY, CONGENITAL HYPOMYELINATING 
EHBP1	PROSTATE CANCER, HEREDITARY, 12 
EHMT1	KLEEFSTRA SYNDROME 
EIF2AK3	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS 
EIF2B1	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 
EIF2B2	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 
EIF2B3	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 
EIF2B4	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 
EIF2B5	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 
EIF4G1	PARKINSON DISEASE 18 
EIF4H	WILLIAMS-BEUREN SYNDROME 
ELAC2	PROSTATE CANCER 
ELANE	CYCLIC NEUTROPENIA 
ELANE	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT 
ELMOD2	PULMONARY FIBROSIS, IDIOPATHIC 
ELN	CUTIS LAXA, AUTOSOMAL DOMINANT 1 
ELN	SUPRAVALVULAR AORTIC STENOSIS 
ELN	WILLIAMS-BEUREN SYNDROME 
ELOVL4	STARGARDT DISEASE 3 
EMD	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED 
EMG1	BOWEN-CONRADI SYNDROME 
EMX2	SCHIZENCEPHALY 
EN2	AUTISM,SUSCEPTIBILITYTO,10
ENAM	AMELOGENESIS IMPERFECTA, TYPE IB 
ENAM	AMELOGENESIS IMPERFECTA, TYPE IC 
ENG	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER 
ENO3	GLYCOGEN STORAGE DISEASE XIII 
ENPP1	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY 
ENPP1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
ENPP1	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2 
ENPP1	OBESITY 
ENPP1	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE 
EP300	COLORECTAL CANCER 
EP300	RUBINSTEIN-TAYBI SYNDROME 1 
EP300	RUBINSTEIN-TAYBI SYNDROME 2 
EPAS1	ERYTHROCYTOSIS, FAMILIAL, 4 
EPB41	ELLIPTOCYTOSIS 1 
EPB41	PYROPOIKILOCYTOSIS, HEREDITARY 
EPB41L1	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11 
EPB42	SPHEROCYTOSIS, TYPE 5 
EPCAM	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8 
EPCAM	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL 
EPHA2	CATARACT, AGE-RELATED CORTICAL, 2 
EPHA2	CATARACT, POSTERIOR POLAR, 1 
EPHA3	COLORECTAL CANCER 
EPHB2	PROSTATE CANCER 
EPHB2	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY 
EPHX1	HYPERCHOLANEMIA, FAMILIAL 
EPHX1	PREECLAMPSIA/ECLAMPSIA1
EPHX2	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
EPM2A	MYOCLONIC EPILEPSY OF LAFORA 
EPO	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2 
EPOR	ERYTHROCYTOSIS, FAMILIAL, 1 
EPX	PEROXIDASE AND PHOSPHOLIPID DEFICIENCY IN EOSINOPHILS 
ERBB2	GASTRIC CANCER 
ERBB2	GASTRIC CANCER, HEREDITARY DIFFUSE 
ERBB2	GLIOMA SUSCEPTIBILITY 1 
ERBB2	LUNG CANCER 
ERBB2	OVARIAN CANCER 
ERBB3	LETHAL CONGENITAL CONTRACTURE SYNDROME 2 
ERC1	THYROID CARCINOMA, PAPILLARY 
ERCC1	CEREBROOCULOFACIOSKELETAL SYNDROME 4 
ERCC2	CEREBROOCULOFACIOSKELETAL SYNDROME 2 
ERCC2	TRICHOTHIODYSTROPHY, PHOTOSENSITIVE 
ERCC2	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D 
ERCC2	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G 
ERCC3	TRICHOTHIODYSTROPHY, PHOTOSENSITIVE 
ERCC3	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B 
ERCC3	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G 
ERCC4	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F 
ERCC4	XFE PROGEROID SYNDROME 
ERCC5	CEREBROOCULOFACIOSKELETAL SYNDROME 1 
ERCC5	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G 
ERCC6	CEREBROOCULOFACIOSKELETAL SYNDROME 1 
ERCC6	COCKAYNE SYNDROME, TYPE B 
ERCC6	DE SANCTIS-CACCHIONE SYNDROME 
ERCC6	LUNG CANCER 
ERCC6	MACULAR DEGENERATION, AGE-RELATED, 5 
ERCC6	UV-SENSITIVE SYNDROME 
ERCC8	COCKAYNE SYNDROME, TYPE A 
ERCC8	UV-SENSITIVE SYNDROME 
ERG	EWING SARCOMA 
ERLIN2	SPASTICPARAPLEGIA18,AUTOSOMALRECESSIVE
ERMAP	BLOOD GROUP--SCIANNA SYSTEM 
ERMAP	RADIN BLOOD GROUP ANTIGEN 
ESCO2	ROBERTS SYNDROME 
ESCO2	SC PHOCOMELIA SYNDROME 
ESPN	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT 
ESR1	MIGRAINEWITHORWITHOUTAURA,SUSCEPTIBILITYTO,1
ESR1	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
ESRRB	DEAFNESS, AUTOSOMAL RECESSIVE 35 
ETFA	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY 
ETFB	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY 
ETFDH	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY 
ETHE1	ENCEPHALOPATHY, ETHYLMALONIC 
ETV1	EWING SARCOMA 
ETV4	EWING SARCOMA 
ETV6	LEUKEMIA, ACUTE MYELOID 
ETV6	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA 
EVC	ELLIS-VAN CREVELD SYNDROME 
EVC	WEYERS ACROFACIAL DYSOSTOSIS 
EVC2	ELLIS-VAN CREVELD SYNDROME 
EVC2	WEYERS ACROFACIAL DYSOSTOSIS 
EWSR1	EWING SARCOMA 
EWSR1	HISTIOCYTOMA, ANGIOMATOID FIBROUS 
EXT1	CHONDROSARCOMA 
EXT1	EXOSTOSES, MULTIPLE, TYPE I 
EXT1	TRICHORHINOPHALANGEAL SYNDROME, TYPE II 
EXT2	EXOSTOSES, MULTIPLE, TYPE II 
EXT2	POTOCKI-SHAFFER SYNDROME 
EYA1	BRANCHIOOTIC SYNDROME 1 
EYA1	BRANCHIOOTORENAL SYNDROME 1 
EYA1	OTOFACIOCERVICAL SYNDROME 
EYA4	CARDIOMYOPATHY, DILATED, 1J 
EYA4	DEAFNESS, AUTOSOMAL DOMINANT 10 
EYS	RETINITIS PIGMENTOSA 25 
EZH2	WEAVER SYNDROME 2 
F10	FACTOR X DEFICIENCY 
F11	FACTOR XI DEFICIENCY 
F12	ANGIOEDEMA, HEREDITARY, TYPE III 
F12	FACTOR XII DEFICIENCY 
F13A1	FACTOR XIII, A SUBUNIT, DEFICIENCY OF 
F13A1	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
F13A1	THROMBOSIS, SUSCEPTIBILITY TO 
F13B	FACTOR XIII, B SUBUNIT, DEFICIENCY OF 
F2	PROTHROMBIN DEFICIENCY, CONGENITAL 
F2	STROKE, ISCHEMIC 
F2	THROMBOSIS, SUSCEPTIBILITY TO 
F5	BUDD-CHIARI SYNDROME 
F5	FACTOR V DEFICIENCY 
F5	STROKE, ISCHEMIC 
F5	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE 
F7	FACTOR VII DEFICIENCY 
F7	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
F8	HEMOPHILIA A 
F9	COUMARIN RESISTANCE 
F9	HEMOPHILIA B 
F9	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT 
FA2H	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE 
FADD	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND 
FAH	TYROSINEMIA, TYPE I 
FAM123B	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS 
FAM126A	LEUKODYSTROPHY, HYPOMYELINATING, 5 
FAM134B	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB 
FAM161A	RETINITIS PIGMENTOSA 28 
FAM20A	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME 
FAM20C	RAINE SYNDROME 
FAM58A	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS 
FAM83H	AMELOGENESIS IMPERFECTA, TYPE III 
FANCA	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCB	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCB	FANCONI ANEMIA, COMPLEMENTATION GROUP B 
FANCB	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS 
FANCC	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCC	FANCONI ANEMIA, COMPLEMENTATION GROUP C 
FANCD2	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCD2	FANCONI ANEMIA, COMPLEMENTATION GROUP D2 
FANCE	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCE	FANCONI ANEMIA, COMPLEMENTATION GROUP E 
FANCF	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCF	FANCONI ANEMIA, COMPLEMENTATION GROUP F 
FANCG	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCG	FANCONI ANEMIA, COMPLEMENTATION GROUP G 
FANCI	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCI	FANCONI ANEMIA, COMPLEMENTATION GROUP I 
FANCI	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY 
FANCL	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCL	FANCONI ANEMIA, COMPLEMENTATION GROUP L 
FANCM	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
FANCM	FANCONI ANEMIA, COMPLEMENTATION GROUP M 
FAS	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 
FASLG	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 
FASLG	SYSTEMIC LUPUS ERYTHEMATOSUS 
FASTKD2	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
FBLN1	SYNPOLYDACTYLY 2 
FBLN5	CUTIS LAXA, AUTOSOMAL DOMINANT 1 
FBLN5	CUTIS LAXA, AUTOSOMAL DOMINANT 2 
FBLN5	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA 
FBLN5	MACULAR DEGENERATION, AGE-RELATED, 3 
FBN1	ACROMICRIC DYSPLASIA 
FBN1	ECTOPIA LENTIS, ISOLATED, AUTOSOMAL DOMINANT 
FBN1	GELEOPHYSIC DYSPLASIA 2 
FBN1	MARFAN SYNDROME 
FBN1	MASS SYNDROME 
FBN1	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME 
FBN1	STIFF SKIN SYNDROME 
FBN1	WEILL-MARCHESANI SYNDROME 2 
FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9 
FBP1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY 
FBXO33	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12 
FBXO7	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET 
FBXW4	SPLIT-HAND/FOOT MALFORMATION 3 
FCGR2B	MALARIA, SUSCEPTIBILITY TO 
FCGR2B	SYSTEMIC LUPUS ERYTHEMATOSUS 
FCGR3A	SYSTEMIC LUPUS ERYTHEMATOSUS 
FCGR3B	HASHIMOTOTHYROIDITIS
FCN3	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY 
FCRL3	RHEUMATOID ARTHRITIS 
FECH	PROTOPORPHYRIA, ERYTHROPOIETIC 
FERMT1	KINDLER SYNDROME 
FERMT3	LEUKOCYTE ADHESION DEFICIENCY, TYPE III 
FEV	SUDDEN INFANT DEATH SYNDROME 
FGA	AFIBRINOGENEMIA, CONGENITAL 
FGA	AMYLOIDOSIS, FAMILIAL VISCERAL 
FGB	AFIBRINOGENEMIA, CONGENITAL 
FGD1	AARSKOG-SCOTT SYNDROME 
FGD4	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H 
FGF10	APLASIA OF LACRIMAL AND SALIVARY GLANDS 
FGF10	LACRIMOAURICULODENTODIGITAL SYNDROME 
FGF14	SPINOCEREBELLAR ATAXIA 27 
FGF20	PARKINSON DISEASE, LATE-ONSET 
FGF23	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT 
FGF23	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL 
FGF3	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA 
FGF3	OTODENTAL DYSPLASIA 
FGF8	HYPOGONADOTROPIC HYPOGONADISM 
FGF8	KALLMANN SYNDROME 6 
FGF9	MULTIPLE SYNOSTOSES SYNDROME 3 
FGFR1	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS 
FGFR1	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME 
FGFR1	HYPOGONADOTROPIC HYPOGONADISM 
FGFR1	JACKSON-WEISS SYNDROME 
FGFR1	KALLMANN SYNDROME 2 
FGFR1	OSTEOGLOPHONIC DYSPLASIA 
FGFR1	PFEIFFER SYNDROME 
FGFR1	TRIGONOCEPHALY, NONSYNDROMIC 
FGFR2	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS 
FGFR2	APERT SYNDROME 
FGFR2	BEARE-STEVENSON CUTIS GYRATA SYNDROME 
FGFR2	CROUZON SYNDROME 
FGFR2	GASTRIC CANCER, HEREDITARY DIFFUSE 
FGFR2	JACKSON-WEISS SYNDROME 
FGFR2	LACRIMOAURICULODENTODIGITAL SYNDROME 
FGFR2	PFEIFFER SYNDROME 
FGFR2	SAETHRE-CHOTZEN SYNDROME 
FGFR2	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION 
FGFR3	ACHONDROPLASIA 
FGFR3	BEARE-STEVENSON CUTIS GYRATA SYNDROME 
FGFR3	BLADDER CANCER 
FGFR3	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME 
FGFR3	CERVICAL CANCER 
FGFR3	COLORECTAL CANCER 
FGFR3	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS 
FGFR3	HYPOCHONDROPLASIA 
FGFR3	KERATOSIS, SEBORRHEIC 
FGFR3	LACRIMOAURICULODENTODIGITAL SYNDROME 
FGFR3	MUENKE SYNDROME 
FGFR3	MYELOMA, MULTIPLE 
FGFR3	NEVUS, EPIDERMAL 
FGFR3	SAETHRE-CHOTZEN SYNDROME 
FGFR3	TESTICULAR GERM CELL TUMOR 
FGFR3	THANATOPHORIC DYSPLASIA, TYPE I 
FGFR3	THANATOPHORIC DYSPLASIA, TYPE II 
FGG	AFIBRINOGENEMIA, CONGENITAL 
FGGY	AMYOTROPHIC LATERAL SCLEROSIS 1 
FH	FUMARASE DEFICIENCY 
FH	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER 
FHIT	RENAL CELL CARCINOMA, NONPAPILLARY 
FHL1	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED 
FHL1	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET 
FHL1	MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE 
FHL1	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY 
FHL1	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT 
FIG4	AMYOTROPHIC LATERAL SCLEROSIS 11 
FIG4	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J 
FIG4	PRIMARYLATERALSCLEROSIS,ADULT,1
FIGLA	PREMATURE OVARIAN FAILURE 6 
FIP1L1	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC 
FKBP10	MACULAR DEGENERATION, AGE-RELATED, 4 
FKBP10	OSTEOGENESIS IMPERFECTA, TYPE XI 
FKBP5	MAJOR DEPRESSIVE DISORDER 
FKBP6	WILLIAMS-BEUREN SYNDROME 
FKRP	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE 
FKRP	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT 
FKRP	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5 
FKTN	CARDIOMYOPATHY, DILATED, 1X 
FKTN	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE 
FKTN	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), 
FKTN	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4 
FLCN	BIRT-HOGG-DUBE SYNDROME 
FLCN	COLORECTAL CANCER 
FLCN	PNEUMOTHORAX, PRIMARY SPONTANEOUS 
FLCN	RENAL CELL CARCINOMA, NONPAPILLARY 
FLG	DERMATITIS, ATOPIC, 2 
FLG	DERMATITIS,ATOPIC
FLG	ICHTHYOSIS VULGARIS 
FLI1	EWING SARCOMA 
FLI1	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE 
FLII	SMITH-MAGENIS SYNDROME 
FLNA	CARDIAC VALVULAR DYSPLASIA, X-LINKED 
FLNA	FG SYNDROME 2 
FLNA	FRONTOMETAPHYSEAL DYSPLASIA 
FLNA	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT 
FLNA	HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT 
FLNA	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED 
FLNA	MELNICK-NEEDLES SYNDROME 
FLNA	OTOPALATODIGITAL SYNDROME, TYPE I 
FLNA	OTOPALATODIGITAL SYNDROME, TYPE II 
FLNA	TERMINAL OSSEOUS DYSPLASIA 
FLNB	ATELOSTEOGENESIS, TYPE I 
FLNB	ATELOSTEOGENESIS, TYPE III 
FLNB	BOOMERANG DYSPLASIA 
FLNB	LARSEN SYNDROME 
FLNB	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME 
FLNC	MYOPATHY, DISTAL, 4 
FLNC	MYOPATHY, MYOFIBRILLAR, 5 
FLT3	LEUKEMIA, ACUTE MYELOID 
FLT4	HEMANGIOMA, CAPILLARY INFANTILE 
FLT4	LYMPHEDEMA, HEREDITARY, IA 
FLVCR1	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA 
FLVCR2.1	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME 
FMO3	TRIMETHYLAMINURIA 
FMR1	FRAGILE X MENTAL RETARDATION SYNDROME 
FMR1	FRAGILE X TREMOR/ATAXIA SYNDROME 
FMR1	PREMATURE OVARIAN FAILURE 1 
FN1	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2 
FN1	PLASMAFIBRONECTINDEFICIENCY
FOLR1	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY 
FOXC1	AXENFELD-RIEGER SYNDROME, TYPE 3 
FOXC1	IRIDOGONIODYSGENESIS, TYPE 1 
FOXC1	PETERS ANOMALY 
FOXC2	LYMPHEDEMA,HEREDITARY,II
FOXC2	LYMPHEDEMA-DISTICHIASIS SYNDROME 
FOXC2	YELLOWNAILSYNDROME
FOXD3	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1 
FOXE1	HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE 
FOXE3	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS 
FOXE3	APHAKIA, CONGENITAL PRIMARY 
FOXF1	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS 
FOXG1	RETT SYNDROME, CONGENITAL VARIANT 
FOXI1	ENLARGED VESTIBULAR AQUEDUCT 
FOXI1	PENDRED SYNDROME 
FOXJ1	ALLERGIC RHINITIS 
FOXL2	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS 
FOXL2	PREMATURE OVARIAN FAILURE 3 
FOXN1	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY 
FOXO1	RHABDOMYOSARCOMA 2 
FOXP1	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES 
FOXP2	SPEECH-LANGUAGE DISORDER 1 
FOXP3	DIABETESMELLITUS,INSULIN-DEPENDENT
FOXP3	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED 
FOXRED1	LEIGH SYNDROME 
FOXRED1	MITOCHONDRIAL COMPLEX I DEFICIENCY 
FRAS1	FRASER SYNDROME 
FREM1	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES 
FREM1	MANITOBA OCULOTRICHOANAL SYNDROME 
FREM2	FRASER SYNDROME 
FRMD7	NYSTAGMUS 1, CONGENITAL, X-LINKED 
FRZB	OSTEOARTHRITIS SUSCEPTIBILITY 1 
FSCN2	RETINITIS PIGMENTOSA 30 
FSHB	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED 
FSHR	OVARIAN DYSGENESIS 1 
FSHR	OVARIAN HYPERSTIMULATION SYNDROME 
FSHR	TWINNING,DIZYGOTIC
FST	POLYCYSTICOVARYSYNDROME1
FTCD	FORMIMINOTRANSFERASE DEFICIENCY 
FTL	HYPERFERRITINEMIA-CATARACT SYNDROME 
FTL	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3 
FTO	GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLY 
FTO	OBESITY 
FTSJ1	MENTAL RETARDATION, X-LINKED 9 
FUCA1	FUCOSIDOSIS 
FUS	AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 
FUS	HISTIOCYTOMA, ANGIOMATOID FIBROUS 
FUS	MYXOID LIPOSARCOMA 
FUT2	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1 
FUT6	FUCOSYLTRANSFERASE 6 DEFICIENCY 
FXN	FRIEDREICH ATAXIA 1 
FXYD2	HYPOMAGNESEMIA 2, RENAL 
FXYD6	SCHIZOPHRENIA 
FXYD6	SCHIZOPHRENIA2
FYCO1	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2 
FZD4	EXUDATIVE VITREORETINOPATHY 1 
FZD6	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10 
G6PC	GLYCOGEN STORAGE DISEASE Ia 
G6PC2	FASTINGPLASMAGLUCOSELEVELQUANTITATIVETRAITLOCUS1
G6PC3	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE 
GAA	GLYCOGEN STORAGE DISEASE II 
GABBR2	TOBACCO ADDICTION, SUSCEPTIBILITY TO 
GABRA1	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5 
GABRA1	EPILEPSY, MYOCLONIC JUVENILE 
GABRA2	ALCOHOL DEPENDENCE 
GABRB3	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5 
GABRD	CHROMOSOME 1p36 DELETION SYNDROME 
GABRD	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10 
GABRD	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 
GABRG2	DRAVET SYNDROME 
GABRG2	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 
GABRG2	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 
GABRG2	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3 
GAD1	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1 
GALC	KRABBE DISEASE 
GALE	GALACTOSE EPIMERASE DEFICIENCY 
GALK1	GALACTOKINASE DEFICIENCY 
GALNS	MUCOPOLYSACCHARIDOSIS TYPE IVA 
GALNT12	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1 
GALNT3	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL 
GALT	GALACTOSEMIA 
GAMT	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY 
GAN	GIANT AXONAL NEUROPATHY 1 
GARS	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D 
GARS	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V 
GATA1	ANEMIA, X-LINKED, WITHOUT THROMBOCYTOPENIA 
GATA1	DOWN SYNDROME 
GATA1	DYSERYTHROPOIETIC ANEMIA WITH THROMBOCYTOPENIA 
GATA1	THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCED 
GATA2	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE 
GATA2	LEUKEMIA, ACUTE MYELOID 
GATA2	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA 
GATA2	MYELODYSPLASTIC SYNDROME 
GATA3	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE 
GATA4	ATRIAL SEPTAL DEFECT 2 
GATA4	ATRIOVENTRICULAR SEPTAL DEFECT 4 
GATA4	VENTRICULAR SEPTAL DEFECT 1 
GATM	ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY 
GBA	GAUCHER DISEASE, PERINATAL LETHAL 
GBA	GAUCHER DISEASE, TYPE I 
GBA	GAUCHER DISEASE, TYPE II 
GBA	GAUCHER DISEASE, TYPE III 
GBA	GAUCHER DISEASE, TYPE IIIC 
GBA	PARKINSON DISEASE, LATE-ONSET 
GBE1	GLYCOGEN STORAGE DISEASE IV 
GBE1	POLYGLUCOSAN BODY DISEASE, ADULT FORM 
GC	GRAVESDISEASE
GCDH	GLUTARIC ACIDEMIA I 
GCGR	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
GCH1	DYSTONIA, DOPA-RESPONSIVE 
GCH1	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B 
GCK	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
GCK	DIABETES MELLITUS, PERMANENT NEONATAL 
GCK	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3 
GCK	MATURITY-ONSET DIABETES OF THE YOUNG 
GCK	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2 
GCKR	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5 
GCLC	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE 
GCLC	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
GCLM	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
GCM2	HYPOPARATHYROIDISM, FAMILIAL ISOLATED 
GCM2	HYPOPARATHYROIDISM,X-LINKED
GCNT2	BLOOD GROUP--I SYSTEM 
GCNT2	CATARACT,CONGENITALORJUVENILE
GCSH	GLYCINE ENCEPHALOPATHY 
GDAP1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K 
GDAP1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL 
GDAP1	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A 
GDAP1	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A 
GDF1	CONOTRUNCAL HEART MALFORMATIONS 
GDF1	TETRALOGY OF FALLOT 
GDF1	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3 
GDF3	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT 
GDF3	MICROPHTHALMIA, ISOLATED 7 
GDF3	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6 
GDF5	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE 
GDF5	BRACHYDACTYLY, TYPE A1 
GDF5	BRACHYDACTYLY, TYPE A2 
GDF5	BRACHYDACTYLY, TYPE C 
GDF5	CHONDRODYSPLASIA, GREBE TYPE 
GDF5	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY 
GDF5	MULTIPLE SYNOSTOSES SYNDROME 2 
GDF5	OSTEOARTHRITIS SUSCEPTIBILITY 5 
GDF5	SYMPHALANGISM, PROXIMAL 
GDF6	COLOBOMA, OCULAR 
GDF6	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT 
GDF6	MICROPHTHALMIA, ISOLATED 4 
GDF6	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6 
GDF6	SPONDYLOCOSTALDYSOSTOSIS5,AUTOSOMALDOMINANT
GDI1	MENTAL RETARDATION, X-LINKED 41 
GDI1	MENTALRETARDATION,X-LINKED3
GDNF	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL 
GDNF	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
GDNF	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3 
GDNF	PHEOCHROMOCYTOMA 
GFAP	ALEXANDER DISEASE 
GFER	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING 
GFI1	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS 
GFI1	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT 
GFI1	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT 
GFM1	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1 
GFPT1	MYASTHENIA, LIMB-GIRDLE, WITH TUBULAR AGGREGATES 
GGCX	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR 
GGCX	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 
GGT1	GAMMAGLUTAMYLTRANSFERASE,PLASMALEVELOF,QUANTITATIVETRAITLOCUS
GH1	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA 
GH1	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB 
GH1	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II 
GH1	KOWARSKI SYNDROME 
GH1	SHORT STATURE, IDIOPATHIC, AUTOSOMAL 
GHR	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
GHR	LARON SYNDROME 
GHR	SHORT STATURE, IDIOPATHIC, AUTOSOMAL 
GHRHR	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB 
GHRL	OBESITY 
GHSR	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB 
GHSR	SHORT STATURE, IDIOPATHIC, AUTOSOMAL 
GIF	INTRINSIC FACTOR DEFICIENCY 
GIGYF2	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT 
GIPC3	DEAFNESS, AUTOSOMAL RECESSIVE 15 
GJA1	ATRIOVENTRICULAR SEPTAL DEFECT 3 
GJA1	HALLERMANN-STREIFFSYNDROME
GJA1	HYPOPLASTIC LEFT HEART SYNDROME 1 
GJA1	OCULODENTODIGITAL DYSPLASIA 
GJA1	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE 
GJA1	SYNDACTYLY, TYPE III 
GJA3	CATARACT, AUTOSOMAL DOMINANT 
GJA3	CATARACT, ZONULAR PULVERULENT 3 
GJA5	ATRIAL FIBRILLATION, FAMILIAL, 11 
GJA5	ATRIAL STANDSTILL 
GJA5	ATRIALFIBRILLATION,FAMILIAL,1
GJA8	CATARACT, ZONULAR PULVERULENT 1 
GJA8	CATARACT-MICROCORNEA SYNDROME 
GJB1	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1 
GJB1	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS 
GJB2	DEAFNESS, AUTOSOMAL DOMINANT 3A 
GJB2	DEAFNESS, AUTOSOMAL RECESSIVE 1A 
GJB2	DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF 
GJB2	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS 
GJB2	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT 
GJB2	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS 
GJB2	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS 
GJB3	DEAFNESS, AUTOSOMAL DOMINANT 2A 
GJB3	DEAFNESS, AUTOSOMAL DOMINANT 2B 
GJB3	DEAFNESS, AUTOSOMAL RECESSIVE 1A 
GJB3	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 
GJB4	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 
GJB6	DEAFNESS, AUTOSOMAL DOMINANT 3A 
GJB6	DEAFNESS, AUTOSOMAL DOMINANT 3B 
GJB6	DEAFNESS, AUTOSOMAL RECESSIVE 1A 
GJB6	DEAFNESS, AUTOSOMAL RECESSIVE 1B 
GJB6	ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT 
GJC2	LEUKODYSTROPHY, HYPOMYELINATING, 2 
GJC2	LYMPHEDEMA, HEREDITARY, IC 
GJC2	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE 
GK	HYPERGLYCEROLEMIA 
GLA	FABRY DISEASE 
GLB1	GM1-GANGLIOSIDOSIS, TYPE I 
GLB1	GM1-GANGLIOSIDOSIS, TYPE II 
GLB1	GM1-GANGLIOSIDOSIS, TYPE III 
GLB1	MUCOPOLYSACCHARIDOSIS TYPE IVB 
GLCCI1	GLUCOCORTICOID THERAPY, RESPONSE TO 
GLDC	GLYCINE ENCEPHALOPATHY 
GLE1	LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE 
GLE1	LETHAL CONGENITAL CONTRACTURE SYNDROME 1 
GLI2	HOLOPROSENCEPHALY 9 
GLI3	ACROCALLOSAL SYNDROME 
GLI3	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME 
GLI3	PALLISTER-HALL SYNDROME 
GLI3	POLYDACTYLY, POSTAXIAL, TYPE A1 
GLI3	POLYDACTYLY, PREAXIAL IV 
GLIS2	NEPHRONOPHTHISIS 7 
GLIS3	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM 
GLMN	GLOMUVENOUS MALFORMATIONS 
GLO1	AUTISM
GLRA1	HYPEREKPLEXIA, HEREDITARY 
GLRB	HYPEREKPLEXIA, HEREDITARY 
GLRX5	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE 
GLUD1	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6 
GLUL	GLUTAMINE DEFICIENCY, CONGENITAL 
GLYCTK	D-GLYCERIC ACIDURIA 
GM2A	GM2-GANGLIOSIDOSIS, AB VARIANT 
GMPS	LEUKEMIA, ACUTE MYELOID 
GNAI2	VENTRICULAR TACHYCARDIA, FAMILIAL 
GNAS	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 
GNAS	COLORECTAL CANCER 
GNAS	MCCUNE-ALBRIGHT SYNDROME 
GNAS	OSSEOUS HETEROPLASIA, PROGRESSIVE 
GNAS	PITUITARY ADENOMA, ACTH-SECRETING 
GNAS	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING 
GNAS	PSEUDOHYPOPARATHYROIDISM, TYPE IA 
GNAS	PSEUDOHYPOPARATHYROIDISM, TYPE IB 
GNAS	PSEUDOHYPOPARATHYROIDISM, TYPE IC 
GNAS	PSEUDOPSEUDOHYPOPARATHYROIDISM 
GNAT1	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3 
GNAT2	ACHROMATOPSIA 4 
GNB3	HYPERTENSION, ESSENTIAL 
GNE	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE 
GNE	NONAKA MYOPATHY 
GNE	SIALURIA 
GNMT	GLYCINE N-METHYLTRANSFERASE DEFICIENCY 
GNPAT	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2 
GNPTAB	MUCOLIPIDOSIS II ALPHA/BETA 
GNPTAB	MUCOLIPIDOSIS III ALPHA/BETA 
GNPTG	MUCOLIPIDOSIS III GAMMA 
GNRHR	FERTILE EUNUCH SYNDROME 
GNRHR	HYPOGONADOTROPIC HYPOGONADISM 
GNS	MUCOPOLYSACCHARIDOSIS TYPE IIID 
GOLGA5	THYROID CARCINOMA, PAPILLARY 
GOPC	SPERMATOGENIC FAILURE 6 
GORAB	GERODERMA OSTEODYSPLASTICUM 
GOSR2	EPILEPSY, PROGRESSIVE MYOCLONIC 6 
GOT1	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 
GP1BA	BERNARD-SOULIER SYNDROME 
GP1BA	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT 
GP1BA	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO 
GP1BA	PSEUDO-VON WILLEBRAND DISEASE 
GP1BB	BERNARD-SOULIER SYNDROME 
GP6	BLEEDING DISORDER, PLATELET-TYPE, 11 
GP9	BERNARD-SOULIER SYNDROME 
GPC3	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 
GPC3	WILMS TUMOR 1 
GPC4	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 
GPC6	OMODYSPLASIA 1 
GPD1L	BRUGADA SYNDROME 2 
GPD1L	SUDDEN INFANT DEATH SYNDROME 
GPD2	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
GPHN	HYPEREKPLEXIA, HEREDITARY 
GPHN	MOLYBDENUM COFACTOR DEFICIENCY 
GPI	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE 
GPIHBP1	HYPERLIPOPROTEINEMIA, TYPE V 
GPR126	STATUREASAQUANTITATIVETRAIT
GPR143	ALBINISM, OCULAR, TYPE I 
GPR143	NYSTAGMUS 6, CONGENITAL, X-LINKED 
GPR56	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL 
GPR98	FEBRILE SEIZURES, FAMILIAL, 4 
GPR98	USHER SYNDROME, TYPE IIC 
GPSM2	DEAFNESS, AUTOSOMAL RECESSIVE 82 
GRHL2	DEAFNESS, AUTOSOMAL DOMINANT 28 
GRHPR	HYPEROXALURIA, PRIMARY, TYPE II 
GRIA3	MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE 
GRIK2	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6 
GRIN1	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8 
GRIN2A	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS 
GRIN2B	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6 
GRK1	OGUCHI DISEASE 1 
GRK1	OGUCHI DISEASE 2 
GRM6	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B 
GRN	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 
GRN	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED 
GRXCR1	DEAFNESS, AUTOSOMAL RECESSIVE 25 
GSN	AMYLOIDOSIS, FINNISH TYPE 
GSS	GLUTATHIONE SYNTHETASE DEFICIENCY 
GSS	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA 
GTF2H5	TRICHOTHIODYSTROPHY, PHOTOSENSITIVE 
GTF2I	WILLIAMS-BEUREN SYNDROME 
GTF2IRD1	WILLIAMS-BEUREN SYNDROME 
GTPBP3	DEAFNESS, AMINOGLYCOSIDE-INDUCED 
GUCA1A	CONE DYSTROPHY 3 
GUCA1B	RETINITIS PIGMENTOSA 48 
GUCY2D	CONE-ROD DYSTROPHY 5 
GUCY2D	CONE-ROD DYSTROPHY 6 
GUCY2D	LEBER CONGENITAL AMAUROSIS 1 
GUSB	MUCOPOLYSACCHARIDOSIS TYPE VII 
GYG1	GLYCOGEN STORAGE DISEASE XV 
GYPA	MALARIA, SUSCEPTIBILITY TO 
GYPC	MALARIA, SUSCEPTIBILITY TO 
GYS1	GLYCOGEN STORAGE DISEASE 0, MUSCLE 
GYS2	GLYCOGEN STORAGE DISEASE 0, LIVER 
H6PD	CORTISONE REDUCTASE DEFICIENCY 
HABP2	THROMBOSIS, SUSCEPTIBILITY TO 
HADH	3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY 
HADH	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4 
HADHA	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY 
HADHA	TRIFUNCTIONAL PROTEIN DEFICIENCY 
HADHB	TRIFUNCTIONAL PROTEIN DEFICIENCY 
HAL	HISTIDINEMIA 
HAMP	HEMOCHROMATOSIS, TYPE 2A 
HAMP	HEMOCHROMATOSIS, TYPE 2B 
HARS2	PERRAULT SYNDROME 
HAVCR1	IgE RESPONSIVENESS, ATOPIC 
HAX1	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE 
HBA1	ALPHA-THALASSEMIA 
HBA1	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED 
HBA1	HEINZ BODY ANEMIAS 
HBA1	HEMOGLOBIN H DISEASE 
HBA2	ALPHA-THALASSEMIA 
HBA2	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED 
HBA2	HEINZ BODY ANEMIAS 
HBA2	HEMOGLOBIN H DISEASE 
HBB	ALPHA-THALASSEMIA 
HBB	BETA THALASSEMIA, DOMINANT INCLUSION BODY TYPE 
HBB	BETA-THALASSEMIA 
HBB	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 
HBB	HEINZ BODY ANEMIAS 
HBB	SICKLE CELL ANEMIA 
HBD	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 
HBG1	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 
HBG2	CYANOSIS, TRANSIENT NEONATAL 
HBG2	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 
HCCS	MICROPHTHALMIA, SYNDROMIC 7 
HCN4	BRUGADA SYNDROME 8 
HCN4	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT 
HCRT	NARCOLEPSY 1 
HDAC4	BRACHYDACTYLY-MENTAL RETARDATION SYNDROME 
HDAC9	PETERS ANOMALY 
HEPACAM	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A 
HEPACAM	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, 
HERC2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1 
HES7	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE 
HESX1	PITUITARY HORMONE DEFICIENCY, COMBINED, 2 
HESX1	SEPTOOPTIC DYSPLASIA 
HEXA	TAY-SACHS DISEASE 
HEXB	SANDHOFF DISEASE 
HFE	ALZHEIMER DISEASE 
HFE	ATRANSFERRINEMIA 
HFE	HEMOCHROMATOSIS 
HFE	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7 
HFE	PORPHYRIA CUTANEA TARDA 
HFE	PORPHYRIA VARIEGATA 
HFE	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2 
HFE2	HEMOCHROMATOSIS, TYPE 2A 
HGD	ALKAPTONURIA 
HGF	DEAFNESS, AUTOSOMAL RECESSIVE 39 
HGSNAT	MUCOPOLYSACCHARIDOSIS TYPE IIIC 
HHIP	STATUREQUANTITATIVETRAITLOCUS13
HIBCH	BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY 
HIC1	MILLER-DIEKER LISSENCEPHALY SYNDROME 
HIP1	PROSTATE CANCER 
HK1	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY 
HK1	NEUROPATHY,HEREDITARYMOTORANDSENSORY,RUSSETYPE
HLA-A	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO 
HLA-A	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1 
HLA-B	BEHCETSYNDROME
HLA-B	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO 
HLA-B	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1 
HLA-C	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
HLA-C	PSORIASIS SUSCEPTIBILITY 1 
HLA-DQA1	CELIAC DISEASE 
HLA-DQB1	CELIAC DISEASE 
HLA-DQB1	CREUTZFELDT-JAKOB DISEASE 
HLA-DQB1	DIABETESMELLITUS,INSULIN-DEPENDENT
HLA-DQB1	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO 
HLA-DRA	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
HLA-DRB1	HEPATITIS C VIRUS, SUSCEPTIBILITY TO 
HLA-DRB1	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO 
HLA-DRB1	RHEUMATOID ARTHRITIS 
HLA-DRB1	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 
HLA-G	ASTHMA, SUSCEPTIBILITY TO 
HLCS	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY 
HMBS	PORPHYRIA, ACUTE INTERMITTENT 
HMCN1	MACULAR DEGENERATION, AGE-RELATED, 1 
HMGA1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
HMGA2	LEIOMYOMA, UTERINE 
HMGA2	LIPOMATOSIS,MULTIPLE
HMGA2	STATUREQUANTITATIVETRAITLOCUS9
HMGCL	3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY 
HMGCS2	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2 DEFICIENCY 
HMMR	BREAST CANCER 
HMOX1	HEME OXYGENASE 1 DEFICIENCY 
HMOX1	PULMONARYDISEASE,CHRONICOBSTRUCTIVE
HMX1	OCULOAURICULAR SYNDROME 
HNF1A	DIABETES MELLITUS, INSULIN-DEPENDENT, 20 
HNF1A	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
HNF1A	DIABETESMELLITUS,INSULIN-DEPENDENT
HNF1A	HEPATIC ADENOMAS, FAMILIAL 
HNF1A	MATURITY-ONSET DIABETES OF THE YOUNG 
HNF1A	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 
HNF1A	RENAL CELL CARCINOMA, NONPAPILLARY 
HNF1B	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
HNF1B	PROSTATE CANCER 
HNF1B	PROSTATECANCER,HEREDITARY,11
HNF1B	RENAL CELL CARCINOMA, NONPAPILLARY 
HNF1B	RENAL CYSTS AND DIABETES SYNDROME 
HNF4A	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
HNF4A	MATURITY-ONSET DIABETES OF THE YOUNG 
HNF4A	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1 
HNMT	ASTHMA, SUSCEPTIBILITY TO 
HOGA1	HYPEROXALURIA, PRIMARY, TYPE III 
HOXA1	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME 
HOXA11	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 
HOXA13	HAND-FOOT-UTERUS SYNDROME 
HOXA13	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS 
HOXA2	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE 
HOXA2	MICROTIA-ANOTIA
HOXD10	VERTICAL TALUS, CONGENITAL 
HOXD13	BRACHYDACTYLY, TYPE D 
HOXD13	BRACHYDACTYLY, TYPE E1 
HOXD13	BRACHYDACTYLY-SYNDACTYLY SYNDROME 
HOXD13	SYNDACTYLY, TYPE V 
HOXD13	SYNPOLYDACTYLY 1 
HOXD13	VATER ASSOCIATION 
HP	ANHAPTOGLOBINEMIA 
HPD	HAWKINSINURIA 
HPD	TYROSINEMIA, TYPE III 
HPGD	DIGITAL CLUBBING, ISOLATED CONGENITAL 
HPGD	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1 
HPRT1	GOUT, HPRT-RELATED 
HPRT1	LESCH-NYHAN SYNDROME 
HPS1	HERMANSKY-PUDLAK SYNDROME 1 
HPS3	HERMANSKY-PUDLAK SYNDROME 1 
HPS3	HERMANSKY-PUDLAK SYNDROME 3 
HPS4	HERMANSKY-PUDLAK SYNDROME 1 
HPS4	HERMANSKY-PUDLAK SYNDROME 4 
HPS5	HERMANSKY-PUDLAK SYNDROME 1 
HPS5	HERMANSKY-PUDLAK SYNDROME 5 
HPS6	HERMANSKY-PUDLAK SYNDROME 1 
HPS6	HERMANSKY-PUDLAK SYNDROME 6 
HPSE2	UROFACIAL SYNDROME 
HR	ALOPECIA UNIVERSALIS CONGENITA 
HR	ATRICHIA WITH PAPULAR LESIONS 
HR	HYPOTRICHOSIS 4 
HRAS	BLADDER CANCER 
HRAS	COSTELLO SYNDROME 
HRAS	THYROID CARCINOMA, HURTHLE CELL 
HRAS	THYROIDCARCINOMA,FOLLICULAR
HRG	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY 
HSD11B1	CORTISONE REDUCTASE DEFICIENCY 
HSD11B2	APPARENT MINERALOCORTICOID EXCESS 
HSD17B10	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY 
HSD17B10	MENTAL RETARDATION, X-LINKED 17 
HSD17B10	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10 
HSD17B3	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY 
HSD17B4	D-BIFUNCTIONAL PROTEIN DEFICIENCY 
HSD17B4	PERRAULT SYNDROME 
HSD3B2	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF 
HSD3B7	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1 
HSF4	CATARACT, LAMELLAR 
HSPB1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F 
HSPB1	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB 
HSPB3	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC 
HSPB8	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L 
HSPB8	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA 
HSPBAP1	RENAL CELL CARCINOMA, NONPAPILLARY 
HSPD1	LEUKODYSTROPHY, HYPOMYELINATING, 4 
HSPD1	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT 
HSPG2	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE 
HSPG2	SCHWARTZ-JAMPEL SYNDROME, TYPE 1 
HTR2A	ALCOHOL DEPENDENCE 
HTR2A	ANOREXIANERVOSA,SUSCEPTIBILITYTO,1
HTR2A	MAJOR DEPRESSIVE DISORDER 
HTR2A	OBSESSIVE-COMPULSIVE DISORDER 
HTR2A	SCHIZOPHRENIA 
HTRA1	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS 
HTRA1	MACULAR DEGENERATION, AGE-RELATED, 7 
HTRA2	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT 
HTRA2	PARKINSON DISEASE, LATE-ONSET 
HTT	HUNTINGTON DISEASE 
HUWE1	MENTAL RETARDATION, X-LINKED 17 
HUWE1	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10 
HUWE1	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE 
HYAL1	MUCOPOLYSACCHARIDOSIS TYPE IX 
HYLS1	HYDROLETHALUS SYNDROME 1 
ICAM1	MALARIA, SUSCEPTIBILITY TO 
ICAM1	PLASMODIUMFALCIPARUMBLOODINFECTIONLEVEL
ICAM4	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER 
ICK	ENDOCRINE-CEREBROOSTEODYSPLASIA 
ICOS	IMMUNODEFICIENCY, COMMON VARIABLE, 1 
IDH1	GLIOMA SUSCEPTIBILITY 1 
IDH2	D-2-@HYDROXYGLUTARIC ACIDURIA 2 
IDH3B	RETINITIS PIGMENTOSA 46 
IDS	MUCOPOLYSACCHARIDOSIS TYPE II 
IDUA	HURLER SYNDROME 
IDUA	HURLER-SCHEIE SYNDROME 
IDUA	SCHEIE SYNDROME 
IER3IP1	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 
IFIH1	DIABETESMELLITUS,INSULIN-DEPENDENT,19
IFIH1	GRAVESDISEASE
IFNAR2	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
IFNG	APLASTIC ANEMIA 
IFNG	HEPATITIS C VIRUS, SUSCEPTIBILITY TO 
IFNG	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
IFNG	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
IFNG	TUBEROUS SCLEROSIS 1 
IFNG	TUBEROUS SCLEROSIS 2 
IFNGR1	ATYPICAL MYCOBACTERIOSIS, FAMILIAL 
IFNGR1	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO 
IFNGR1	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
IFNGR1	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
IFNGR2	ATYPICAL MYCOBACTERIOSIS, FAMILIAL 
IFRD1	SPINOCEREBELLARATAXIA18
IFT122	CRANIOECTODERMAL DYSPLASIA 1 
IFT43	CRANIOECTODERMAL DYSPLASIA 1 
IFT43	CRANIOECTODERMAL DYSPLASIA 3 
IFT80	ASPHYXIATING THORACIC DYSTROPHY 2 
IFT80	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III 
IGBP1	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, 
IGF1	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY 
IGF1R	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO 
IGF2	BECKWITH-WIEDEMANN SYNDROME 
IGF2	HEMIHYPERPLASIA,ISOLATED
IGF2	SILVER-RUSSELL SYNDROME 
IGF2BP2	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
IGFBP7	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS 
IGHG1	MYELOMA, MULTIPLE 
IGHG2	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY 
IGHM	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE 
IGHMBP2	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1 
IGKC	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY 
IGKV1D-39	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY 
IGKV2D-40	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY 
IGLL1	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE 
IHH	ACROCAPITOFEMORAL DYSPLASIA 
IHH	BRACHYDACTYLY, TYPE A1 
IKBKAP	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III 
IKBKG	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1 
IKBKG	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, 
IKBKG	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY 
IKBKG	IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA 
IKBKG	INCONTINENTIA PIGMENTI 
IKBKG	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2 
IL10	BEHCETSYNDROME
IL10	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO 
IL10	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
IL10	RHEUMATOID ARTHRITIS 
IL10RA	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE 
IL10RB	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
IL10RB	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE 
IL11RA	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES 
IL12B	ASTHMA, SUSCEPTIBILITY TO 
IL12B	ATYPICAL MYCOBACTERIOSIS, FAMILIAL 
IL12B	PSORIASIS SUSCEPTIBILITY 1 
IL12B	PSORIASISSUSCEPTIBILITY11
IL12RB1	ATYPICAL MYCOBACTERIOSIS, FAMILIAL 
IL12RB2	BEHCETSYNDROME
IL13	ALLERGIC RHINITIS 
IL13	ASTHMA, SUSCEPTIBILITY TO 
IL17F	CANDIDIASIS, FAMILIAL, 6 
IL17RA	CANDIDIASIS, FAMILIAL, 5 
IL1B	GASTRIC CANCER, HEREDITARY DIFFUSE 
IL1RAPL1	MENTAL RETARDATION, X-LINKED 21 
IL1RN	GASTRIC CANCER, HEREDITARY DIFFUSE 
IL1RN	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4 
IL1RN	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS 
IL21R	IgE RESPONSIVENESS, ATOPIC 
IL23R	BEHCETSYNDROME
IL23R	INFLAMMATORY BOWEL DISEASE 1 
IL23R	INFLAMMATORY BOWEL DISEASE 17 
IL23R	PSORIASIS SUSCEPTIBILITY 1 
IL23R	PSORIASISSUSCEPTIBILITY7
IL28B	HEPATITIS C VIRUS, SUSCEPTIBILITY TO 
IL2RA	DIABETES MELLITUS, INSULIN-DEPENDENT, 10 
IL2RA	INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF 
IL2RG	COMBINED IMMUNODEFICIENCY, X-LINKED 
IL2RG	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED 
IL31RA	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2 
IL36RN	PUSTULAR PSORIASIS, GENERALIZED 
IL4	STROKE, ISCHEMIC 
IL4R	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
IL4R	IgE RESPONSIVENESS, ATOPIC 
IL6	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN 
IL6	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
IL6	INFLAMMATORY BOWEL DISEASE 1 
IL6	KAPOSI SARCOMA 
IL6	OSTEOPOROSIS 
IL6	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE 
IL7R	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO 
IL7R	MULTIPLESCLEROSIS,SUSCEPTIBILITYTO,3
IL7R	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
ILDR1	DEAFNESS, AUTOSOMAL RECESSIVE 42 
IMMP2L	GILLES DE LA TOURETTE SYNDROME 
IMPAD1	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE 
IMPDH1	LEBER CONGENITAL AMAUROSIS 11 
IMPDH1	RETINITIS PIGMENTOSA 10 
IMPG2	RETINITIS PIGMENTOSA 56 
INF2	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E 
INF2	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 
ING1	SQUAMOUS CELL CARCINOMA, HEAD AND NECK 
ING3	SQUAMOUS CELL CARCINOMA, HEAD AND NECK 
INPP5E	JOUBERT SYNDROME 
INPP5E	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS 
INPPL1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
INS	DIABETES MELLITUS, INSULIN-DEPENDENT, 2 
INS	DIABETES MELLITUS, PERMANENT NEONATAL 
INS	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1 
INS	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10 
INS-IGF2	DIABETES MELLITUS, INSULIN-DEPENDENT, 2 
INS-IGF2	DIABETES MELLITUS, PERMANENT NEONATAL 
INS-IGF2	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10 
INSL3	CRYPTORCHIDISM, UNILATERAL OR BILATERAL 
INSR	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS 
INSR	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
INSR	DONOHUE SYNDROME 
INSR	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5 
INSR	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC 
INVS	NEPHRONOPHTHISIS 2 
IQCB1	SENIOR-LOKEN SYNDROME 5 
IQSEC2	MENTAL RETARDATION, X-LINKED 1 
IRAK3	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5 
IRAK4	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1 
IRAK4	IRAK4 DEFICIENCY 
IRF1	CHROMOSOME 5q DELETION SYNDROME 
IRF1	GASTRIC CANCER 
IRF1	GASTRIC CANCER, HEREDITARY DIFFUSE 
IRF1	LUNG CANCER 
IRF4	MYELOMA, MULTIPLE 
IRF5	INFLAMMATORY BOWEL DISEASE 14 
IRF5	RHEUMATOID ARTHRITIS 
IRF5	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10 
IRF6	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO 
IRF6	POPLITEAL PTERYGIUM SYNDROME 
IRF6	VAN DER WOUDE SYNDROME 1 
IRGM	INFLAMMATORY BOWEL DISEASE 19 
IRGM	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
IRS1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
IRS2	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
ISCU	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY 
ITCH	AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM 
ITGA2	BLEEDINGDISORDER,PLATELET-TYPE,9
ITGA2B	GLANZMANN THROMBASTHENIA 
ITGA6	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA 
ITGA7	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY 
ITGAM	SYSTEMICLUPUSERYTHEMATOSUS,SUSCEPTIBILITYTO,6
ITGAX	SYSTEMIC LUPUS ERYTHEMATOSUS 
ITGB2	LEUKOCYTE ADHESION DEFICIENCY, TYPE I 
ITGB3	GLANZMANN THROMBASTHENIA 
ITGB3	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED 
ITGB3	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
ITGB4	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA 
ITGB4	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED 
ITGB4	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE 
ITIH4	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
ITK	LYMPHOPROLIFERATIVE SYNDROME, EBV-ASSOCIATED, AUTOSOMAL, 1 
ITM2B	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1 
ITM2B	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2 
ITPA	INOSINE TRIPHOSPHATASE DEFICIENCY 
ITPKC	KAWASAKI DISEASE 
ITPR1	SPINOCEREBELLAR ATAXIA 15 
ITPR3	DIABETESMELLITUS,INSULIN-DEPENDENT
IVD	ISOVALERIC ACIDEMIA 
IYD	THYROID DYSHORMONOGENESIS 4 
J01415.24	KEARNS-SAYRE SYNDROME 
JAG1	ALAGILLE SYNDROME 1 
JAG1	TETRALOGY OF FALLOT 
JAK2	BUDD-CHIARI SYNDROME 
JAK2	LEUKEMIA, ACUTE MYELOID 
JAK2	MYELOFIBROSIS 
JAK2	POLYCYTHEMIA VERA 
JAK2	THROMBOCYTHEMIA, ESSENTIAL 
JAK3	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
JAM3	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, 
JPH2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17 
JPH3	HUNTINGTON DISEASE-LIKE 2 
JUP	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12 
JUP	NAXOS DISEASE 
KAL1	KALLMANN SYNDROME 1 
KALRN	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5 
KANK1	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2 
KARS	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B 
KAT6B	OHDO SYNDROME, SBBYS VARIANT 
KBTBD13	NEMALINE MYOPATHY 6 
KCNA1	EPISODIC ATAXIA, TYPE 1 
KCNA5	ATRIAL FIBRILLATION, FAMILIAL, 7 
KCNC3	SPINOCEREBELLAR ATAXIA 13 
KCNE1	JERVELL AND LANGE-NIELSEN SYNDROME 1 
KCNE1	JERVELL AND LANGE-NIELSEN SYNDROME 2 
KCNE1	LONG QT SYNDROME 5 
KCNE1L	AMME COMPLEX 
KCNE2	ATRIAL FIBRILLATION, FAMILIAL, 3 
KCNE2	ATRIAL FIBRILLATION, FAMILIAL, 4 
KCNE2	LONG QT SYNDROME 6 
KCNE3	BRUGADA SYNDROME 6 
KCNE3	HYPERKALEMIC PERIODIC PARALYSIS 
KCNE3	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 
KCNH2	LONG QT SYNDROME 2 
KCNH2	SHORT QT SYNDROME 1 
KCNJ1	BARTTER SYNDROME, ANTENATAL, TYPE 2 
KCNJ10	ENLARGED VESTIBULAR AQUEDUCT 
KCNJ10	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND 
KCNJ11	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
KCNJ11	DIABETES MELLITUS, PERMANENT NEONATAL 
KCNJ11	DIABETES MELLITUS, TRANSIENT NEONATAL, 3 
KCNJ11	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2 
KCNJ12	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2 
KCNJ13	LEBER CONGENITAL AMAUROSIS 16 
KCNJ13	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE 
KCNJ2	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS 
KCNJ2	ATRIAL FIBRILLATION, FAMILIAL, 9 
KCNJ2	SHORT QT SYNDROME 3 
KCNJ5	HYPERALDOSTERONISM, FAMILIAL, TYPE III 
KCNJ5	LONG QT SYNDROME 13 
KCNJ8	SUDDEN INFANT DEATH SYNDROME 
KCNK18	MIGRAINE, WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13 
KCNK9	BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME 
KCNMA1	GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA 
KCNMB1	HYPERTENSION, DIASTOLIC, RESISTANCE TO 
KCNQ1	ATRIAL FIBRILLATION, FAMILIAL, 3 
KCNQ1	JERVELL AND LANGE-NIELSEN SYNDROME 1 
KCNQ1	LONG QT SYNDROME 1 
KCNQ1	SHORT QT SYNDROME 2 
KCNQ2	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7 
KCNQ2	SEIZURES, BENIGN FAMILIAL NEONATAL, 1 
KCNQ3	SEIZURES, BENIGN FAMILIAL NEONATAL, 2 
KCNQ4	DEAFNESS, AUTOSOMAL DOMINANT 2A 
KCNV2	RETINAL CONE DYSTROPHY 3B 
KCTD7	EPILEPSY, PROGRESSIVE MYOCLONIC 3 
KDM5C	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE 
KDM6A	KABUKI SYNDROME 2 
KDR	HEMANGIOMA, CAPILLARY INFANTILE 
KEL	BLOOD GROUP--KELL SYSTEM 
KERA	CORNEA PLANA 2 
KHK	FRUCTOSURIA, ESSENTIAL 
KIAA0196	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT 
KIAA0319	DYSLEXIA,SUSCEPTIBILITYTO,2
KIAA0415	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE 
KIAA1279	GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME 
KIF1A	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9 
KIF1A	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC 
KIF1A	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE 
KIF1B	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1 
KIF1B	NEUROBLASTOMA, SUSCEPTIBILITY TO 
KIF1B	PHEOCHROMOCYTOMA 
KIF21A	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1 
KIF22	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2 
KIF5A	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT 
KIF7	ACROCALLOSAL SYNDROME 
KIF7	BARDET-BIEDL SYNDROME 
KIF7	HYDROLETHALUS SYNDROME 2 
KIF7	JOUBERT SYNDROME 3 
KIF7	PALLISTER-HALL SYNDROME 
KIR3DL1	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
KIR3DS1	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 
KIRREL3	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4 
KISS1R	HYPOGONADOTROPIC HYPOGONADISM 
KISS1R	PRECOCIOUS PUBERTY, CENTRAL 
KIT	GASTROINTESTINAL STROMAL TUMOR 
KIT	LEUKEMIA, ACUTE MYELOID 
KIT	PIEBALD TRAIT 
KIT	TESTICULAR GERM CELL TUMOR 
KITLG	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2 
KITLG	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7 
KL	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL 
KLF1	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV 
KLF1	BLOOD GROUP--LUTHERAN INHIBITOR 
KLF1	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6 
KLF11	MATURITY-ONSET DIABETES OF THE YOUNG 
KLF11	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7 
KLF6	GASTRIC CANCER 
KLF6	GASTRIC CANCER, HEREDITARY DIFFUSE 
KLF6	PROSTATE CANCER 
KLHDC8B	LYMPHOMA, HODGKIN 
KLHL7	RETINITIS PIGMENTOSA 42 
KLK4	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1 
KLKB1	PREKALLIKREIN DEFICIENCY 
KNG1	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY 
KRAS	BLADDER CANCER 
KRAS	BREAST CANCER 
KRAS	CARDIOFACIOCUTANEOUS SYNDROME 
KRAS	COSTELLO SYNDROME 
KRAS	GASTRIC CANCER 
KRAS	GASTRIC CANCER, HEREDITARY DIFFUSE 
KRAS	JUVENILE MYELOMONOCYTIC LEUKEMIA 
KRAS	LEUKEMIA, ACUTE MYELOID 
KRAS	LUNG CANCER 
KRAS	NOONAN SYNDROME 3 
KRAS	PANCREATIC CANCER 
KRIT1	CEREBRAL CAVERNOUS MALFORMATIONS 
KRT1	EPIDERMOLYTIC HYPERKERATOSIS 
KRT1	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE 
KRT1	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS 
KRT1	KERATOSIS PALMOPLANTARIS STRIATA I 
KRT1	KERATOSIS PALMOPLANTARIS STRIATA III 
KRT1	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC 
KRT1	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC 
KRT10	EPIDERMOLYTIC HYPERKERATOSIS 
KRT10	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR 
KRT10	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS 
KRT12	CORNEAL DYSTROPHY, MEESMANN 
KRT13	WHITE SPONGE NEVUS 
KRT14	DERMATOPATHIA PIGMENTOSA RETICULARIS 
KRT14	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 
KRT14	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE 
KRT14	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED 
KRT14	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED 
KRT14	NAEGELI SYNDROME 
KRT16	PACHYONYCHIA CONGENITA, TYPE 1 
KRT16	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC 
KRT16	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC 
KRT16	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 
KRT17	PACHYONYCHIA CONGENITA, TYPE 2 
KRT17	STEATOCYSTOMA MULTIPLEX 
KRT18	CIRRHOSIS, FAMILIAL 
KRT2	ICHTHYOSIS, BULLOUS TYPE 
KRT3	CORNEAL DYSTROPHY, MEESMANN 
KRT4	WHITE SPONGE NEVUS 
KRT5	DOWLING-DEGOS DISEASE 
KRT5	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA 
KRT5	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION 
KRT5	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE 
KRT5	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED 
KRT5	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED 
KRT6A	PACHYONYCHIA CONGENITA, TYPE 1 
KRT6B	PACHYONYCHIA CONGENITA, TYPE 2 
KRT6C	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC 
KRT74	HYPOTRICHOSIS 3 
KRT74	WOOLLY HAIR, AUTOSOMAL DOMINANT 
KRT75	PSEUDOFOLLICULITIS BARBAE 
KRT8	CIRRHOSIS, FAMILIAL 
KRT81	MONILETHRIX 
KRT83	MONILETHRIX 
KRT85	ECTODERMAL DYSPLASIA, 'PURE' HAIR-NAIL TYPE 
KRT86	MONILETHRIX 
KRT9	KNUCKLE PADS 
KRT9	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC 
KYNU	HYDROXYKYNURENINURIA
L1CAM	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED 
L1CAM	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
L1CAM	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS 
L1CAM	MASA SYNDROME 
L2HGDH	L-2-HYDROXYGLUTARIC ACIDURIA 
LAMA2	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A 
LAMA3	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE 
LAMA3	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE 
LAMA3	LARYNGOONYCHOCUTANEOUS SYNDROME 
LAMB1	CUTISLAXA,NEONATAL,WITHMARFANOIDPHENOTYPE
LAMB2	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY 
LAMB2	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES 
LAMB2	PIERSON SYNDROME 
LAMB3	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE 
LAMB3	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE 
LAMC1	PELVICORGANPROLAPSE,SUSCEPTIBILITYTO
LAMC2	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE 
LAMC2	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE 
LAMC3	CORTICAL MALFORMATIONS, OCCIPITAL 
LAMP2	DANON DISEASE 
LAMTOR2	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN 
LARGE	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE 
LARGE	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), 
LAT2	WILLIAMS-BEUREN SYNDROME 
LBR	HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA 
LBR	PELGER-HUET ANOMALY 
LBR	REYNOLDS SYNDROME 
LCA5	LEBER CONGENITAL AMAUROSIS 5 
LCAT	FISH-EYE DISEASE 
LCAT	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY 
LCORL	STATUREQUANTITATIVETRAITLOCUS13
LCT	LACTASE DEFICIENCY, CONGENITAL 
LCT	LACTOSE INTOLERANCE, ADULT TYPE 
LDB3	CARDIOMYOPATHY, DILATED, 1C 
LDB3	MYOPATHY, MYOFIBRILLAR, 4 
LDB3	TIBIAL MUSCULAR DYSTROPHY, TARDIVE 
LDHA	GLYCOGEN STORAGE DISEASE XI 
LDHB	LACTATE DEHYDROGENASE B DEFICIENCY 
LDLR	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
LDLRAP1	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE 
LEMD3	BUSCHKE-OLLENDORFF SYNDROME 
LEMD3	MELORHEOSTOSIS,ISOLATED
LEP	OBESITY 
LEPRE1	OSTEOGENESIS IMPERFECTA, TYPE VIII 
LEPREL1	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION 
LFNG	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE 
LGALS2	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
LGI1	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 
LGI1	GLIOMA SUSCEPTIBILITY 1 
LGR4	SCHIZOPHRENIA 
LHCGR	LEYDIG CELL HYPOPLASIA, TYPE I 
LHCGR	PRECOCIOUS PUBERTY, MALE-LIMITED 
LHFPL5	DEAFNESS, AUTOSOMAL RECESSIVE 67 
LHX3	PITUITARY HORMONE DEFICIENCY, COMBINED, 2 
LHX3	PITUITARY HORMONE DEFICIENCY, COMBINED, 3 
LHX4	PITUITARY HORMONE DEFICIENCY, COMBINED, 4 
LIFR	STUVE-WIEDEMANN SYNDROME 
LIG4	LIG4 SYNDROME 
LIG4	MYELOMA, MULTIPLE 
LIG4	OMENN SYNDROME 
LIG4	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION 
LIMK1	WILLIAMS-BEUREN SYNDROME 
LIPA	LYSOSOMAL ACID LIPASE DEFICIENCY 
LIPC	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
LIPC	HEPATIC LIPASE DEFICIENCY 
LIPC	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 
LIPH	HYPOTRICHOSIS 7 
LIPI	HYPERTRIGLYCERIDEMIA, FAMILIAL 
LIPN	ICHTHYOSIS, LAMELLAR, 4 
LITAF	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C 
LMAN1	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1 
LMBR1	ACHEIROPODY 
LMBR1	POLYDACTYLY, PREAXIAL II 
LMBR1	SYNDACTYLY, TYPE IV 
LMBRD1	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE 
LMF1	LIPASE DEFICIENCY, COMBINED 
LMNA	CARDIOMYOPATHY, DILATED, 1A 
LMNA	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM 
LMNA	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1 
LMNA	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT 
LMNA	HEART-HAND SYNDROME, SLOVENIAN TYPE 
LMNA	HUTCHINSON-GILFORD PROGERIA SYNDROME 
LMNA	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2 
LMNA	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY 
LMNA	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED 
LMNA	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B 
LMNA	RESTRICTIVE DERMOPATHY, LETHAL 
LMNA	WERNER SYNDROME 
LMNB1	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT 
LMNB2	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO 
LMX1B	GLAUCOMA 1, OPEN ANGLE, A 
LMX1B	NAIL-PATELLA SYNDROME 
LOR	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 
LOR	VOHWINKEL SYNDROME, VARIANT FORM 
LOX	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA 
LOXHD1	DEAFNESS, AUTOSOMAL RECESSIVE 77 
LOXL1	EXFOLIATION SYNDROME 
LPAR6	HYPOTRICHOSIS 8 
LPIN1	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE 
LPIN2	MAJEED SYNDROME 
LPL	HYPERLIPIDEMIA, FAMILIAL COMBINED 
LPL	HYPERLIPOPROTEINEMIA, TYPE I 
LPL	HYPERLIPOPROTEINEMIA, TYPE V 
LPP	LEUKEMIA, ACUTE MYELOID 
LRAT	LEBER CONGENITAL AMAUROSIS 14 
LRP2	DONNAI-BARROW SYNDROME 
LRP4	CENANI-LENZ SYNDACTYLY SYNDROME 
LRP4	SCLEROSTEOSIS 2 
LRP5	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1 
LRP5	EXUDATIVE VITREORETINOPATHY 1 
LRP5	EXUDATIVE VITREORETINOPATHY 4 
LRP5	HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS 
LRP5	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1 
LRP5	OSTEOPOROSIS 
LRP5	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME 
LRP5	VAN BUCHEM DISEASE, TYPE 2 
LRP6	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2 
LRP8	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
LRPPRC	LEIGH SYNDROME, FRENCH CANADIAN TYPE 
LRRC8A	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT 
LRRK2	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT 
LRRK2	PARKINSON DISEASE, LATE-ONSET 
LRSAM1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P 
LRTOMT	DEAFNESS, AUTOSOMAL RECESSIVE 63 
LTA	LEPROSY, SUSCEPTIBILITY TO, 4 
LTA	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
LTA	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO 
LTBP2	GLAUCOMA 3, PRIMARY CONGENITAL, D 
LTBP2	MICROSPHEROPHAKIA 
LTBP3	TOOTH AGENESIS, SELECTIVE, 6 
LTBP4	CUTIS LAXA WITH SEVERE PULMONARY, GASTROINTESTINAL, AND URINARY ABNORMALITIES 
LTF	SPECIFIC GRANULE DEFICIENCY 
LYST	CHEDIAK-HIGASHI SYNDROME 
LYZ	AMYLOIDOSIS, FAMILIAL VISCERAL 
LZTS1	ESOPHAGEAL CANCER 
MACROD2	KABUKI SYNDROME 1 
MAD1L1	PROSTATE CANCER 
MAF	CATARACT, PULVERULENT, JUVENILE-ONSET 
MAGT1	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS 
MAGT1	MENTAL RETARDATION, X-LINKED 95 
MAK	RETINITIS PIGMENTOSA 62 
MAMLD1	HYPOSPADIAS 1, X-LINKED 
MAMLD1	HYPOSPADIAS 2, X-LINKED 
MAN1B1	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15 
MAN2B1	MANNOSIDOSIS, ALPHA B, LYSOSOMAL 
MANBA	MANNOSIDOSIS, BETA A, LYSOSOMAL 
MANF	PANCREATIC CANCER 
MAOA	BRUNNER SYNDROME 
MAP2K1	CARDIOFACIOCUTANEOUS SYNDROME 
MAP2K2	CARDIOFACIOCUTANEOUS SYNDROME 
MAP3K1	46,XY SEX REVERSAL 6 
MAP3K8	LUNG CANCER 
MAPK10	EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT TYPE 
MAPK8IP1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
MAPT	FRONTOTEMPORAL DEMENTIA 
MAPT	PARKINSON DISEASE, LATE-ONSET 
MAPT	PARKINSON-DEMENTIA SYNDROME 
MAPT	PICK DISEASE OF BRAIN 
MAPT	SUPRANUCLEAR PALSY, PROGRESSIVE, 1 
MARVELD2	DEAFNESS, AUTOSOMAL RECESSIVE 49 
MASP1	3MC SYNDROME 1 
MASP1	3MC SYNDROME 2 
MASP2	MASP2 DEFICIENCY 
MASTL	THROMBOCYTOPENIA 2 
MAT1A	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY 
MATN3	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5 
MATN3	OSTEOARTHRITIS SUSCEPTIBILITY 2 
MATN3	OSTEOARTHRITIS SUSCEPTIBILITY 3 
MATN3	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED 
MATR3	MYOPATHY, DISTAL, 2 
MAX	PHEOCHROMOCYTOMA 
MBD5	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1 
MBL2	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
MBL2	MANNOSE-BINDING PROTEIN DEFICIENCY 
MBNL1	MYOTONIC DYSTROPHY 1 
MBTPS2	ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA SYNDROME 
MBTPS2	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED 
MC1R	ALBINISM, OCULOCUTANEOUS, TYPE II 
MC1R	ENTEROPATHY,PROTEIN-LOSING
MC1R	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC 
MC1R	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5 
MC1R	MELANOMA,CUTANEOUSMALIGNANT,SUSCEPTIBILITYTO,1
MC1R	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 
MC2R	GLUCOCORTICOID DEFICIENCY 1 
MC3R	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9 
MC3R	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
MC3R	OBESITY 
MC4R	OBESITY 
MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY 
MCCC2	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY 
MCEE	METHYLMALONYL-CoA EPIMERASE DEFICIENCY 
MCF2L2	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
MCFD2	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1 
MCFD2	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2 
MCM6	LACTOSE INTOLERANCE, ADULT TYPE 
MCM6	STATUREASAQUANTITATIVETRAIT
MCOLN1	MUCOLIPIDOSIS IV 
MCPH1	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE 
MDM2	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO 
ME2	EPILEPSY,IDIOPATHICGENERALIZED
ME2	OPIOIDDEPENDENCE,SUSCEPTIBILITYTO,1
MECP2	ANGELMAN SYNDROME 
MECP2	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3 
MECP2	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS 
MECP2	LUBS X-LINKED MENTAL RETARDATION SYNDROME 
MECP2	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13 
MECP2	RETT SYNDROME 
MED12	LUJAN-FRYNS SYNDROME 
MED12	OPITZ-KAVEGGIA SYNDROME 
MED13L	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1 
MED17	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY 
MED23	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18 
MED25	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2 
MEF2A	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1 
MEF2C	MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRAL 
MEFV	FAMILIAL MEDITERRANEAN FEVER 
MEFV	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT 
MEGF10	MYOPATHY, EARLY-ONSET, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA 
MEIS1	RESTLESSLEGSSYNDROME,SUSCEPTIBILITYTO,7
MEN1	HYPERPARATHYROIDISM 1 
MEN1	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I 
MERTK	RETINITIS PIGMENTOSA 
MERTK	RETINITIS PIGMENTOSA 38 
MESP2	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE 
MET	AUTISM,SUSCEPTIBILITYTO,9
MET	COLORECTAL CANCER 
MET	HEPATOCELLULAR CARCINOMA 
MET	RENAL CELL CARCINOMA, PAPILLARY, 1 
MEX3C	HYPERTENSION,ESSENTIAL,SUSCEPTIBILITYTO,8
MFAP4	SMITH-MAGENIS SYNDROME 
MFN2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2 
MFN2	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI 
MFRP.1	MICROPHTHALMIA, ISOLATED 5 
MFRP.1	NANOPHTHALMOS 2 
MFSD8	CEROID LIPOFUSCINOSIS, NEURONAL, 7 
MGAT2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa 
MGP	KEUTEL SYNDROME 
MICA	PSORIASIS SUSCEPTIBILITY 1 
MICA	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO 
MICB	RHEUMATOID ARTHRITIS 
MID1	OPITZ GBBB SYNDROME, X-LINKED 
MIF	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE 
MINPP1	THYROIDCARCINOMA,FOLLICULAR
MIP	CATARACT, AUTOSOMAL DOMINANT 
MIPOL1	LAURIN-SANDROWSYNDROME
MITF	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS 
MITF	TIETZ SYNDROME 
MITF	WAARDENBURG SYNDROME, TYPE 2A 
MKKS	BARDET-BIEDL SYNDROME 
MKKS	MCKUSICK-KAUFMAN SYNDROME 
MKS1	BARDET-BIEDL SYNDROME 
MKS1	MECKEL SYNDROME, TYPE 1 
MLC1	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1 
MLF1	LEUKEMIA, ACUTE MYELOID 
MLH1	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2 
MLH1	ENDOMETRIAL CANCER 
MLH1	MISMATCH REPAIR CANCER SYNDROME 
MLH1	MUIR-TORRE SYNDROME 
MLH3	COLORECTAL CANCER 
MLH3	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7 
MLH3	ENDOMETRIAL CANCER 
MLL2	KABUKI SYNDROME 1 
MLLT10	LEUKEMIA, ACUTE MYELOID 
MLPH	GRISCELLI SYNDROME, TYPE 3 
MLXIPL	WILLIAMS-BEUREN SYNDROME 
MLYCD	MALONYL-CoA DECARBOXYLASE DEFICIENCY 
MMAA	METHYLMALONIC ACIDURIA, cblA TYPE 
MMAB	METHYLMALONIC ACIDURIA, cblB TYPE 
MMACHC	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE 
MMADHC	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE 
MMD2	MIYOSHIMUSCULARDYSTROPHY2
MMP1	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE 
MMP1	PULMONARYDISEASE,CHRONICOBSTRUCTIVE
MMP13	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE 
MMP2	TORG-WINCHESTER SYNDROME 
MMP20	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1 
MMP20	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2 
MMP9	INTERVERTEBRAL DISC DISEASE 
MMP9	METAPHYSEAL ANADYSPLASIA 2 
MN1	MENINGIOMA, FAMILIAL 
MNX1	CURRARINO SYNDROME 
MOCS1	MOLYBDENUM COFACTOR DEFICIENCY 
MOCS2	MOLYBDENUM COFACTOR DEFICIENCY 
MOG	NARCOLEPSY 7 
MOGS	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb 
MPDU1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If 
MPI	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib 
MPL	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL 
MPL	POLYCYTHEMIA VERA 
MPL	THROMBOCYTHEMIA, ESSENTIAL 
MPO	ALZHEIMER DISEASE 
MPO	MYELOPEROXIDASE DEFICIENCY 
MPST	MERCAPTOLACTATE-CYSTEINEDISULFIDURIA
MPV17	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE) 
MPV17	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE) 
MPZ	ADIE PUPIL 
MPZ	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I 
MPZ	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J 
MPZ	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B 
MPZ	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D 
MPZ	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS 
MPZ	NEUROPATHY, CONGENITAL HYPOMYELINATING 
MPZ	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA 
MRAP	GLUCOCORTICOID DEFICIENCY 2 
MRE11A	ATAXIA-TELANGIECTASIA-LIKE DISORDER 
MRPS16	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2 
MRPS22	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5 
MS4A1	IMMUNODEFICIENCY, COMMON VARIABLE, 5 
MS4A2	IgE RESPONSIVENESS, ATOPIC 
MSH2	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8 
MSH2	ENDOMETRIAL CANCER 
MSH2	GLIOMA SUSCEPTIBILITY 1 
MSH2	LYNCH SYNDROME I 
MSH2	MISMATCH REPAIR CANCER SYNDROME 
MSH2	MUIR-TORRE SYNDROME 
MSH2	NEUROFIBROMATOSIS, TYPE I 
MSH3	ENDOMETRIAL CANCER 
MSH6	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 
MSH6	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5 
MSH6	ENDOMETRIAL CANCER 
MSH6	MISMATCH REPAIR CANCER SYNDROME 
MSMB	PROSTATE CANCER, HEREDITARY, 13 
MSR1	BARRETT ESOPHAGUS 
MSR1	PROSTATE CANCER 
MSRB3	DEAFNESS, AUTOSOMAL RECESSIVE 74 
MSTN	MUSCLE HYPERTROPHY 
MSX1	OROFACIAL CLEFT 5 
MSX1	TOOTH AGENESIS, SELECTIVE, 1 
MSX1	WITKOP SYNDROME 
MSX2	CRANIOSYNOSTOSIS, TYPE 2 
MSX2	PARIETAL FORAMINA 
MSX2	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA 
MT-ATP6	LEBER OPTIC ATROPHY 
MT-ATP6	LEIGH SYNDROME 
MT-ATP6	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA 
MT-ATP6	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL 
MT-CO1	COLORECTAL CANCER 
MT-CO1	DEAFNESS, AMINOGLYCOSIDE-INDUCED 
MT-CO1	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL 
MT-CO1	LEBER OPTIC ATROPHY 
MT-CO1	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
MT-CO1	MYOGLOBINURIA, RECURRENT 
MT-CO2	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
MT-CO3	LEBER OPTIC ATROPHY 
MT-CO3	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
MT-CO3	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE 
MT-CO3	MYOGLOBINURIA, RECURRENT 
MT-CYB	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID 
MT-CYB	LEBER OPTIC ATROPHY 
MT-CYB	MITOCHONDRIAL COMPLEX III DEFICIENCY 
MT-ND1	ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL 
MT-ND1	LEBER OPTIC ATROPHY 
MT-ND1	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE 
MT-ND2	ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL 
MT-ND2	LEBER OPTIC ATROPHY 
MT-ND2	MITOCHONDRIAL COMPLEX I DEFICIENCY 
MT-ND3	LEIGH SYNDROME 
MT-ND3	MITOCHONDRIAL COMPLEX I DEFICIENCY 
MT-ND4	DEAFNESS, AMINOGLYCOSIDE-INDUCED 
MT-ND4	LEBER OPTIC ATROPHY 
MT-ND4	LEBER OPTIC ATROPHY AND DYSTONIA 
MT-ND4	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE 
MT-ND4L	LEBER OPTIC ATROPHY 
MT-ND5	LEBER OPTIC ATROPHY 
MT-ND5	LEIGH SYNDROME 
MT-ND5	MITOCHONDRIAL COMPLEX I DEFICIENCY 
MT-ND5	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE 
MT-ND5	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA 
MT-ND6	LEBER OPTIC ATROPHY 
MT-ND6	LEBER OPTIC ATROPHY AND DYSTONIA 
MT-ND6	LEIGH SYNDROME 
MT-ND6	MITOCHONDRIAL COMPLEX I DEFICIENCY 
MT-ND6	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE 
MT-ND6	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA 
MTHFD1	COLORECTAL CANCER 
MTHFD1	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE 
MTHFR	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE 
MTHFR	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE 
MTHFR	OROFACIALCLEFT1
MTHFR	SCHIZOPHRENIA 
MTHFR	STROKE, ISCHEMIC 
MTHFR	THROMBOSIS, SUSCEPTIBILITY TO 
MTM1	MYOPATHY, CENTRONUCLEAR, X-LINKED 
MTMR14	MYOPATHY, CENTRONUCLEAR, 1 
MTMR2	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1 
MTPAP	ATAXIA, SPASTIC, 4, AUTOSOMAL RECESSIVE 
MTR	DOWN SYNDROME 
MTR	METHYLCOBALAMIN DEFICIENCY, cblG TYPE 
MTR	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE 
MTR	OROFACIALCLEFT1
MTRR	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, 
MTRR	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE 
MTTP	ABDOMINALOBESITY-METABOLICSYNDROME
MTTP	ABETALIPOPROTEINEMIA 
MTUS1	HEPATOCELLULAR CARCINOMA 
MUC3A	INFLAMMATORYBOWELDISEASE11
MUC5B	PANBRONCHIOLITIS,DIFFUSE
MUC5B	PULMONARY FIBROSIS, IDIOPATHIC 
MUC7	ASTHMA, SUSCEPTIBILITY TO 
MUSK	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR 
MUT	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY 
MUT	METHYLMALONYL-CoA EPIMERASE DEFICIENCY 
MUTYH	FAMILIAL ADENOMATOUS POLYPOSIS, 2 
MUTYH	GASTRIC CANCER 
MUTYH	GASTRIC CANCER, HEREDITARY DIFFUSE 
MUTYH	PILOMATRIXOMA 
MVK	HYPER-IgD SYNDROME 
MVK	MEVALONIC ACIDURIA 
MXI1	PROSTATE CANCER 
MYBPC1	ARTHROGRYPOSIS, DISTAL, TYPE 1B 
MYBPC3	CARDIOMYOPATHY, DILATED, 1A 
MYBPC3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4 
MYC	BURKITT LYMPHOMA 
MYCN	FEINGOLD SYNDROME 1 
MYD88	MYD88 DEFICIENCY 
MYF6	MUSCULAR DYSTROPHY, BECKER TYPE 
MYF6	MUSCULAR DYSTROPHY, DUCHENNE TYPE 
MYF6	MYOPATHY, CENTRONUCLEAR, 1 
MYF6	MYOPATHY, CENTRONUCLEAR, 3 
MYH11	AORTIC ANEURYSM, FAMILIAL THORACIC 4 
MYH11	AORTICANEURYSM,FAMILIALTHORACIC1
MYH14	DEAFNESS, AUTOSOMAL DOMINANT 4 
MYH14	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS 
MYH2	INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT 
MYH3	ARTHROGRYPOSIS, DISTAL, TYPE 2A 
MYH3	ARTHROGRYPOSIS, DISTAL, TYPE 2B 
MYH6	ATRIAL SEPTAL DEFECT 3 
MYH6	CARDIOMYOPATHY, DILATED, 1EE 
MYH6	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
MYH6	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14 
MYH6	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO 
MYH7	CARDIOMYOPATHY, DILATED, 1S 
MYH7	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
MYH7	MYOPATHY, DISTAL, 1 
MYH7	MYOPATHY, MYOSIN STORAGE 
MYH7	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED 
MYH8	ARTHROGRYPOSIS, DISTAL, TYPE 7 
MYH8	CARNEY COMPLEX VARIANT 
MYH9	DEAFNESS, AUTOSOMAL DOMINANT 17 
MYH9	EPSTEIN SYNDROME 
MYH9	FECHTNER SYNDROME 
MYH9	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS 
MYH9	MAY-HEGGLIN ANOMALY 
MYH9	SEBASTIAN SYNDROME 
MYL2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10 
MYL3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8 
MYLK	AORTIC ANEURYSM, FAMILIAL THORACIC 7 
MYLK2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
MYO15A	DEAFNESS, AUTOSOMAL RECESSIVE 3 
MYO1A	DEAFNESS, AUTOSOMAL DOMINANT 48 
MYO1E	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6 
MYO3A	DEAFNESS, AUTOSOMAL RECESSIVE 30 
MYO5A	ELEJALDE DISEASE 
MYO5A	GRISCELLI SYNDROME, TYPE 1 
MYO5A	GRISCELLI SYNDROME, TYPE 3 
MYO5B	DIARRHEA 2, WITH MICROVILLUS ATROPHY 
MYO6	DEAFNESS, AUTOSOMAL DOMINANT 22 
MYO6	DEAFNESS, AUTOSOMAL RECESSIVE 37 
MYO7A	DEAFNESS, AUTOSOMAL DOMINANT 11 
MYO7A	DEAFNESS, AUTOSOMAL RECESSIVE 2 
MYO7A	USHER SYNDROME, TYPE I 
MYO9B	CELIAC DISEASE, SUSCEPTIBILITY TO, 4 
MYOC	GLAUCOMA 1, OPEN ANGLE, A 
MYOC	GLAUCOMA 3, PRIMARY CONGENITAL, A 
MYOT	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A 
MYOT	MYOPATHY, MYOFIBRILLAR, 3 
MYOT	MYOPATHY, SPHEROID BODY 
MYOZ2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16 
NAA10	OGDEN SYNDROME 
NAGA	KANZAKI DISEASE 
NAGA	SCHINDLER DISEASE, TYPE I 
NAGLU	MUCOPOLYSACCHARIDOSIS TYPE IIIB 
NAGS	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY 
NAIP	SPINAL MUSCULAR ATROPHY, TYPE I 
NAIP	SPINAL MUSCULAR ATROPHY, TYPE II 
NAIP	SPINAL MUSCULAR ATROPHY, TYPE III 
NAT2	ACETYLATION, SLOW 
NAT8L	N-ACETYLASPARTATE DEFICIENCY 
NBEAL2	GRAY PLATELET SYNDROME 
NBN	APLASTIC ANEMIA 
NBN	BREAST CANCER 
NBN	NIJMEGEN BREAKAGE SYNDROME 
NCF1	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, 
NCF2	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, 
NCF4	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, 
NCOA4	THYROID CARCINOMA, PAPILLARY 
NCR3	MALARIA, MILD, SUSCEPTIBILITY TO 
NCSTN	ACNE INVERSA, FAMILIAL, 1 
NDE1	LISSENCEPHALY 4 
NDN	PRADER-WILLI SYNDROME 
NDP	EXUDATIVE VITREORETINOPATHY 1 
NDP	EXUDATIVE VITREORETINOPATHY 2, X-LINKED 
NDP	NORRIE DISEASE 
NDRG1	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D 
NDUFA1	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFA10	LEIGH SYNDROME 
NDUFA11	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFA13	THYROID CARCINOMA, HURTHLE CELL 
NDUFA2	LEIGH SYNDROME 
NDUFA2	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFAF1	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFAF2	LEIGH SYNDROME 
NDUFAF2	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFAF3	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFAF4	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS1	LEIGH SYNDROME 
NDUFS1	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS2	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS3	LEIGH SYNDROME 
NDUFS3	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS4	LEIGH SYNDROME 
NDUFS4	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS6	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS7	LEIGH SYNDROME 
NDUFS7	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFS8	LEIGH SYNDROME 
NDUFS8	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFV1	ALEXANDER DISEASE 
NDUFV1	LEIGH SYNDROME 
NDUFV1	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFV2	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NDUFV2	PARKINSON DISEASE, LATE-ONSET 
NEB	NEMALINE MYOPATHY 2 
NEFH	AMYOTROPHIC LATERAL SCLEROSIS 1 
NEFL	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E 
NEFL	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F 
NEK1	SHORT RIB-POLYDACTYLY SYNDROME, TYPE II 
NEK8	NEPHRONOPHTHISIS 9 
NELF	HYPOGONADOTROPIC HYPOGONADISM 
NEU1	NEURAMINIDASE DEFICIENCY 
NEUROD1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
NEUROD1	MATURITY-ONSET DIABETES OF THE YOUNG 
NEUROD1	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6 
NEUROG3	DIARRHEA 4, MALABSORPTIVE, CONGENITAL 
NEXN	CARDIOMYOPATHY, DILATED, 1CC 
NEXN	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20 
NF1	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB 
NF1	COLORECTAL CANCER 
NF1	JUVENILE MYELOMONOCYTIC LEUKEMIA 
NF1	NEUROFIBROMATOSIS, FAMILIAL SPINAL 
NF1	NEUROFIBROMATOSIS, TYPE I 
NF1	NEUROFIBROMATOSIS-NOONAN SYNDROME 
NF1	WATSON SYNDROME 
NF2	MENINGIOMA, FAMILIAL 
NF2	MESOTHELIOMA, MALIGNANT 
NF2	NEUROFIBROMATOSIS, TYPE II 
NF2	SCHWANNOMATOSIS 
NFKBIA	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL 
NFKBIL1	RHEUMATOID ARTHRITIS 
NFU1	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1 
NGF	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V 
NHEJ1	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, 
NHLRC1	MYOCLONIC EPILEPSY OF LAFORA 
NHP2	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1 
NHP2	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2 
NHS	CATARACT, CONGENITAL, X-LINKED 
NHS	NANCE-HORAN SYNDROME 
NIPA1	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT 
NIPAL4	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 
NIPAL4	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE, NIPAL4-RELATED 
NIPBL	CORNELIA DE LANGE SYNDROME 1 
NKX2-1	CHOREA, BENIGN HEREDITARY 
NKX2-1	CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS 
NKX2-5	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION 
NKX2-5	CONOTRUNCAL HEART MALFORMATIONS 
NKX2-5	HYPOPLASTIC LEFT HEART SYNDROME 2 
NKX2-5	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5 
NKX2-5	TETRALOGY OF FALLOT 
NKX2-5	VENTRICULAR SEPTAL DEFECT 3 
NKX2-6	CONOTRUNCAL HEART MALFORMATIONS 
NKX3-2	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA 
NLGN3	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1 
NLGN3	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1 
NLGN4X	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2 
NLGN4X	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2 
NLRP1	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 
NLRP1	VITILIGO-ASSOCIATEDMULTIPLEAUTOIMMUNEDISEASESUSCEPTIBILITY6
NLRP12	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2 
NLRP2	HYDATIDIFORM MOLE, RECURRENT, 1 
NLRP3	CINCA SYNDROME 
NLRP3	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1 
NLRP3	MUCKLE-WELLS SYNDROME 
NLRP7	HYDATIDIFORM MOLE, RECURRENT, 1 
NME1	NEUROBLASTOMA, SUSCEPTIBILITY TO 
NOBOX	PREMATURE OVARIAN FAILURE 5 
NOD2	BLAU SYNDROME 
NOD2	INFLAMMATORY BOWEL DISEASE 1 
NOD2	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO 
NOD2	SARCOIDOSIS, EARLY-ONSET 
NOD2	SARCOIDOSIS, SUSCEPTIBILITY TO, 1 
NODAL	HETEROTAXY, VISCERAL, 5, AUTOSOMAL 
NOG	BRACHYDACTYLY, TYPE B2 
NOG	MULTIPLE SYNOSTOSES SYNDROME 1 
NOG	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES 
NOG	SYMPHALANGISM, PROXIMAL 
NOG	TARSAL-CARPAL COALITION SYNDROME 
NOP10	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1 
NOP56	SPINOCEREBELLAR ATAXIA 36 
NOS1	PYLORICSTENOSIS,INFANTILEHYPERTROPHIC1
NOS1AP	QTINTERVAL,VARIATIONIN
NOS2	HYPERTENSION, ESSENTIAL 
NOS2	MALARIA, SUSCEPTIBILITY TO 
NOS2	PLASMODIUMFALCIPARUMBLOODINFECTIONLEVEL
NOS3	ALZHEIMER DISEASE 
NOS3	HYPERTENSION, ESSENTIAL 
NOS3	PREECLAMPSIA/ECLAMPSIA1
NOS3	STROKE, ISCHEMIC 
NOTCH1	AORTIC VALVE DISEASE 
NOTCH2	ALAGILLE SYNDROME 2 
NOTCH2	HAJDU-CHENEY SYNDROME 
NOTCH3	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS 
NPAS2	MAJOR DEPRESSIVE DISORDER 
NPC1	NIEMANN-PICK DISEASE, TYPE C1 
NPC2	NIEMANN-PICK DISEASE, TYPE C2 
NPHP1	JOUBERT SYNDROME 4 
NPHP1	NEPHRONOPHTHISIS 1 
NPHP1	SENIOR-LOKEN SYNDROME 1 
NPHP3	MECKEL SYNDROME, TYPE 7 
NPHP3	NEPHRONOPHTHISIS 3 
NPHP3	RENAL-HEPATIC-PANCREATIC DYSPLASIA 
NPHP4	NEPHRONOPHTHISIS 4 
NPHP4	SENIOR-LOKEN SYNDROME 4 
NPHS1	NEPHROTIC SYNDROME, TYPE 1 
NPHS1	NEPHROTIC SYNDROME, TYPE 2 
NPHS2	NEPHROTIC SYNDROME, TYPE 2 
NPM1	ACUTE PROMYELOCYTIC LEUKEMIA 
NPM1	LEUKEMIA, ACUTE MYELOID 
NPPA	ATRIAL FIBRILLATION, FAMILIAL, 6 
NPR2	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE 
NPSR1	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2 
NQO2	BREAST CANCER 
NR0B1	46,XY SEX REVERSAL 2 
NR0B1	ADRENAL HYPOPLASIA, CONGENITAL 
NR0B2	OBESITY 
NR2E3	ENHANCED S-CONE SYNDROME 
NR2E3	RETINITIS PIGMENTOSA 37 
NR3C2	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION 
NR3C2	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT 
NR4A2	PARKINSON DISEASE, LATE-ONSET 
NR4A3	CHONDROSARCOMA, EXTRASKELETAL MYXOID 
NR4A3	EWING SARCOMA 
NR5A1	46,XY SEX REVERSAL 3 
NR5A1	PREMATURE OVARIAN FAILURE 7 
NR5A1	SPERMATOGENIC FAILURE 8 
NRAS	COLORECTAL CANCER 
NRAS	JUVENILE MYELOMONOCYTIC LEUKEMIA 
NRAS	NOONAN SYNDROME 6 
NRAS	THYROIDCARCINOMA,FOLLICULAR
NRG1	SCHIZOPHRENIA6
NRL	RETINITIS PIGMENTOSA 27 
NRTN	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
NRXN1	AUTISM
NRXN1	PITT-HOPKINS-LIKE SYNDROME 2 
NRXN1	SCHIZOPHRENIA 17 
NSD1	BECKWITH-WIEDEMANN SYNDROME 
NSD1	LEUKEMIA, ACUTE MYELOID 
NSD1	SOTOS SYNDROME 
NSD1	WEAVER SYNDROME 1 
NSDHL	CK SYNDROME 
NSDHL	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB 
NT5C3	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA 
NT5E	CALCIFICATION OF JOINTS AND ARTERIES 
NTF4	GLAUCOMA 1, OPEN ANGLE, O 
NTRK1	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS 
NTRK1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V 
NTRK1	THYROID CARCINOMA, FAMILIAL MEDULLARY 
NTRK1	THYROID CARCINOMA, PAPILLARY 
NTRK2	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY 
NUBPL	MITOCHONDRIAL COMPLEX I DEFICIENCY 
NUP214	LEUKEMIA, ACUTE MYELOID 
NUP62	STRIATONIGRAL DEGENERATION, INFANTILE 
NYX	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A 
OAS1	DIABETESMELLITUS,INSULIN-DEPENDENT
OAT	GYRATE ATROPHY OF CHOROID AND RETINA 
OBSL1	THREE M SYNDROME 2 
OCA2	ALBINISM, OCULOCUTANEOUS, TYPE II 
OCA2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1 
OCLN	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA 
OCRL	DENT DISEASE 1 
OCRL	DENT DISEASE 2 
OCRL	LOWE OCULOCEREBRORENAL SYNDROME 
ODC1	COLORECTAL CANCER 
OFD1	JOUBERT SYNDROME 10 
OFD1	OROFACIODIGITAL SYNDROME I 
OFD1	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2 
OGDH	ALPHA-KETOGLUTARATEDEHYDROGENASEDEFICIENCY
OGG1	RENAL CELL CARCINOMA, NONPAPILLARY 
OLR1	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
OPA1	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO 
OPA1	OPTIC ATROPHY 1 
OPA1	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, 
OPA3	3-@METHYLGLUTACONIC ACIDURIA, TYPE III 
OPA3	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT 
OPCML	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 
OPCML	OVARIAN CANCER 
OPHN1	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE 
OPN1LW	BLUE CONE MONOCHROMACY 
OPN1LW	COLORBLINDNESS, PARTIAL, PROTAN SERIES 
OPN1MW	BLUE CONE MONOCHROMACY 
OPN1MW	COLORBLINDNESS, PARTIAL, DEUTAN SERIES 
OPN1MW2	BLUE CONE MONOCHROMACY 
OPN1MW2	COLORBLINDNESS, PARTIAL, DEUTAN SERIES 
OPN1SW	TRITANOPIA 
OPRM1	EPILEPSY,IDIOPATHICGENERALIZED
OPTN	AMYOTROPHIC LATERAL SCLEROSIS 12 
OPTN	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO 
OPTN	GLAUCOMA, PRIMARY OPEN ANGLE 
ORAI1	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 
ORC1	MEIER-GORLIN SYNDROME 1 
ORC4	MEIER-GORLIN SYNDROME 2 
ORC6	MEIER-GORLIN SYNDROME 3 
ORMDL3	ASTHMA, SUSCEPTIBILITY TO 
OSMR	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1 
OSTM1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1 
OSTM1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5 
OTC	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO 
OTOA	DEAFNESS, AUTOSOMAL RECESSIVE 22 
OTOF	DEAFNESS, AUTOSOMAL RECESSIVE 9 
OTX2	MICROPHTHALMIA, SYNDROMIC 5 
OTX2	PITUITARY HORMONE DEFICIENCY, COMBINED, 6 
OTX2	SEPTOOPTIC DYSPLASIA 
OXCT1	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY 
P2RX7	LEUKEMIA, CHRONIC LYMPHOCYTIC 
P2RY12	BLEEDING DISORDER, PLATELET-TYPE, 8 
PABPN1	OCULOPHARYNGEAL MUSCULAR DYSTROPHY 
PACRG	LEPROSY,SUSCEPTIBILITYTO,2
PADI4	RHEUMATOID ARTHRITIS 
PAFAH1B1	CHROMOSOME 17p13.3 DUPLICATION SYNDROME 
PAFAH1B1	LISSENCEPHALY 1 
PAFAH1B1	MILLER-DIEKER LISSENCEPHALY SYNDROME 
PAH	PHENYLKETONURIA 
PAK3	MENTAL RETARDATION, X-LINKED 30 
PALB2	BREAST CANCER 
PALB2	FANCONI ANEMIA, COMPLEMENTATION GROUP A 
PALB2	FANCONI ANEMIA, COMPLEMENTATION GROUP N 
PALB2	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3 
PALLD	PANCREATIC CANCER 
PALLD	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1 
PANK2	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, 
PANK2	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 
PAPSS2	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PAKISTANI TYPE 
PARK2	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 
PARK2	LEPROSY,SUSCEPTIBILITYTO,2
PARK2	LUNG CANCER 
PARK2	OVARIAN CANCER 
PARK2	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE 
PARK2	PARKINSON DISEASE, LATE-ONSET 
PARK7	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1 
PARK7	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET 
PARK7	PARKINSON DISEASE, LATE-ONSET 
PAX2	PAPILLORENAL SYNDROME 
PAX3	CRANIOFACIAL-DEAFNESS-HAND SYNDROME 
PAX3	RHABDOMYOSARCOMA 2 
PAX3	WAARDENBURG SYNDROME, TYPE 1 
PAX3	WAARDENBURG SYNDROME, TYPE 3 
PAX4	DIABETES MELLITUS, KETOSIS-PRONE 
PAX4	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
PAX4	DIABETESMELLITUS,INSULIN-DEPENDENT
PAX4	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9 
PAX6	ANIRIDIA 
PAX6	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION 
PAX6	CATARACT, AUTOSOMAL DOMINANT 
PAX6	COLOBOMA OF OPTIC NERVE 
PAX6	COLOBOMA, OCULAR 
PAX6	FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME 
PAX6	KERATITIS, HEREDITARY 
PAX6	OPTIC NERVE HYPOPLASIA, BILATERAL 
PAX6	PETERS ANOMALY 
PAX7	RHABDOMYOSARCOMA 2 
PAX8	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2 
PAX9	TOOTH AGENESIS, SELECTIVE, 1 
PAX9	TOOTH AGENESIS, SELECTIVE, 3 
PAXIP1	ALZHEIMER DISEASE 
PBRM1	RENAL CELL CARCINOMA, NONPAPILLARY 
PC	PYRUVATE CARBOXYLASE DEFICIENCY 
PCBD1	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D 
PCCA	PROPIONIC ACIDEMIA 
PCCB	PROPIONIC ACIDEMIA 
PCDH15	DEAFNESS, AUTOSOMAL RECESSIVE 23 
PCDH15	USHER SYNDROME, TYPE I 
PCDH15	USHER SYNDROME, TYPE ID 
PCDH15	USHER SYNDROME, TYPE IF 
PCDH19	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9 
PCK2	PHOSPHOENOLPYRUVATECARBOXYKINASEDEFICIENCY,MITOCHONDRIAL
PCM1	THYROID CARCINOMA, PAPILLARY 
PCNT	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II 
PCSK1	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12 
PCSK1	PROPROTEIN CONVERTASE 1/3 DEFICIENCY 
PCSK9	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3 
PCSK9	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2 
PDCD1	AUTOIMMUNE DISEASE 
PDCD1	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO 
PDCD1	SYSTEMIC LUPUS ERYTHEMATOSUS 
PDCD1	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2 
PDCD10	CEREBRAL CAVERNOUS MALFORMATIONS 3 
PDE11A	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2 
PDE4D	STROKE,SUSCEPTIBILITYTO,1
PDE6A	RETINITIS PIGMENTOSA 43 
PDE6B	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2 
PDE6B	RETINITIS PIGMENTOSA 40 
PDE6C	CONE DYSTROPHY 4 
PDE6G	RETINITIS PIGMENTOSA 57 
PDE6H	RETINAL CONE DYSTROPHY 3A 
PDE8B	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3 
PDE8B	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 
PDGFB	DERMATOFIBROSARCOMA PROTUBERANS 
PDGFB	MENINGIOMA, FAMILIAL 
PDGFRA	GASTROINTESTINAL STROMAL TUMOR 
PDGFRA	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC 
PDGFRB	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC 
PDGFRB	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA 
PDGFRL	COLORECTAL CANCER 
PDGFRL	HEPATOCELLULAR CARCINOMA 
PDHA1	LEIGH SYNDROME, X-LINKED 
PDHA1	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY 
PDHB	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY 
PDHB	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY 
PDHX	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY 
PDLIM4	OSTEOPOROSIS 
PDP1	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY 
PDSS1	COENZYME Q10 DEFICIENCY 
PDSS2	COENZYME Q10 DEFICIENCY 
PDX1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
PDX1	DIABETES MELLITUS, PERMANENT NEONATAL 
PDX1	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4 
PDX1	PANCREATIC AGENESIS, CONGENITAL 
PDYN	SPINOCEREBELLAR ATAXIA 23 
PDZD7	USHER SYNDROME, TYPE IIA 
PDZD7	USHER SYNDROME, TYPE IIC 
PEPD	PROLIDASE DEFICIENCY 
PER2	ADVANCED SLEEP-PHASE SYNDROME, FAMILIAL 
PEX1	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX1	PEROXISOME BIOGENESIS DISORDERS 
PEX1	REFSUM DISEASE, INFANTILE 
PEX1	ZELLWEGER SYNDROME 
PEX10	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX10	PEROXISOME BIOGENESIS DISORDERS 
PEX10	REFSUM DISEASE, INFANTILE 
PEX10	ZELLWEGER SYNDROME 
PEX12	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX12	PEROXISOME BIOGENESIS DISORDERS 
PEX12	REFSUM DISEASE, INFANTILE 
PEX12	ZELLWEGER SYNDROME 
PEX13	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX13	REFSUM DISEASE, INFANTILE 
PEX13	ZELLWEGER SYNDROME 
PEX14	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX14	REFSUM DISEASE, INFANTILE 
PEX14	ZELLWEGER SYNDROME 
PEX16	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX16	PEROXISOME BIOGENESIS DISORDERS 
PEX16	REFSUM DISEASE, INFANTILE 
PEX16	ZELLWEGER SYNDROME 
PEX19	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX19	PEROXISOME BIOGENESIS DISORDERS 
PEX19	REFSUM DISEASE, INFANTILE 
PEX19	ZELLWEGER SYNDROME 
PEX2	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX2	PEROXISOME BIOGENESIS DISORDERS 
PEX2	REFSUM DISEASE, INFANTILE 
PEX2	ZELLWEGER SYNDROME 
PEX26	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX26	PEROXISOME BIOGENESIS DISORDERS 
PEX26	REFSUM DISEASE, INFANTILE 
PEX26	ZELLWEGER SYNDROME 
PEX3	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX3	PEROXISOME BIOGENESIS DISORDERS 
PEX3	REFSUM DISEASE, INFANTILE 
PEX3	ZELLWEGER SYNDROME 
PEX5	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX5	REFSUM DISEASE, INFANTILE 
PEX5	ZELLWEGER SYNDROME 
PEX6	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM 
PEX6	PEROXISOME BIOGENESIS DISORDERS 
PEX6	REFSUM DISEASE, INFANTILE 
PEX6	ZELLWEGER SYNDROME 
PEX7	PEROXISOME BIOGENESIS DISORDERS 
PEX7	REFSUM DISEASE, ADULT 
PEX7	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1 
PFKM	GLYCOGEN STORAGE DISEASE VII 
PGAM2	GLYCOGEN STORAGE DISEASE X 
PGK1	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY 
PGM1	GLYCOGEN STORAGE DISEASE XIV 
PHB	BREAST CANCER 
PHEX	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT 
PHF11	ASTHMA, SUSCEPTIBILITY TO 
PHF11	IgE RESPONSIVENESS, ATOPIC 
PHF6	BORJESON-FORSSMAN-LEHMANN SYNDROME 
PHF8	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME 
PHGDH	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY 
PHKA1	GLYCOGEN STORAGE DISEASE, TYPE IXd 
PHKA2	GLYCOGEN STORAGE DISEASE IXa1 
PHKB	GLYCOGEN STORAGE DISEASE IXb 
PHKG2	GLYCOGEN STORAGE DISEASE IXc 
PHOX2A	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2 
PHOX2B	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL 
PHOX2B	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
PHOX2B	NEUROBLASTOMA, SUSCEPTIBILITY TO 
PHOX2B	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2 
PHYH	REFSUM DISEASE, ADULT 
PICALM	LEUKEMIA, ACUTE MYELOID 
PIGA	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 
PIGM	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY 
PIGN	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 
PIGR	IgANEPHROPATHY,SUSCEPTIBILITYTO,1
PIGV	HYPERPHOSPHATASIA WITH MENTAL RETARDATION 
PIK3CA	BREAST CANCER 
PIK3CA	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 
PIK3CA	COLORECTAL CANCER 
PIK3CA	GASTRIC CANCER, HEREDITARY DIFFUSE 
PIK3CA	HEPATOCELLULAR CARCINOMA 
PIK3CA	KERATOSIS, SEBORRHEIC 
PIK3CA	LUNG CANCER 
PIK3CA	NEVUS, EPIDERMAL 
PIK3CA	OVARIAN CANCER 
PIKFYVE	CORNEAL DYSTROPHY, FLECK 
PINK1	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET 
PINK1	PARKINSON DISEASE, LATE-ONSET 
PIP5K1C	LETHAL CONGENITAL CONTRACTURAL SYNDROME 3 
PITPNM3	CONE-ROD DYSTROPHY 5 
PITX1	CLUBFOOT, CONGENITAL 
PITX2	AXENFELD-RIEGER SYNDROME, TYPE 1 
PITX2	IRIDOGONIODYSGENESIS, TYPE 2 
PITX2	PETERS ANOMALY 
PITX2	RING DERMOID OF CORNEA 
PITX3	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS 
PITX3	CATARACT, AUTOSOMAL DOMINANT 
PITX3	CATARACT, POSTERIOR POLAR, 4 
PKD1	POLYCYSTIC KIDNEY DISEASE 1 
PKD1	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS 
PKD2	POLYCYSTIC KIDNEY DISEASE 2 
PKHD1	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE 
PKLR	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES 
PKLR	PYRUVATE KINASE DEFICIENCY OF RED CELLS 
PKP1	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME 
PKP2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9 
PLA2G2A	COLORECTAL CANCER 
PLA2G5	FLECK RETINA, FAMILIAL BENIGN 
PLA2G6	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A 
PLA2G6	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B 
PLA2G6	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE 
PLA2G7	ASTHMA, SUSCEPTIBILITY TO 
PLA2G7	IgE RESPONSIVENESS, ATOPIC 
PLA2G7	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY 
PLAG1	SALIVARY GLAND ADENOMA, PLEOMORPHIC 
PLAGL1	DIABETES MELLITUS, TRANSIENT NEONATAL, 1 
PLAT	THROMBOPHILIA,FAMILIAL,DUETODECREASEDRELEASEOFTISSUEPLASMINOGEN
PLAU	ALZHEIMER DISEASE 
PLAU	QUEBEC PLATELET DISORDER 
PLCB1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12 
PLCD1	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3 
PLCE1	NEPHROTIC SYNDROME, TYPE 3 
PLDN	HERMANSKY-PUDLAK SYNDROME 9 
PLEC	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY 
PLEC	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA 
PLEC	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE 
PLEC	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q 
PLEKHA1	MACULAR DEGENERATION, AGE-RELATED, 1 
PLEKHG4	SPINOCEREBELLAR ATAXIA 31 
PLEKHG4	SPINOCEREBELLARATAXIA4
PLEKHG5	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4 
PLEKHM1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6 
PLG	PLASMINOGEN DEFICIENCY, TYPE I 
PLG	THROMBOSIS, SUSCEPTIBILITY TO 
PLIN1	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4 
PLN	CARDIOMYOPATHY, DILATED, 1P 
PLN	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18 
PLOD1	EHLERS-DANLOS SYNDROME, TYPE VI 
PLOD1	NEVO SYNDROME 
PLOD2	BRUCK SYNDROME 2 
PLOD3	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS 
PLP1	PELIZAEUS-MERZBACHER DISEASE 
PLP1	SPASTIC PARAPLEGIA 2, X-LINKED 
PML	ACUTE PROMYELOCYTIC LEUKEMIA 
PMM2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia 
PMP22	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS 
PMP22	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A 
PMP22	GUILLAIN-BARRE SYNDROME, FAMILIAL 
PMP22	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS 
PMP22	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES 
PMP22	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA 
PMS2	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4 
PMS2	MISMATCH REPAIR CANCER SYNDROME 
PNKD	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1 
PNKP	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10 
PNLIP	PANCREATICLIPASEDEFICIENCY
PNMT	HYPERTENSION, ESSENTIAL 
PNP	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY 
PNPLA2	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY 
PNPLA3	FATTYLIVERDISEASE,NONALCOHOLIC,SUSCEPTIBILITYTO,1
PNPLA6	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE 
PNPO	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY 
POF1B	PREMATURE OVARIAN FAILURE 2B 
POLG	LEIGH SYNDROME 
POLG	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE) 
POLG	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE) 
POLG	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE) 
POLG	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, 
POLG	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS 
POLG2	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, 
POLH	XERODERMA PIGMENTOSUM, VARIANT TYPE 
POLR1C	TREACHER COLLINS SYNDROME 3 
POLR1D	TREACHER COLLINS SYNDROME 2 
POLR3A	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR 
POLR3D	TEMPERATURESENSITIVITYCOMPLEMENTATION,CELLCYCLESPECIFIC,tsBN51
POMC	OBESITY 
POMC	PROOPIOMELANOCORTIN DEFICIENCY 
POMGNT1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE 
POMGNT1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), 
POMGNT1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3 
POMP	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA 
POMT1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE 
POMT1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), 
POMT1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1 
POMT2	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE 
POMT2	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), 
POMT2	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2 
PON1	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5 
POP1	ANAUXETIC DYSPLASIA 
POR	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS 
POR	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY 
PORCN	FOCAL DERMAL HYPOPLASIA 
POU1F1	PITUITARY HORMONE DEFICIENCY, COMBINED, 1 
POU1F1	PITUITARY HORMONE DEFICIENCY, COMBINED, 2 
POU3F4	DEAFNESS, X-LINKED 2 
POU4F3	DEAFNESS, AUTOSOMAL DOMINANT 15 
POU6F2	WILMS TUMOR 5 
PPARG	BODYMASSINDEX
PPARG	CAROTID INTIMAL MEDIAL THICKNESS 1 
PPARG	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
PPARG	GLIOMA SUSCEPTIBILITY 1 
PPARG	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2 
PPARG	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3 
PPARG	OBESITY 
PPARGC1B	OBESITY 
PPBP	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10 
PPIB	OSTEOGENESIS IMPERFECTA, TYPE IX 
PPM1B	HYPOTONIA-CYSTINURIA SYNDROME 
PPM1D	BREAST CANCER 
PPOX	PORPHYRIA VARIEGATA 
PPP1R17	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT 
PPP1R3A	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
PPP1R3A	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3 
PPP2R1B	LUNG CANCER 
PPP2R2B	SPINOCEREBELLAR ATAXIA 12 
PPT1	CEROID LIPOFUSCINOSIS, NEURONAL, 1 
PQBP1	RENPENNING SYNDROME 1 
PRCC	RENAL CELL CARCINOMA, PAPILLARY, 1 
PRCD	RETINITIS PIGMENTOSA 36 
PRDM5	BRITTLE CORNEA SYNDROME 2 
PREPL	HYPOTONIA-CYSTINURIA SYNDROME 
PRF1	APLASTIC ANEMIA 
PRF1	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2 
PRF1	LYMPHOMA, NON-HODGKIN, FAMILIAL 
PRG4	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME 
PRICKLE1	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B 
PRICKLE1	NEURAL TUBE DEFECTS 
PRICKLE2	EPILEPSY, PROGRESSIVE MYOCLONIC 5 
PRKAG2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 
PRKAG2	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL 
PRKAG2	WOLFF-PARKINSON-WHITE SYNDROME 
PRKAR1A	ACRODYSOSTOSIS WITH HORMONE RESISTANCE 
PRKAR1A	CARNEY COMPLEX, TYPE 1 
PRKAR1A	MYXOMA, INTRACARDIAC 
PRKAR1A	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1 
PRKAR1A	THYROID CARCINOMA, PAPILLARY 
PRKCG	SPINOCEREBELLAR ATAXIA 14 
PRKCH	STROKE, ISCHEMIC 
PRKCSH	POLYCYSTIC LIVER DISEASE 
PRKRA	DYSTONIA 16 
PRNP	CREUTZFELDT-JAKOB DISEASE 
PRNP	FATAL FAMILIAL INSOMNIA 
PRNP	GERSTMANN-STRAUSSLER DISEASE 
PRNP	HUNTINGTON DISEASE-LIKE 1 
PRNP	KURU, SUSCEPTIBILITY TO 
PRNP	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES 
PROC	THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL 
PROC	THROMBOSIS, SUSCEPTIBILITY TO 
PRODH	HYPERPROLINEMIA, TYPE I 
PRODH	SCHIZOPHRENIA 
PRODH	SCHIZOPHRENIA 4 
PROK2	HYPOGONADOTROPIC HYPOGONADISM 
PROK2	KALLMANN SYNDROME 4 
PROKR2	KALLMANN SYNDROME 3 
PROM1	CONE-ROD DYSTROPHY 12 
PROM1	MACULAR DYSTROPHY, RETINAL, 2 
PROM1	RETINITIS PIGMENTOSA 41 
PROM1	STARGARDT DISEASE 4 
PROP1	PITUITARY HORMONE DEFICIENCY, COMBINED, 2 
PROS1	THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL 
PROZ	PROTEIN Z DEFICIENCY 
PRPF3	RETINITIS PIGMENTOSA 18 
PRPF31	RETINITIS PIGMENTOSA 11 
PRPF6	RETINITIS PIGMENTOSA 60 
PRPF8	RETINITIS PIGMENTOSA 13 
PRPH	AMYOTROPHIC LATERAL SCLEROSIS 1 
PRPH2	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2 
PRPH2	FUNDUS ALBIPUNCTATUS 
PRPH2	MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET 
PRPH2	PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM 
PRPH2	RETINITIS PIGMENTOSA 
PRPH2	RETINITIS PIGMENTOSA 7 
PRPS1	ARTS SYNDROME 
PRPS1	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5 
PRPS1	DEAFNESS, X-LINKED 1 
PRPS1	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY 
PRRX1	AGNATHIA-OTOCEPHALY COMPLEX 
PRSS1	PANCREATITIS, HEREDITARY 
PRSS12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1 
PRTN3	WEGENERGRANULOMATOSIS
PRX	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS 
PSAP	COMBINED SAPOSIN DEFICIENCY 
PSAP	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY 
PSAP	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY 
PSAP	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY 
PSAT1	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY 
PSEN1	ACNE INVERSA, FAMILIAL, 3 
PSEN1	ALZHEIMER DISEASE 3 
PSEN1	CARDIOMYOPATHY, DILATED, 1U 
PSEN1	FRONTOTEMPORAL DEMENTIA 
PSEN1	PICK DISEASE OF BRAIN 
PSEN2	ALZHEIMER DISEASE 4 
PSEN2	CARDIOMYOPATHY, DILATED, 1V 
PSENEN	ACNE INVERSA, FAMILIAL, 2 
PSMA6	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
PSMB8	NAKAJO SYNDROME 
PSMC3IP	OVARIAN DYSGENESIS 3 
PSPH	PHOSPHOSERINE PHOSPHATASE DEFICIENCY 
PSTPIP1	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE 
PTCH1	BASAL CELL NEVUS SYNDROME 
PTCH1	BASALCELLCARCINOMA,SUSCEPTIBILITYTO,1
PTCH1	HOLOPROSENCEPHALY 7 
PTCH1	MEDULLOBLASTOMA 
PTCH2	BASALCELLCARCINOMA,SUSCEPTIBILITYTO,1
PTCH2	MACROSTOMIA,ISOLATED
PTCH2	MEDULLOBLASTOMA 
PTEN	BANNAYAN-RILEY-RUVALCABA SYNDROME 
PTEN	CHROMOSOME 10q23 DELETION SYNDROME 
PTEN	COWDEN DISEASE 
PTEN	ENDOMETRIAL CANCER 
PTEN	GLIOMA SUSCEPTIBILITY 1 
PTEN	GLIOMA SUSCEPTIBILITY 2 
PTEN	JUVENILE POLYPOSIS SYNDROME 
PTEN	MACROCEPHALY/AUTISM SYNDROME 
PTEN	MELANOMA,CUTANEOUSMALIGNANT,SUSCEPTIBILITYTO,1
PTEN	MENINGIOMA, FAMILIAL 
PTEN	PROSTATE CANCER 
PTEN	PROTEUS SYNDROME 
PTEN	SQUAMOUS CELL CARCINOMA, HEAD AND NECK 
PTEN	THYROIDCARCINOMA,FOLLICULAR
PTEN	VACTERL ASSOCIATION WITH HYDROCEPHALUS 
PTF1A	DIABETES MELLITUS, PERMANENT NEONATAL, WITH CEREBELLAR AGENESIS 
PTGDR	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1 
PTGER2	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE 
PTGIS	HYPERTENSION, ESSENTIAL 
PTH	HYPOPARATHYROIDISM, FAMILIAL ISOLATED 
PTH1R	CHONDRODYSPLASIA, BLOMSTRAND TYPE 
PTH1R	EIKEN SKELETAL DYSPLASIA 
PTH1R	ENCHONDROMATOSIS,MULTIPLE
PTH1R	FAILURE OF TOOTH ERUPTION, PRIMARY 
PTH1R	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE 
PTHLH	BRACHYDACTYLY, TYPE E2 
PTPN1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
PTPN11	JUVENILE MYELOMONOCYTIC LEUKEMIA 
PTPN11	LEOPARD SYNDROME 1 
PTPN11	METACHONDROMATOSIS 
PTPN11	NOONAN SYNDROME 1 
PTPN14	CHOANAL ATRESIA AND LYMPHEDEMA 
PTPN22	DIABETESMELLITUS,INSULIN-DEPENDENT
PTPN22	RHEUMATOID ARTHRITIS 
PTPN22	SYSTEMIC LUPUS ERYTHEMATOSUS 
PTPRC	HEPATITIS C VIRUS, SUSCEPTIBILITY TO 
PTPRC	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO 
PTPRC	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
PTPRJ	COLORECTAL CANCER 
PTPRO	NEPHROTIC SYNDROME, TYPE 2 
PTPRO	NEPHROTIC SYNDROME, TYPE 6 
PTPRQ	DEAFNESS, AUTOSOMAL RECESSIVE 84 
PTPRZ1	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO 
PTRF	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4 
PTS	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A 
PUS1	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1 
PVRL1	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME 
PVRL1	ROSSELLI-GULIENETTISYNDROME
PVRL4	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1 
PYCR1	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB 
PYCR1	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA 
PYCR1	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB 
PYCR1	GERODERMA OSTEODYSPLASTICUM 
PYCR1	WRINKLY SKIN SYNDROME 
PYGL	GLYCOGEN STORAGE DISEASE VI 
PYGM	GLYCOGEN STORAGE DISEASE V 
PYY	OBESITY 
QDPR	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C 
RAB18	WARBURG MICRO SYNDROME 1 
RAB18	WARBURG MICRO SYNDROME 3 
RAB23	CARPENTER SYNDROME 
RAB27A	GRISCELLI SYNDROME, TYPE 2 
RAB39B	MENTAL RETARDATION, X-LINKED 72 
RAB3GAP1	WARBURG MICRO SYNDROME 1 
RAB3GAP2	MARTSOLF SYNDROME 
RAB3GAP2	WARBURG MICRO SYNDROME 2 
RAB7A	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B 
RAC2	NEUTROPHIL IMMUNODEFICIENCY SYNDROME 
RAD50	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER 
RAD51	BREAST CANCER 
RAD51B	LEIOMYOMA, UTERINE 
RAD51C	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3 
RAD51C	FANCONI ANEMIA, COMPLEMENTATION GROUP O 
RAD51D	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4 
RAD54L	BREAST CANCER 
RAD54L	LYMPHOMA, NON-HODGKIN, FAMILIAL 
RAF1	LEOPARD SYNDROME 2 
RAF1	NOONAN SYNDROME 5 
RAG1	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE 
RAG1	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS 
RAG1	OMENN SYNDROME 
RAG1	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
RAG2	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS 
RAG2	OMENN SYNDROME 
RAG2	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, 
RAI1	POTOCKI-LUPSKI SYNDROME 
RAI1	SMITH-MAGENIS SYNDROME 
RANBP2	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, 3, SUCEPTIBILITY TO 
RAPSN	FETAL AKINESIA DEFORMATION SEQUENCE 
RAPSN	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR 
RARA	ACUTE PROMYELOCYTIC LEUKEMIA 
RARS2	PONTOCEREBELLAR HYPOPLASIA, TYPE 6 
RASA1	BASALCELLCARCINOMA,SUSCEPTIBILITYTO,1
RASA1	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 
RASA1	PARKES WEBER SYNDROME 
RASGRP1	SYSTEMIC LUPUS ERYTHEMATOSUS 
RASSF1	LUNG CANCER 
RASSF8	SYNPOLYDACTYLY 2 
RAX	MICROPHTHALMIA, ISOLATED 3 
RAX2	CONE-ROD DYSTROPHY 11 
RAX2	MACULAR DEGENERATION, AGE-RELATED, 6 
RB1	BLADDER CANCER 
RB1	OSTEOGENIC SARCOMA 
RB1	RETINOBLASTOMA 
RB1	SMALLCELLCANCEROFTHELUNG
RB1CC1	BREAST CANCER 
RBM10	TARP SYNDROME 
RBM20	CARDIOMYOPATHY, DILATED, 1DD 
RBM28	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME 
RBMY1A1	SPERMATOGENIC FAILURE, Y-LINKED, 2 
RCBTB1	ALCOHOL DEPENDENCE 
RD3	LEBER CONGENITAL AMAUROSIS 12 
RDH12	LEBER CONGENITAL AMAUROSIS 13 
RDH12	LEBER CONGENITAL AMAUROSIS 3 
RDH5	FUNDUS ALBIPUNCTATUS 
RDX	DEAFNESS, AUTOSOMAL RECESSIVE 24 
RECQL4	BALLER-GEROLD SYNDROME 
RECQL4	RAPADILINO SYNDROME 
RECQL4	ROTHMUND-THOMSON SYNDROME 
REEP1	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT 
REG1A	PANCREATITIS, HEREDITARY 
RELN	LISSENCEPHALY 2 
REN	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2 
REN	RENAL TUBULAR DYSGENESIS 
RET	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL 
RET	COLORECTAL CANCER 
RET	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 
RET	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA 
RET	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB 
RET	PHEOCHROMOCYTOMA 
RET	RENAL ADYSPLASIA 
RET	THYROID CARCINOMA, FAMILIAL MEDULLARY 
RET	THYROID CARCINOMA, PAPILLARY 
RETN	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
RFC2	WILLIAMS-BEUREN SYNDROME 
RFT1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In 
RFX5	BARE LYMPHOCYTE SYNDROME, TYPE II 
RFX6	PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA 
RFXANK	BARE LYMPHOCYTE SYNDROME, TYPE II 
RFXAP	BARE LYMPHOCYTE SYNDROME, TYPE II 
RGR	RETINITIS PIGMENTOSA 44 
RGS4	SCHIZOPHRENIA 
RGS4	SCHIZOPHRENIA 9 
RGS5	HYPERTENSION, ESSENTIAL 
RGS9	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 
RGS9BP	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION 
RHAG	RH-NULL, REGULATOR TYPE 
RHAG	STOMATOCYTOSISI
RHCE	BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE 
RHO	FUNDUS ALBIPUNCTATUS 
RHO	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1 
RHO	RETINITIS PIGMENTOSA 4 
RIMS1	CONE-ROD DYSTROPHY 7 
RIN2	MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS 
RLBP1	BOTHNIA RETINAL DYSTROPHY 
RLBP1	FUNDUS ALBIPUNCTATUS 
RLBP1	NEWFOUNDLAND ROD-CONE DYSTROPHY 
RLBP1	RETINITIS PIGMENTOSA 
RNASEH2A	AICARDI-GOUTIERES SYNDROME 4 
RNASEH2B	AICARDI-GOUTIERES SYNDROME 2 
RNASEH2C	AICARDI-GOUTIERES SYNDROME 3 
RNASEL	PROSTATE CANCER 
RNASEL	PROSTATE CANCER, HEREDITARY, 1 
RNASET2	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY 
RNF114	PSORIASISSUSCEPTIBILITY12
RNF135	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB 
RNF135	MACROCEPHALY, MACROSOMIA, FACIAL DYSMORPHISM SYNDROME 
RNF139	RENAL CELL CARCINOMA, NONPAPILLARY 
RNF168	RIDDLE SYNDROME 
RNF212	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1 
RNF213	MOYAMOYA DISEASE 2 
RNF6	ESOPHAGEAL CANCER 
ROBO2	VESICOURETERAL REFLUX 2 
ROBO3	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 
ROM1	RETINITIS PIGMENTOSA 
ROR2	BRACHYDACTYLY, TYPE B1 
ROR2	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 
RP1	HYPERTRIGLYCERIDEMIA, FAMILIAL 
RP1	RETINITIS PIGMENTOSA 1 
RP11-155D18.11.1	AMINOACYLASE 1 DEFICIENCY 
RP11-566K11.2.1	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 
RP11-566K11.2.1	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR 
RP1L1	OCCULT MACULAR DYSTROPHY 
RP2	CHROMOSOME Xp11.3 DELETION SYNDROME 
RP2	RETINITIS PIGMENTOSA 2 
RP4-559A3.7.1	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA 
RP4-559A3.7.1	GERODERMA OSTEODYSPLASTICUM 
RP4-559A3.7.1	WRINKLY SKIN SYNDROME 
RP9	RETINITIS PIGMENTOSA 
RP9	RETINITIS PIGMENTOSA 9 
RPE65	LEBER CONGENITAL AMAUROSIS 2 
RPE65	RETINITIS PIGMENTOSA 20 
RPGR	CONE-ROD DYSTROPHY, X-LINKED, 1 
RPGR	MACULAR DEGENERATION, X-LINKED ATROPHIC 
RPGR	RETINITIS PIGMENTOSA 3 
RPGR	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH 
RPGRIP1	CONE-ROD DYSTROPHY 13 
RPGRIP1	LEBER CONGENITAL AMAUROSIS 6 
RPGRIP1L	COACH SYNDROME 
RPGRIP1L	JOUBERT SYNDROME 7 
RPGRIP1L	MECKEL SYNDROME, TYPE 5 
RPIA	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY 
RPL10	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5 
RPL11	DIAMOND-BLACKFAN ANEMIA 7 
RPL35A	DIAMOND-BLACKFAN ANEMIA 5 
RPL5	DIAMOND-BLACKFAN ANEMIA 6 
RPS10	DIAMOND-BLACKFAN ANEMIA 9 
RPS14	CHROMOSOME 5q DELETION SYNDROME 
RPS17	DIAMOND-BLACKFAN ANEMIA 4 
RPS17L	DIAMOND-BLACKFAN ANEMIA 4 
RPS19	DIAMOND-BLACKFAN ANEMIA 
RPS24	DIAMOND-BLACKFAN ANEMIA 3 
RPS26	DIAMOND-BLACKFAN ANEMIA 10 
RPS6KA3	COFFIN-LOWRY SYNDROME 
RPS6KA3	MENTAL RETARDATION, X-LINKED 19 
RPS7	DIAMOND-BLACKFAN ANEMIA 8 
RPSA	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5 
RRAS2	OVARIAN CANCER 
RRM2B	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH 
RRM2B	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, 
RS1	RETINOSCHISIS 1, X-LINKED, JUVENILE 
RSPH4A	CILIARY DYSKINESIA, PRIMARY, 11 
RSPH9	CILIARY DYSKINESIA, PRIMARY, 12 
RSPO1	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 
RSPO4	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4 
RTL1	UNIPARENTAL DISOMY, PATERNAL, CHROMOSOME 14 
RTN4R	SCHIZOPHRENIA 
RUNX1	LEUKEMIA, ACUTE MYELOID 
RUNX1	LEUKEMIA, CHRONIC MYELOID 
RUNX1	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY 
RUNX1	RHEUMATOID ARTHRITIS 
RUNX1T1	COLORECTAL CANCER 
RUNX2	CLEIDOCRANIAL DYSPLASIA 
RXFP2	CRYPTORCHIDISM, UNILATERAL OR BILATERAL 
RYR1	CENTRAL CORE DISEASE OF MUSCLE 
RYR1	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1 
RYR1	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA 
RYR1	MYOPATHY, CENTRONUCLEAR, 1 
RYR1	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION 
RYR2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 
RYR2	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR 
SACS	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE 
SAG	OGUCHI DISEASE 1 
SAG	RETINITIS PIGMENTOSA 47 
SALL1	TOWNES-BROCKS SYNDROME 
SALL4	DUANE-RADIAL RAY SYNDROME 
SALL4	IVIC SYNDROME 
SAMD9	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL 
SAMHD1	AICARDI-GOUTIERES SYNDROME 5 
SAMHD1	CHILBLAIN LUPUS 2 
SAR1B	CHYLOMICRON RETENTION DISEASE 
SARS2	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS 
SART3	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1 
SAT1	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED 
SATB2	CHROMOSOME 2q32-q33 DELETION SYNDROME 
SATB2	CLEFT PALATE, ISOLATED 
SBDS	APLASTIC ANEMIA 
SBDS	SHWACHMAN-DIAMOND SYNDROME 
SBF2	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2 
SC5DL	LATHOSTEROLOSIS 
SCARB1	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 
SCARB2	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE 
SCARF2	VAN DEN ENDE-GUPTA SYNDROME 
SCGB1A1	ASTHMA, SUSCEPTIBILITY TO 
SCGB3A2	ASTHMA, SUSCEPTIBILITY TO 
SCN1A	DRAVET SYNDROME 
SCN1A	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 
SCN1A	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2 
SCN1A	MIGRAINE, FAMILIAL HEMIPLEGIC, 3 
SCN1B	BRUGADA SYNDROME 5 
SCN1B	DRAVET SYNDROME 
SCN1B	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 
SCN2A	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11 
SCN2A	SEIZURES, BENIGN FAMILIAL INFANTILE, 3 
SCN3B	BRUGADA SYNDROME 7 
SCN4A	HYPERKALEMIC PERIODIC PARALYSIS 
SCN4A	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 
SCN4A	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2 
SCN4A	MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE 
SCN4A	MYOTONIA, POTASSIUM-AGGRAVATED 
SCN4A	PARAMYOTONIA CONGENITA OF VON EULENBURG 
SCN4B	LONG QT SYNDROME 10 
SCN5A	ATRIAL FIBRILLATION, FAMILIAL, 10 
SCN5A	ATRIAL STANDSTILL 
SCN5A	BRUGADA SYNDROME 1 
SCN5A	CARDIOMYOPATHY, DILATED, 1E 
SCN5A	LONG QT SYNDROME 3 
SCN5A	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA 
SCN5A	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE 
SCN5A	SUDDEN INFANT DEATH SYNDROME 
SCN5A	VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY 
SCN8A	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA 
SCN9A	DRAVET SYNDROME 
SCN9A	ERYTHERMALGIA, PRIMARY 
SCN9A	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2 
SCN9A	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7 
SCN9A	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE 
SCN9A	PAROXYSMAL EXTREME PAIN DISORDER 
SCNN1A	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2 
SCNN1A	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE 
SCNN1B	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1 
SCNN1B	LIDDLE SYNDROME 
SCNN1B	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE 
SCNN1G	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3 
SCNN1G	LIDDLE SYNDROME 
SCNN1G	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE 
SCO1	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE 
SCO1	MITOCHONDRIAL COMPLEX IV DEFICIENCY 
SCO2	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE 
SCP2	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY 
SDC3	OBESITY 
SDCCAG8	SENIOR-LOKEN SYNDROME 7 
SDHA	CARDIOMYOPATHY, DILATED, 1GG 
SDHA	LEIGH SYNDROME 
SDHA	MITOCHONDRIAL COMPLEX II DEFICIENCY 
SDHA	PARAGANGLIOMAS 5 
SDHAF1	MITOCHONDRIAL COMPLEX II DEFICIENCY 
SDHAF2	PARAGANGLIOMAS 2 
SDHB	COWDEN-LIKE SYNDROME 
SDHB	GASTROINTESTINAL STROMAL TUMOR 
SDHB	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA 
SDHB	PARAGANGLIOMAS 4 
SDHB	PHEOCHROMOCYTOMA 
SDHC	GASTROINTESTINAL STROMAL TUMOR 
SDHC	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA 
SDHC	PARAGANGLIOMAS 3 
SDHD	CARCINOID TUMORS, INTESTINAL 
SDHD	COWDEN-LIKE SYNDROME 
SDHD	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA 
SDHD	PARAGANGLIOMAS 1 
SDHD	PHEOCHROMOCYTOMA 
SEC23A	CRANIOLENTICULOSUTURAL DYSPLASIA 
SEC23B	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II 
SEC63	POLYCYSTIC LIVER DISEASE 
SECISBP2	THYROID HORMONE METABOLISM, ABNORMAL 
SELE	HYPERTENSION, ESSENTIAL 
SELE	IgANEPHROPATHY,SUSCEPTIBILITYTO,1
SELL	IgANEPHROPATHY,SUSCEPTIBILITYTO,1
SELP	IgE RESPONSIVENESS, ATOPIC 
SELP	STROKE, ISCHEMIC 
SEMA3E	CHARGE SYNDROME 
SEMA4A	CONE-ROD DYSTROPHY 10 
SEMA4A	RETINITIS PIGMENTOSA 35 
SEMA5A	CRI-DU-CHAT SYNDROME 
SEPN1	RIGID SPINE MUSCULAR DYSTROPHY 1 
SEPSECS	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D 
SEPT9	AMYOTROPHY, HEREDITARY NEURALGIC 
SERPINA1	ALPHA-1-ANTITRYPSIN DEFICIENCY 
SERPINA1	PULMONARYDISEASE,CHRONICOBSTRUCTIVE
SERPINA6	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY 
SERPINB6	DEAFNESS, AUTOSOMAL RECESSIVE 91 
SERPINC1	ANTITHROMBIN III DEFICIENCY 
SERPINC1	THROMBOSIS, SUSCEPTIBILITY TO 
SERPIND1	HEPARIN COFACTOR II DEFICIENCY 
SERPIND1	THROMBOSIS, SUSCEPTIBILITY TO 
SERPINE1	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY 
SERPINF1	OSTEOGENESIS IMPERFECTA, TYPE VI 
SERPINF2	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY 
SERPING1	ANGIOEDEMA, HEREDITARY, TYPE I 
SERPING1	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF 
SERPINH1	OSTEOGENESIS IMPERFECTA, TYPE X 
SERPINH1	PRETERM PREMATURE RUPTURE OF THE MEMBRANES 
SERPINI1	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES 
SETBP1	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME 
SETX	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE 
SETX	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1 
SF3B1	MYELODYSPLASTIC SYNDROME 
SFTPA1	PULMONARY FIBROSIS, IDIOPATHIC 
SFTPA1	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS 
SFTPA2	PULMONARY FIBROSIS, IDIOPATHIC 
SFTPB	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS 
SFTPB	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1 
SFTPC	INTERSTITIALPNEUMONITIS,DESQUAMATIVE,FAMILIAL
SFTPC	PULMONARY FIBROSIS, IDIOPATHIC 
SFTPC	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS 
SFTPC	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1 
SFTPC	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2 
SGCA	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D 
SGCB	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E 
SGCD	CARDIOMYOPATHY, DILATED, 1L 
SGCD	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F 
SGCE	MYOCLONIC DYSTONIA 
SGCG	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C 
SGSH	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT 
SGSH	MUCOPOLYSACCHARIDOSIS TYPE IIIA 
SH2B3	CELIACDISEASE,SUSCEPTIBILITYTO,13
SH2B3	DIABETESMELLITUS,INSULIN-DEPENDENT
SH2B3	ERYTHROCYTOSIS, FAMILIAL, 1 
SH2B3	MYELOFIBROSIS 
SH2B3	THROMBOCYTHEMIA, ESSENTIAL 
SH2D1A	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1 
SH3BP2	CHERUBISM 
SH3GL1	LEUKEMIA, ACUTE MYELOID 
SH3PXD2B	FRANK-TER HAAR SYNDROME 
SH3TC2	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C 
SH3TC2	MONONEUROPATHY OF THE MEDIAN NERVE, MILD 
SHANK2	AUTISM, SUSCEPTIBILITY TO, 17 
SHANK3	CHROMOSOME 22q13.3 DELETION SYNDROME 
SHANK3	SCHIZOPHRENIA 15 
SHFM1	SPLIT-HAND/FOOTMALFORMATION1
SHFM1	SPLIT-HAND/FOOTMALFORMATION1WITHSENSORINEURALHEARINGLOSS
SHH	COLOBOMA, OCULAR 
SHH	HOLOPROSENCEPHALY 3 
SHH	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5 
SHH	POLYDACTYLY, PREAXIAL II 
SHH	SCHIZENCEPHALY 
SHH	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR 
SHOC2	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 
SHOX	LANGER MESOMELIC DYSPLASIA 
SHOX	LERI-WEILL DYSCHONDROSTEOSIS 
SHOX	SHORT STATURE, IDIOPATHIC, AUTOSOMAL 
SHOX	SHORT STATURE, IDIOPATHIC, X-LINKED 
SHROOM4	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME 
SI	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL 
SIAE	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6 
SIGMAR1	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE 
SIL1	MARINESCO-SJOGREN SYNDROME 
SIM1	OBESITY 
SIX1	BRANCHIOOTIC SYNDROME 3 
SIX1	DEAFNESS, AUTOSOMAL DOMINANT 23 
SIX3	HOLOPROSENCEPHALY 2 
SIX3	SCHIZENCEPHALY 
SIX5	BRANCHIOOTORENAL SYNDROME 2 
SIX6	MICROPHTHALMIA, ISOLATED, WITH CATARACT 2 
SLC10A2	BILE ACID MALABSORPTION, PRIMARY 
SLC11A1	BURULI ULCER, SUSCEPTIBILITY TO 
SLC11A1	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
SLC11A2	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 
SLC12A1	BARTTER SYNDROME, ANTENATAL, TYPE 1 
SLC12A3	GITELMAN SYNDROME 
SLC12A6	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY 
SLC14A1	BLOOD GROUP--KIDD SYSTEM 
SLC16A1	ERYTHROCYTE LACTATE TRANSPORTER DEFECT 
SLC16A1	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7 
SLC16A12	CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA 
SLC16A2	ALLAN-HERNDON-DUDLEY SYNDROME 
SLC17A3	GLYCOGEN STORAGE DISEASE Ic 
SLC17A5	INFANTILE SIALIC ACID STORAGE DISORDER 
SLC17A5	SIALURIA, FINNISH TYPE 
SLC17A8	DEAFNESS, AUTOSOMAL DOMINANT 25 
SLC19A2	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME 
SLC19A3	BASAL GANGLIA DISEASE, BIOTIN-RESPONSIVE 
SLC1A3	ALTERNATING HEMIPLEGIA OF CHILDHOOD 
SLC1A3	EPISODIC ATAXIA, TYPE 6 
SLC22A12	HYPOURICEMIA, RENAL, 1 
SLC22A18	BREAST CANCER 
SLC22A18	LUNG CANCER 
SLC22A18	RHABDOMYOSARCOMA 1 
SLC22A4	INFLAMMATORY BOWEL DISEASE 1 
SLC22A4	RHEUMATOID ARTHRITIS 
SLC22A5	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY 
SLC24A1	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D 
SLC24A4	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6 
SLC24A5	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4 
SLC25A12	HYPOMYELINATION, GLOBAL CEREBRAL 
SLC25A13	CITRULLINEMIA, TYPE II, ADULT-ONSET 
SLC25A13	CITRULLINEMIA, TYPE II, NEONATAL-ONSET 
SLC25A15	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME 
SLC25A19	MICROCEPHALY, AMISH TYPE 
SLC25A19	STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY 
SLC25A20	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY 
SLC25A22	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3 
SLC25A3	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY 
SLC25A38	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE 
SLC25A4	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
SLC25A4	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, 
SLC26A2	ACHONDROGENESIS, TYPE IB 
SLC26A2	ATELOSTEOGENESIS, TYPE II 
SLC26A2	DIASTROPHIC DYSPLASIA 
SLC26A2	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4 
SLC26A3	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL 
SLC26A4	ENLARGED VESTIBULAR AQUEDUCT 
SLC26A4	PENDRED SYNDROME 
SLC26A5	DEAFNESS, AUTOSOMAL RECESSIVE 61 
SLC27A4	ICHTHYOSIS PREMATURITY SYNDROME 
SLC29A3	HISTIOCYTOSISWITHJOINTCONTRACTURESANDSENSORINEURALDEAFNESS
SLC29A3	HYPERPIGMENTATION, CUTANEOUS, WITH HYPERTRICHOSIS, HEPATOSPLENOMEGALY, 
SLC2A1	GLUT1 DEFICIENCY SYNDROME 1 
SLC2A1	GLUT1 DEFICIENCY SYNDROME 2 
SLC2A10	ARTERIAL TORTUOSITY SYNDROME 
SLC2A2	FANCONI-BICKEL SYNDROME 
SLC2A4	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
SLC2A9	HYPOURICEMIA, RENAL, 2 
SLC30A8	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
SLC33A1	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT 
SLC34A1	FANCONI RENOTUBULAR SYNDROME 2 
SLC34A1	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1 
SLC34A2	PULMONARY ALVEOLAR MICROLITHIASIS 
SLC34A2	TESTICULARMICROLITHIASIS
SLC34A3	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY 
SLC35A1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf 
SLC35C1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc 
SLC35D1	SCHNECKENBECKEN DYSPLASIA 
SLC36A2	HYPERGLYCINURIA 
SLC36A2	IMINOGLYCINURIA 
SLC37A4	GLYCOGEN STORAGE DISEASE Ib 
SLC37A4	GLYCOGEN STORAGE DISEASE Ic 
SLC39A13	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE 
SLC39A4	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE 
SLC3A1	CYSTINURIA 
SLC3A1	HYPOTONIA-CYSTINURIA SYNDROME 
SLC40A1	HEMOCHROMATOSIS, TYPE 4 
SLC44A4	NEURAMINIDASE DEFICIENCY 
SLC45A2	ALBINISM, OCULOCUTANEOUS, TYPE IV 
SLC45A2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5 
SLC46A1	FOLATE MALABSORPTION, HEREDITARY 
SLC4A1	BLOOD GROUP--DIEGO SYSTEM 
SLC4A1	BLOOD GROUP--FROESE 
SLC4A1	BLOOD GROUP--SWANN SYSTEM 
SLC4A1	BLOOD GROUP--WALDNER TYPE 
SLC4A1	BLOOD GROUP--WRIGHT ANTIGEN 
SLC4A1	ELLIPTOCYTOSIS 2 
SLC4A1	MALARIA, SUSCEPTIBILITY TO 
SLC4A1	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT 
SLC4A1	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE 
SLC4A1	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA 
SLC4A1	SPHEROCYTOSIS, TYPE 4 
SLC4A11	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS 
SLC4A11	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4 
SLC4A11	CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE 
SLC4A4	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL 
SLC5A1	GLUCOSE/GALACTOSE MALABSORPTION 
SLC5A2	RENAL GLUCOSURIA 
SLC5A5	THYROID DYSHORMONOGENESIS 1 
SLC6A14	BODYMASSINDEXQUANTITATIVETRAITLOCUS11
SLC6A18	IMINOGLYCINURIA 
SLC6A19	HARTNUP DISORDER 
SLC6A19	HYPERGLYCINURIA 
SLC6A19	IMINOGLYCINURIA 
SLC6A2	ORTHOSTATIC INTOLERANCE 
SLC6A20	HYPERGLYCINURIA 
SLC6A20	IMINOGLYCINURIA 
SLC6A3	ATTENTION DEFICIT-HYPERACTIVITY DISORDER 
SLC6A3	MAJORAFFECTIVEDISORDER1
SLC6A3	PARKINSONISM-DYSTONIA, INFANTILE 
SLC6A3	TOBACCO ADDICTION, SUSCEPTIBILITY TO 
SLC6A4	ALCOHOL DEPENDENCE 
SLC6A4	ANXIETY
SLC6A4	OBSESSIVE-COMPULSIVE DISORDER 
SLC6A5	HYPEREKPLEXIA, HEREDITARY 
SLC6A8	CREATINE DEFICIENCY SYNDROME, X-LINKED 
SLC7A7	LYSINURIC PROTEIN INTOLERANCE 
SLC7A9	CYSTINURIA 
SLC9A3R1	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2 
SLC9A6	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE 
SLC9A9	AUTISM, SUSCEPTIBILITY TO, 16 
SLCO1B1	HYPERBILIRUBINEMIA, ROTOR TYPE 
SLCO1B3	HYPERBILIRUBINEMIA, ROTOR TYPE 
SLCO2A1	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2 
SLCO5A1	MESOMELIA-SYNOSTOSES SYNDROME 
SLITRK1	GILLES DE LA TOURETTE SYNDROME 
SLITRK1	TRICHOTILLOMANIA 
SLURP1	MAL DE MELEDA 
SLX4	FANCONI ANEMIA, COMPLEMENTATION GROUP P 
SMAD1	PULMONARY HYPERTENSION, PRIMARY, 1 
SMAD3	COLORECTAL CANCER 
SMAD3	LOEYS-DIETZ SYNDROME, TYPE 1C 
SMAD4	COLORECTAL CANCER 
SMAD4	JUVENILE POLYPOSIS SYNDROME 
SMAD4	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME 
SMAD4	PANCREATIC CANCER 
SMAD4	PULMONARY HYPERTENSION, PRIMARY, 1 
SMAD7	COLORECTAL CANCER 
SMAD7	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3 
SMAD9	PULMONARY HYPERTENSION, PRIMARY, 1 
SMARCA4	RHABDOID TUMOR PREDISPOSITION SYNDROME 2 
SMARCAD1	ADERMATOGLYPHIA 
SMARCAL1	IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE 
SMARCB1	MENINGIOMA, FAMILIAL 
SMARCB1	RHABDOID TUMOR PREDISPOSITION SYNDROME 1 
SMARCB1	SCHWANNOMATOSIS 
SMC1A	CORNELIA DE LANGE SYNDROME 2 
SMC3	CORNELIA DE LANGE SYNDROME 3 
SMN1	ARTHROGRYPOSISMULTIPLEXCONGENITA,NEUROGENICTYPE
SMN1	SPINAL MUSCULAR ATROPHY, TYPE I 
SMN1	SPINAL MUSCULAR ATROPHY, TYPE II 
SMN1	SPINAL MUSCULAR ATROPHY, TYPE III 
SMN1	SPINAL MUSCULAR ATROPHY, TYPE IV 
SMN2	ARTHROGRYPOSISMULTIPLEXCONGENITA,NEUROGENICTYPE
SMN2	SPINAL MUSCULAR ATROPHY, TYPE I 
SMN2	SPINAL MUSCULAR ATROPHY, TYPE II 
SMN2	SPINAL MUSCULAR ATROPHY, TYPE III 
SMN2	SPINAL MUSCULAR ATROPHY, TYPE IV 
SMOC1	MICROPHTHALMIA WITH LIMB ANOMALIES 
SMOC2	DENTIN DYSPLASIA, TYPE I 
SMPD1	NIEMANN-PICK DISEASE, TYPE A 
SMPD1	NIEMANN-PICK DISEASE, TYPE B 
SMPX	DEAFNESS, X-LINKED 4 
SMS	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE 
SNAI2	PIEBALD TRAIT 
SNAI2	WAARDENBURG SYNDROME, TYPE 2D 
SNAP29	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA 
SNCA	DEMENTIA, LEWY BODY 
SNCA	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT 
SNCA	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT 
SNCA	PARKINSON DISEASE, LATE-ONSET 
SNCAIP	PARKINSON DISEASE, LATE-ONSET 
SNCB	DEMENTIA, LEWY BODY 
SNRNP200	RETINITIS PIGMENTOSA 33 
SNRPN	PRADER-WILLI SYNDROME 
SNTA1	LONG QT SYNDROME 12 
SNX3	MICROPHTHALMIA,SYNDROMIC8
SOBP	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS 
SOCS3	DERMATITIS,ATOPIC,4
SOD1	AMYOTROPHIC LATERAL SCLEROSIS 1 
SOD2	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6 
SORL1	ALZHEIMER DISEASE 
SORT1	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 
SOS1	FIBROMATOSIS, GINGIVAL, 1 
SOS1	NOONAN SYNDROME 1 
SOS1	NOONAN SYNDROME 4 
SOST	HYPEROSTOSIS CORTICALIS GENERALISATA 
SOST	SCLEROSTEOSIS 1 
SOX10	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG 
SOX10	WAARDENBURG SYNDROME, TYPE 2E 
SOX10	WAARDENBURG SYNDROME, TYPE 4A 
SOX10	WAARDENBURG SYNDROME, TYPE 4C 
SOX17	VESICOURETERAL REFLUX 3 
SOX18	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME 
SOX2	MICROPHTHALMIA, SYNDROMIC 3 
SOX2	SEPTOOPTIC DYSPLASIA 
SOX3	46,XX SEX REVERSAL 3 
SOX3	MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM 
SOX3	PANHYPOPITUITARISM, X-LINKED 
SOX3	SEPTOOPTIC DYSPLASIA 
SOX9	46,XX SEX REVERSAL 2 
SOX9	CAMPOMELIC DYSPLASIA 
SP110	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY 
SP110	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
SP7	OSTEOGENESIS IMPERFECTA, TYPE XII 
SPAST	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT 
SPATA16	SPERMATOGENIC FAILURE 6 
SPATA7	LEBER CONGENITAL AMAUROSIS 3 
SPATA7	RETINITIS PIGMENTOSA 
SPECC1L	FACIAL CLEFTING, OBLIQUE, 1 
SPECC1L	MACROSTOMIA,ISOLATED
SPG11	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE 
SPG20	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE 
SPG21	MAST SYNDROME 
SPG7	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE 
SPINK1	PANCREATITIS, HEREDITARY 
SPINK1	TROPICAL CALCIFIC PANCREATITIS 
SPINK5	IgE RESPONSIVENESS, ATOPIC 
SPINK5	NETHERTON SYNDROME 
SPINT2	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL 
SPR	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY 
SPRED1	LEGIUS SYNDROME 
SPTA1	ELLIPTOCYTOSIS 2 
SPTA1	PYROPOIKILOCYTOSIS, HEREDITARY 
SPTA1	SPHEROCYTOSIS, TYPE 3 
SPTAN1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5 
SPTB	ELLIPTOCYTOSIS 2 
SPTBN2	SPINOCEREBELLAR ATAXIA 5 
SPTLC1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA 
SPTLC2	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC 
SQSTM1	PAGET DISEASE OF BONE 
SRD5A2	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS 
SRD5A3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq 
SRD5A3	KAHRIZI SYNDROME 
SRPX2	CENTRALOPATHICEPILEPSY
SRPX2	POLYMICROGYRIA,BILATERALPERISYLVIAN
SRPX2	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED 
SRY	46,XX SEX REVERSAL 1 
SRY	46,XY SEX REVERSAL 1 
SSTR5	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING 
ST14	ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE 
ST3GAL3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12 
ST3GAL5	AMISH INFANTILE EPILEPSY SYNDROME 
STAR	LIPOID CONGENITAL ADRENAL HYPERPLASIA 
STAT1	ATYPICAL MYCOBACTERIOSIS, FAMILIAL 
STAT1	CANDIDIASIS, FAMILIAL, 7 
STAT1	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE 
STAT3	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT 
STAT4	RHEUMATOID ARTHRITIS 
STAT4	SYSTEMIC LUPUS ERYTHEMATOSUS 
STAT4	SYSTEMICLUPUSERYTHEMATOSUS,SUSCEPTIBILITYTO,11
STAT5B	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY 
STIL	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE 
STIM1	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 
STK10	TESTICULAR GERM CELL TUMOR 
STK11	PEUTZ-JEGHERS SYNDROME 
STK11	TESTICULAR GERM CELL TUMOR 
STOM	STOMATOCYTOSISI
STOX1	PREECLAMPSIA/ECLAMPSIA 4 
STOX1	PREECLAMPSIA/ECLAMPSIA1
STRA6	MICROPHTHALMIA, SYNDROMIC 9 
STRADA	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY 
STRC	DEAFNESS, AUTOSOMAL RECESSIVE 16 
STRC	DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY 
STS	ICHTHYOSIS, X-LINKED 
STX11	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4 
STX16	PSEUDOHYPOPARATHYROIDISM, TYPE IB 
STXBP1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4 
STXBP2	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5 
SUCLA2	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE) 
SUCLA2	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE) 
SUCLA2	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH METHYLMALONIC 
SUCLG1	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH 
SUFU	MEDULLOBLASTOMA 
SULF1	MESOMELIA-SYNOSTOSES SYNDROME 
SUMF1	MULTIPLE SULFATASE DEFICIENCY 
SUMO1	OROFACIAL CLEFT 10 
SUMO4	DIABETES MELLITUS, INSULIN-DEPENDENT, 5 
SUOX	SULFOCYSTEINURIA 
SURF1	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE 
SURF1	LEIGH SYNDROME 
SUZ12	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB 
SYCP3	SPERMATOGENIC FAILURE 4 
SYN1	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR 
SYN2	SCHIZOPHRENIA 
SYNE1	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT 
SYNE1	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8 
SYNE2	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT 
SYNGAP1	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5 
SYP	MENTAL RETARDATION, X-LINKED 96 
SYT14	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11 
T	CHORDOMA, SUSCEPTIBILITY TO 
T	NEURAL TUBE DEFECTS 
T	SACRAL DEFECT WITH ANTERIOR MENINGOCELE 
TAAR6	SCHIZOPHRENIA5
TAB2	CHROMOSOME 6q24-q25 DELETION SYNDROME 
TAC3	HYPOGONADOTROPIC HYPOGONADISM 
TACC3	BLADDER CANCER 
TACO1	LEIGH SYNDROME 
TACR3	HYPOGONADOTROPIC HYPOGONADISM 
TACSTD2	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE 
TAF1	DYSTONIA 3, TORSION, X-LINKED 
TAF15	CHONDROSARCOMA, EXTRASKELETAL MYXOID 
TAF8	YT BLOOD GROUP ANTIGEN 
TAGAP	DIABETESMELLITUS,INSULIN-DEPENDENT,21
TALDO1	TRANSALDOLASE DEFICIENCY 
TAP1	BARE LYMPHOCYTE SYNDROME, TYPE I 
TAP2	BARE LYMPHOCYTE SYNDROME, TYPE I 
TAP2	BARE LYMPHOCYTE SYNDROME, TYPE II 
TAPBP	BARE LYMPHOCYTE SYNDROME, TYPE I 
TARDBP	AMYOTROPHIC LATERAL SCLEROSIS 10, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 
TARDBP	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 
TAS2R16	ALCOHOL DEPENDENCE 
TAS2R38	THIOUREA TASTING 
TAT	TYROSINEMIA, TYPE II 
TAZ	BARTH SYNDROME 
TAZ	CARDIOMYOPATHY, DILATED, 3A 
TAZ	LEFT VENTRICULAR NONCOMPACTION, X-LINKED 
TBC1D24	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE 
TBCE	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME 
TBCE	KENNY-CAFFEY SYNDROME, TYPE 1 
TBL2	WILLIAMS-BEUREN SYNDROME 
TBP	PARKINSON DISEASE, LATE-ONSET 
TBP	SPINOCEREBELLAR ATAXIA 17 
TBX1	CHROMOSOME 22q11.2 DUPLICATION SYNDROME 
TBX1	CONOTRUNCAL HEART MALFORMATIONS 
TBX1	DIGEORGE SYNDROME 
TBX1	VELOCARDIOFACIAL SYNDROME 
TBX15	COUSIN SYNDROME 
TBX19	ACTH DEFICIENCY, ISOLATED 
TBX2	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME 
TBX20	ATRIAL SEPTAL DEFECT 4 
TBX21	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE 
TBX22	CLEFT PALATE, X-LINKED 
TBX3	ULNAR-MAMMARY SYNDROME 
TBX4	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME 
TBX4	SMALL PATELLA SYNDROME 
TBX5	HOLT-ORAM SYNDROME 
TBX6	DEAFNESS, AUTOSOMAL RECESSIVE 67 
TBXA2R	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO 
TBXAS1	GHOSAL HEMATODIAPHYSEAL DYSPLASIA 
TCAP	CARDIOMYOPATHY, DILATED, 1N 
TCAP	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
TCAP	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G 
TCF4	PALLISTER-HALL SYNDROME 
TCF4	PITT-HOPKINS SYNDROME 
TCF7L2	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
TCIRG1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1 
TCN2	TRANSCOBALAMIN II DEFICIENCY 
TCOF1	TREACHER COLLINS SYNDROME 1 
TCTN1	JOUBERT SYNDROME 13 
TCTN2	MECKEL SYNDROME, TYPE 8 
TDP1	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 
TDRD7	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4 
TEAD1	SVEINSSON CHORIORETINAL ATROPHY 
TECR	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14 
TECTA	DEAFNESS, AUTOSOMAL DOMINANT 12 
TECTA	DEAFNESS, AUTOSOMAL RECESSIVE 21 
TEK	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL 
TERT	APLASTIC ANEMIA 
TERT	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1 
TERT	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2 
TERT	PULMONARY FIBROSIS, IDIOPATHIC 
TET2	MYELODYSPLASTIC SYNDROME 
TET2	MYELOFIBROSIS 
TET2	POLYCYTHEMIA VERA 
TET2	THROMBOCYTHEMIA, ESSENTIAL 
TET2	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT 
TF	ATRANSFERRINEMIA 
TFAP2A	BRANCHIOOCULOFACIAL SYNDROME 
TFAP2B	CHAR SYNDROME 
TFE3	ALVEOLAR SOFT PART SARCOMA 
TFE3	RENAL CELL CARCINOMA, PAPILLARY, 1 
TFE3	RENAL CELL CARCINOMA, Xp11-ASSOCIATED 
TFG	CHONDROSARCOMA, EXTRASKELETAL MYXOID 
TFG	THYROID CARCINOMA, PAPILLARY 
TFR2	HEMOCHROMATOSIS, TYPE 3 
TG	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3 
TG	THYROID DYSHORMONOGENESIS 3 
TGFB1	CAMURATI-ENGELMANN DISEASE 
TGFB1	CORNEAL DYSTROPHY, AVELLINO TYPE 
TGFB1	CYSTIC FIBROSIS 
TGFB2	PETERS ANOMALY 
TGFB3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1 
TGFBI	CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I 
TGFBI	CORNEAL DYSTROPHY, AVELLINO TYPE 
TGFBI	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE 
TGFBI	CORNEAL DYSTROPHY, GROENOUW TYPE I 
TGFBI	CORNEAL DYSTROPHY, LATTICE TYPE I 
TGFBI	CORNEAL DYSTROPHY, LATTICE TYPE IIIA 
TGFBI	CORNEALDYSTROPHYOFBOWMANLAYER,TYPEII
TGFBR1	AUDITORYNEUROPATHY,AUTOSOMALDOMINANT,1
TGFBR1	LOEYS-DIETZ SYNDROME, TYPE 1A 
TGFBR1	LOEYS-DIETZ SYNDROME, TYPE 2A 
TGFBR1	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO 
TGFBR2	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6 
TGFBR2	ESOPHAGEAL CANCER 
TGFBR2	LOEYS-DIETZ SYNDROME, TYPE 1B 
TGFBR2	LOEYS-DIETZ SYNDROME, TYPE 2B 
TGFBR2	MARFAN SYNDROME 
TGIF1	HOLOPROSENCEPHALY 4 
TGIF1	HYPOTRICHOSIS 1 
TGM1	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1 
TGM1	ICHTHYOSIS, LAMELLAR, 1 
TGM5	PEELING SKIN SYNDROME 
TGM5	PEELING SKIN SYNDROME, ACRAL TYPE 
TGM6	SPINOCEREBELLAR ATAXIA 35 
TH	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE 
THAP1	DYSTONIA 6, TORSION 
THBD	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6 
THBD	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
THBS2	INTERVERTEBRAL DISC DISEASE 
THPO	THROMBOCYTHEMIA, ESSENTIAL 
THRA	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6 
THRB	HYPOTHYROIDISM,CONGENITAL,NONGOITROUS,3
THRB	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT 
THRB	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE 
THRB	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY 
TIMM8A	MOHR-TRANEBJAERG SYNDROME 
TIMM8A	OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA 
TIMP3	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY 
TINF2	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1 
TINF2	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3 
TINF2	REVESZ SYNDROME 
TIRAP	BACTEREMIA, SUSCEPTIBILITY TO, 1 
TIRAP	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1 
TIRAP	MALARIA, SUSCEPTIBILITY TO 
TIRAP	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
TJP2	HYPERCHOLANEMIA, FAMILIAL 
TK2	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE) 
TK2	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE) 
TKT	WERNICKE-KORSAKOFFSYNDROME
TLL1	ATRIAL SEPTAL DEFECT 6 
TLR1	LEPROSY, SUSCEPTIBILITY TO, 3 
TLR1	LEPROSY, SUSCEPTIBILITY TO, 5 
TLR2	COLORECTAL CANCER 
TLR2	LEPROSY, SUSCEPTIBILITY TO, 3 
TLR3	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2 
TLR3	MACULAR DEGENERATION, AGE-RELATED, 1 
TLR4	COLORECTAL CANCER 
TLR4	LONGEVITY1
TLR4	MACULAR DEGENERATION, AGE-RELATED, 10 
TLR5	AUTOIMMUNE DISEASE 
TLR5	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO 
TLR5	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1 
TMC1	DEAFNESS, AUTOSOMAL DOMINANT 36 
TMC1	DEAFNESS, AUTOSOMAL RECESSIVE 7 
TMC6	EPIDERMODYSPLASIA VERRUCIFORMIS 
TMC8	EPIDERMODYSPLASIA VERRUCIFORMIS 
TMCO1	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION 
TMEM126A	OPTIC ATROPHY 7 
TMEM127	PHEOCHROMOCYTOMA 
TMEM216	JOUBERT SYNDROME 2 
TMEM216	MECKEL SYNDROME, TYPE 2 
TMEM43	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5 
TMEM67	BARDET-BIEDL SYNDROME 
TMEM67	COACH SYNDROME 
TMEM67	JOUBERT SYNDROME 6 
TMEM67	MECKEL SYNDROME, TYPE 3 
TMEM67	NEPHRONOPHTHISIS 11 
TMEM70	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1 
TMEM70	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2 
TMIE	DEAFNESS, AUTOSOMAL RECESSIVE 6 
TMPO	CARDIOMYOPATHY, DILATED, 1T 
TMPRSS15	ENTEROKINASE DEFICIENCY 
TMPRSS3	DEAFNESS, AUTOSOMAL RECESSIVE 10 
TMPRSS3	DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8 
TMPRSS6	IRON-REFRACTORY IRON DEFICIENCY ANEMIA 
TNF	ASTHMA, SUSCEPTIBILITY TO 
TNF	HEPATITIS B VIRUS, SUSCEPTIBILITY TO 
TNF	MALARIA, SUSCEPTIBILITY TO 
TNF	MIGRAINEWITHORWITHOUTAURA,SUSCEPTIBILITYTO,1
TNF	PLASMODIUMFALCIPARUMBLOODINFECTIONLEVEL
TNF	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO 
TNFRSF10B	SQUAMOUS CELL CARCINOMA, HEAD AND NECK 
TNFRSF11A	OSTEOGENIC SARCOMA 
TNFRSF11A	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7 
TNFRSF11A	PAGET DISEASE OF BONE 
TNFRSF11A	POLYOSTOTIC OSTEOLYTIC DYSPLASIA, HEREDITARY EXPANSILE 
TNFRSF11B	PAGET DISEASE, JUVENILE 
TNFRSF13B	IMMUNODEFICIENCY, COMMON VARIABLE, 2 
TNFRSF13B	IMMUNOGLOBULIN A DEFICIENCY 2 
TNFRSF13C	IMMUNODEFICIENCY, COMMON VARIABLE, 4 
TNFRSF1A	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT 
TNFSF11	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2 
TNFSF4	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO 
TNFSF4	SYSTEMIC LUPUS ERYTHEMATOSUS 
TNNC1	CARDIOMYOPATHY, DILATED, 1Z 
TNNC1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 
TNNC1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13 
TNNI2	ARTHROGRYPOSIS, DISTAL, TYPE 2B 
TNNI3	CARDIOMYOPATHY, DILATED, 1FF 
TNNI3	CARDIOMYOPATHY, DILATED, 2A 
TNNI3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7 
TNNI3	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 
TNNT1	NEMALINE MYOPATHY 5 
TNNT2	CARDIOMYOPATHY, DILATED, 1D 
TNNT2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2 
TNNT2	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3 
TNNT3	ARTHROGRYPOSIS, DISTAL, TYPE 2B 
TNXB	EHLERS-DANLOS SYNDROME, TYPE III 
TNXB	EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY 
TOPORS	RETINITIS PIGMENTOSA 31 
TOR1A	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT 
TOR1A	MYOCLONIC DYSTONIA 
TP53	ADRENOCORTICAL CARCINOMA, HEREDITARY 
TP53	BREAST CANCER 
TP53	COLORECTAL CANCER 
TP53	ESOPHAGEAL CANCER 
TP53	HEPATOCELLULAR CARCINOMA 
TP53	LI-FRAUMENI SYNDROME 1 
TP53	LUNG CANCER 
TP53	NASOPHARYNGEALCARCINOMA
TP53	NASOPHARYNGEALCARCINOMA,SUSCEPTIBILITYTO,2
TP53	OSTEOGENIC SARCOMA 
TP53	PANCREATIC CANCER 
TP53	PAPILLOMA OF CHOROID PLEXUS 
TP53	SQUAMOUS CELL CARCINOMA, HEAD AND NECK 
TP63	ADULT SYNDROME 
TP63	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE 
TP63	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 
TP63	LIMB-MAMMARY SYNDROME 
TP63	RAPP-HODGKIN SYNDROME 
TP63	SPLIT-HAND/FOOT MALFORMATION 4 
TPCN2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10 
TPH2	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7 
TPH2	MAJOR DEPRESSIVE DISORDER 
TPM1	CARDIOMYOPATHY, DILATED, 1Y 
TPM1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3 
TPM2	ARTHROGRYPOSIS, DISTAL, TYPE 1A 
TPM2	ARTHROGRYPOSIS, DISTAL, TYPE 2B 
TPM2	NEMALINE MYOPATHY 4 
TPM3	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION 
TPM3	NEMALINE MYOPATHY 1 
TPM3	THYROID CARCINOMA, PAPILLARY 
TPMT	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY 
TPO	THYROID DYSHORMONOGENESIS 2A 
TPP1	CEROID LIPOFUSCINOSIS, NEURONAL, 2 
TPR	THYROID CARCINOMA, PAPILLARY 
TPRN	DEAFNESS, AUTOSOMAL RECESSIVE 79 
TRAF3IP2	PSORIASIS SUSCEPTIBILITY 13 
TRAPPC2	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED 
TRAPPC2P1	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED 
TRAPPC9	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13 
TREH	TREHALASEDEFICIENCY
TREM2	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 
TREX1	AICARDI-GOUTIERES SYNDROME 1 
TREX1	CHILBLAIN LUPUS 1 
TREX1	SYSTEMIC LUPUS ERYTHEMATOSUS 
TREX1	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY 
TRH	THYROTROPIN-RELEASINGHORMONEDEFICIENCY
TRIM24	THYROID CARCINOMA, PAPILLARY 
TRIM27	THYROID CARCINOMA, PAPILLARY 
TRIM32	BARDET-BIEDL SYNDROME 
TRIM32	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H 
TRIM33	THYROID CARCINOMA, PAPILLARY 
TRIM37	MULIBREY NANISM 
TRIOBP	DEAFNESS, AUTOSOMAL RECESSIVE 28 
TRIP11	ACHONDROGENESIS, TYPE IA 
TRMU	DEAFNESS, AMINOGLYCOSIDE-INDUCED 
TRMU	LIVER FAILURE, INFANTILE, TRANSIENT 
TRPC6	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 
TRPM1	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C 
TRPM4	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB 
TRPM6	HYPOMAGNESEMIA 1, INTESTINAL 
TRPM7	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1 
TRPS1	TRICHORHINOPHALANGEAL SYNDROME, TYPE I 
TRPS1	TRICHORHINOPHALANGEAL SYNDROME, TYPE II 
TRPS1	TRICHORHINOPHALANGEAL SYNDROME, TYPE III 
TRPV4	BRACHYOLMIA TYPE 3 
TRPV4	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC 
TRPV4	METATROPIC DYSPLASIA 
TRPV4	PARASTREMMATIC DWARFISM 
TRPV4	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY 
TRPV4	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1 
TRPV4	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE 
TRPV4	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE 
TRPV4	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE 
TSC1	FOCAL CORTICAL DYSPLASIA OF TAYLOR 
TSC1	LYMPHANGIOLEIOMYOMATOSIS 
TSC1	TUBEROUS SCLEROSIS 1 
TSC2	LYMPHANGIOLEIOMYOMATOSIS 
TSC2	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS 
TSC2	TUBEROUS SCLEROSIS 1 
TSC2	TUBEROUS SCLEROSIS 2 
TSEN2	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B 
TSEN34	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C 
TSEN54	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A 
TSEN54	PONTOCEREBELLAR HYPOPLASIA, TYPE 4 
TSFM	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 
TSG101	BREAST CANCER 
TSHB	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4 
TSHR	HYPERTHYROIDISM, FAMILIAL GESTATIONAL 
TSHR	HYPERTHYROIDISM, NONAUTOIMMUNE 
TSHR	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1 
TSPAN12	EXUDATIVE VITREORETINOPATHY 5 
TSPAN7	MENTAL RETARDATION, X-LINKED 58 
TSPYL1	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME 
TTBK2	SPINOCEREBELLAR ATAXIA 11 
TTC19	MITOCHONDRIAL COMPLEX III DEFICIENCY 
TTC21B	ASPHYXIATING THORACIC DYSTROPHY 4 
TTC21B	BARDET-BIEDL SYNDROME 
TTC21B	JOUBERT SYNDROME 
TTC21B	NEPHRONOPHTHISIS 12 
TTC37	TRICHOHEPATOENTERICSYNDROME
TTC8	BARDET-BIEDL SYNDROME 
TTC8	RETINITIS PIGMENTOSA 51 
TTN	CARDIOMYOPATHY, DILATED, 1G 
TTN	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9 
TTN	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE 
TTN	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J 
TTN	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY 
TTN	TIBIAL MUSCULAR DYSTROPHY, TARDIVE 
TTPA	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF 
TTR	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED 
TTR	CARPAL TUNNEL SYNDROME 
TTR	DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA 
TUBA1A	LISSENCEPHALY 3 
TUBA8	POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA 
TUBB1	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED 
TUBB2B	POLYMICROGYRIA, ASYMMETRIC 
TUBB3	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 
TUBB3	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR 
TUBB3	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC 
TUBB3	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5 
TUBB3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 
TUFM	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4 
TULP1	LEBER CONGENITAL AMAUROSIS 15 
TULP1	RETINITIS PIGMENTOSA 14 
TUSC3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7 
TUSC3	PROSTATE CANCER 
TWIST1	CRANIOSYNOSTOSIS, TYPE 1 
TWIST1	ROBINOW-SORAUF SYNDROME 
TWIST1	SAETHRE-CHOTZEN SYNDROME 
TWIST2	SETLEIS SYNDROME 
TXNDC3	CILIARY DYSKINESIA, PRIMARY, 6 
TYK2	TYROSINE KINASE 2 DEFICIENCY 
TYMP	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE) 
TYR	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS 
TYR	ALBINISM, OCULOCUTANEOUS, TYPE IA 
TYR	ALBINISM, OCULOCUTANEOUS, TYPE IB 
TYR	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3 
TYROBP	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 
TYRP1	ALBINISM, OCULOCUTANEOUS, TYPE III 
UBA1	SPINAL MUSCULAR ATROPHY, X-LINKED 2 
UBB	CLEFT PALATE, ISOLATED 
UBE2A	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE 
UBE3A	ANGELMAN SYNDROME 
UBIAD1	CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER 
UBQLN2	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 
UBR1	JOHANSON-BLIZZARD SYNDROME 
UCHL1	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT 
UCHL1	PARKINSON DISEASE, LATE-ONSET 
UCP1	OBESITY 
UCP2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4 
UCP2	BODYMASSINDEX
UCP2	OBESITY 
UCP3	OBESITY 
UGT1A1	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A1	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A1	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A1	GILBERT SYNDROME 
UGT1A1	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A10	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A10	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A10	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A10	GILBERT SYNDROME 
UGT1A10	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A3	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A3	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A3	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A3	GILBERT SYNDROME 
UGT1A3	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A4	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A4	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A4	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A4	GILBERT SYNDROME 
UGT1A4	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A5	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A5	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A5	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A5	GILBERT SYNDROME 
UGT1A5	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A6	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A6	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A6	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A6	GILBERT SYNDROME 
UGT1A6	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A7	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A7	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A7	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A7	GILBERT SYNDROME 
UGT1A7	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A8	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A8	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A8	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A8	GILBERT SYNDROME 
UGT1A8	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT1A9	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 
UGT1A9	CRIGLER-NAJJAR SYNDROME, TYPE I 
UGT1A9	CRIGLER-NAJJAR SYNDROME, TYPE II 
UGT1A9	GILBERT SYNDROME 
UGT1A9	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL 
UGT2B17	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12 
UMOD	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA 
UMOD	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1 
UMOD	MEDULLARY CYSTIC KIDNEY DISEASE 2 
UMPS	OROTIC ACIDURIA 
UNC13D	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3 
UNC93B1	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1 
UNG	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5 
UPB1	BETA-UREIDOPROPIONASE DEFICIENCY 
UPF3B	LUJAN-FRYNS SYNDROME 
UPF3B	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14 
UPK3A	RENAL ADYSPLASIA 
UQCC	STATUREQUANTITATIVETRAITLOCUS14
UQCRB	MITOCHONDRIAL COMPLEX III DEFICIENCY 
UQCRQ	MITOCHONDRIAL COMPLEX III DEFICIENCY 
UROC1	UROCANASE DEFICIENCY 
UROD	PORPHYRIA CUTANEA TARDA 
UROS	PORPHYRIA, CONGENITAL ERYTHROPOIETIC 
USF1	HYPERLIPIDEMIA, COMBINED, 1 
USF1	HYPERLIPIDEMIA, FAMILIAL COMBINED 
USH1C	DEAFNESS, AUTOSOMAL RECESSIVE 18 
USH1C	USHER SYNDROME, TYPE I 
USH1C	USHER SYNDROME, TYPE IC 
USH1G	USHER SYNDROME, TYPE I 
USH1G	USHER SYNDROME, TYPE IG 
USH2A	RETINITIS PIGMENTOSA 
USH2A	RETINITIS PIGMENTOSA 39 
USH2A	USHER SYNDROME, TYPE IIA 
USP9Y	SPERMATOGENIC FAILURE, Y-LINKED, 2 
VANGL1	NEURAL TUBE DEFECTS 
VANGL1	SACRAL DEFECT WITH ANTERIOR MENINGOCELE 
VAPB	AMYOTROPHIC LATERAL SCLEROSIS 8 
VAPB	SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT 
VCAN	WAGNER SYNDROME 1 
VCL	CARDIOMYOPATHY, DILATED, 1W 
VCL	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15 
VCP	AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 
VCP	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL 
VDR	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO 
VDR	OSTEOPOROSIS 
VDR	VITAMIN D-DEPENDENT RICKETS, TYPE 2A 
VEGFA	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
VEGFA	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1 
VHL	ERYTHROCYTOSIS, FAMILIAL, 2 
VHL	PHEOCHROMOCYTOMA 
VHL	RENAL CELL CARCINOMA, NONPAPILLARY 
VHL	VON HIPPEL-LINDAU SYNDROME 
VIPR2	SCHIZOPHRENIA 16 
VKORC1	COUMARIN RESISTANCE 
VKORC1	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2 
VLDLR	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 
VMA21	MYOPATHY,X-LINKED,WITHEXCESSIVEAUTOPHAGY
VPS13A	CHOREOACANTHOCYTOSIS 
VPS13B	COHEN SYNDROME 
VPS33B	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1 
VPS35	PARKINSON DISEASE 17 
VRK1	PONTOCEREBELLAR HYPOPLASIA, TYPE 1 
VSX1	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1 
VSX1	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME 
VSX1	KERATOCONUS 1 
VSX2	MICROPHTHALMIA, ISOLATED 2 
VSX2	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3 
VWF	VON WILLEBRAND DISEASE, TYPE 1 
VWF	VON WILLEBRAND DISEASE, TYPE 2 
VWF	VON WILLEBRAND DISEASE, TYPE 3 
WAS	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED 
WAS	THROMBOCYTOPENIA 1 
WAS	WISKOTT-ALDRICH SYNDROME 
WBSCR16	WILLIAMS-BEUREN SYNDROME 
WBSCR22	WILLIAMS-BEUREN SYNDROME 
WBSCR27	WILLIAMS-BEUREN SYNDROME 
WDPCP	BARDET-BIEDL SYNDROME 
WDR11	GLIOMA SUSCEPTIBILITY 1 
WDR19	ASPHYXIATING THORACIC DYSTROPHY 5 
WDR19	CRANIOECTODERMAL DYSPLASIA 4 
WDR19	NEPHRONOPHTHISIS 13 
WDR35	CRANIOECTODERMAL DYSPLASIA 2 
WDR35	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III 
WDR35	SHORT RIB-POLYDACTYLY SYNDROME, TYPE V 
WDR36	GLAUCOMA 1, OPEN ANGLE, G 
WDR36	GLAUCOMA, PRIMARY OPEN ANGLE 
WDR62	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL 
WDR62	PACHYGYRIAWITHMENTALRETARDATION,SEIZURES,ANDARACHNOIDCYSTS
WDR65	VAN DER WOUDE SYNDROME 2 
WDR72	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3 
WFS1	DEAFNESS, AUTOSOMAL DOMINANT 6 
WFS1	DIABETES MELLITUS, NONINSULIN-DEPENDENT 
WFS1	WOLFRAM SYNDROME 1 
WFS1	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT 
WHSC1	WOLF-HIRSCHHORN SYNDROME 
WHSC1L1	LEUKEMIA, ACUTE MYELOID 
WHSC2	WOLF-HIRSCHHORN SYNDROME 
WISP3	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD 
WNK1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA 
WNK1	PSEUDOHYPOALDOSTERONISM, TYPE II 
WNK4	PSEUDOHYPOALDOSTERONISM, TYPE II 
WNT10A	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE 
WNT10A	ODONTOONYCHODERMAL DYSPLASIA 
WNT10A	SCHOPF-SCHULZ-PASSARGE SYNDROME 
WNT10A	TOOTH AGENESIS, SELECTIVE, 4 
WNT10B	SPLIT-HAND/FOOT MALFORMATION 6 
WNT3	TETRAAMELIA, AUTOSOMAL RECESSIVE 
WNT4	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS 
WNT4	MAYER-ROKITANSKY-KUSTER-HAUSERSYNDROME
WNT4	MULLERIAN APLASIA AND HYPERANDROGENISM 
WNT5A	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 
WNT7A	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND 
WNT7A	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY 
WRAP53	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3 
WRN	COLORECTAL CANCER 
WRN	WERNER SYNDROME 
WT1	DENYS-DRASH SYNDROME 
WT1	FRASIER SYNDROME 
WT1	MEACHAM SYNDROME 
WT1	MESOTHELIOMA, MALIGNANT 
WT1	NEPHROTIC SYNDROME, TYPE 4 
WT1	WILMS TUMOR 1 
WT1	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION 
WWOX	ESOPHAGEAL CANCER 
XBP1	MAJOR AFFECTIVE DISORDER 7 
XBP1	MAJORAFFECTIVEDISORDER1
XDH	XANTHINURIA, TYPE I 
XIAP	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2 
XK	MCLEOD SYNDROME 
XPA	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A 
XPC	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C 
XPNPEP3	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1 
XRCC3	BREAST CANCER 
XRCC3	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6 
XYLT1	PSEUDOXANTHOMA ELASTICUM 
XYLT2	PSEUDOXANTHOMA ELASTICUM 
YARS	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C 
YARS2	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2 
YTHDF2	LONGEVITY1
YWHAE	CHROMOSOME 17p13.3 DUPLICATION SYNDROME 
YWHAE	MILLER-DIEKER LISSENCEPHALY SYNDROME 
ZBTB16	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION 
ZBTB24	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 
ZBTB38	STATUREQUANTITATIVETRAITLOCUS10
ZDHHC15	MENTAL RETARDATION, X-LINKED 91 
ZDHHC9	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE 
ZEB1	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6 
ZEB1	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3 
ZEB2	MOWAT-WILSON SYNDROME 
ZFAT	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3 
ZFHX3	PROSTATE CANCER 
ZFHX4	PTOSIS,HEREDITARYCONGENITAL1
ZFP57	DIABETES MELLITUS, TRANSIENT NEONATAL, 1 
ZFP90	3-@METHYLGLUTACONIC ACIDURIA, TYPE III 
ZFPM2	DIAPHRAGMATIC HERNIA 3 
ZFPM2	TETRALOGY OF FALLOT 
ZFYVE26	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE 
ZFYVE27	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT 
ZIC1	DANDY-WALKERSYNDROME
ZIC2	HOLOPROSENCEPHALY 5 
ZIC3	HETEROTAXY, VISCERAL, 1, X-LINKED 
ZIC3	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS 
ZIC4	DANDY-WALKERSYNDROME
ZMPSTE24	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY 
ZMPSTE24	RESTRICTIVE DERMOPATHY, LETHAL 
ZNF365	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO 
ZNF41	MENTAL RETARDATION, X-LINKED 89 
ZNF469	BRITTLE CORNEA SYNDROME 1 
ZNF513	RETINITIS PIGMENTOSA 58 
ZNF592	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5 
ZNF644	MYOPIA 21, AUTOSOMAL DOMINANT 
ZNF674	MENTAL RETARDATION, X-LINKED 92 
ZNF711	MENTAL RETARDATION, X-LINKED 97 
ZNF750	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS 
ZNF81	MENTAL RETARDATION, X-LINKED 45 
